{"query": "In Arabian horses, severe combined immunodeficiency (SCID) is inherited in an autosomal recessive pattern. Describe the expected clinical outcome for homozygous affected foals versus heterozygous carriers, and explain how DNA testing can be used in breeding decisions to reduce the incidence of SCID.", "response": "Rubric (Total Score: 1.0 point; Minimum: 0 points)  \n- 0.4 points: Correctly states that homozygous foals are affected/fatal—born lacking an immune system and typically die from opportunistic infections within about 3 months.  \n- 0.4 points: Correctly states that heterozygous carriers are clinically asymptomatic (healthy) but carry the mutation.  \n- 0.2 points: Correctly explains that DNA testing identifies carriers so breeders can avoid carrier-to-carrier matings (or otherwise plan matings) to minimize affected foals.  \n\nDeductions (maximum −0.25 points):  \n- Deduct 0.05–0.25 points for excessive irrelevant material (e.g., long discussions of unrelated equine diseases, detailed immunology beyond what is needed) that obscures the required points."}
{"query": "Ovine babesiosis is a hemolytic disease in small ruminants transmitted by ixodid ticks. Identify the most pathogenic Babesia species implicated in ovine babesiosis and name the tick genus that generally transmits it; additionally, list four common clinical signs of the infection.", "response": "Rubric (Total = 1.0 point; Minimum = 0 points):  \n- **0.4 points:** Correctly identifies **Babesia ovis** as the most pathogenic species.  \n- **0.2 points:** Correctly names **Rhipicephalus** as the tick genus that generally transmits it.  \n- **0.4 points:** Lists **any four** of the following clinical signs: **fever, hemoglobinuria, anemia, anorexia, weakness, jaundice, death**. (0.1 each up to 0.4)\n\nDeductions (max 0.25 points):  \n- Deduct **0.05–0.25** if the response includes substantial irrelevant or speculative content beyond what is asked (severity-based).  \n- Final score cannot go below **0**."}
{"query": "Explain how Sertoli cells simultaneously promote spermatogenesis and protect developing haploid germ cells from immune attack, and predict how a reduced Sertoli cell population during testicular development would be expected to affect adult sperm output and testicular size.", "response": "Rubric (Total = 1.0 point; Min = 0 points):  \n- (0.4 points) Spermatogenesis support role: States that Sertoli cells nourish/support developing germ cells and that this support is necessary for normal spermatogenesis.  \n- (0.4 points) Immune protection mechanism: States that Sertoli cells form the blood-testis barrier via tight junctions, which protects haploid germ cells from the innate immune system.  \n- (0.2 points) Developmental consequence prediction: Predicts that fewer Sertoli cells leads to lower adult sperm production capacity and smaller testicular size (both outcomes must be mentioned for full credit on this point).  \n\nDeductions (maximum total deduction = 0.25 points):  \n- Deduct 0.1–0.25 points if the response includes substantial irrelevant material (e.g., detailed discussion of unrelated testicular cell types, hormones, or immune pathways not necessary to answer the question), with the deduction scaled to how much it obscures or replaces the required points.  \n- Final score cannot be below 0."}
{"query": "Explain how circular RNAs (circRNAs) can regulate adipocyte differentiation through a competing endogenous RNA (ceRNA) mechanism, and illustrate the mechanism with two specific examples by naming the circRNA, the miRNA it sponges/binds, and the reported effect on adipocyte differentiation.", "response": "Rubric (Total Score: 1.0 point; Minimum: 0.0 points):  \n- (0.4 points) Correctly explains the ceRNA mechanism for circRNAs in adipocyte differentiation: circRNA acts as a “sponge”/binder for miRNA, reducing miRNA availability and thereby modulating downstream gene regulation that affects differentiation.  \n- (0.3 points) Example 1 is fully correct: circFUT10 sponges let-7 and inhibits adipocyte differentiation (all three elements: circRNA, miRNA, effect).  \n- (0.3 points) Example 2 is fully correct: circPPARγ binds miR-92a-3p and facilitates adipocyte differentiation (all three elements: circRNA, miRNA, effect).  \n\nDeductions (max 0.25 points; final score not below 0):  \n- Deduct 0.05–0.25 points for excessive irrelevant content that goes beyond what is asked (e.g., lengthy discussion of unrelated circRNA roles in cancer or lipid metabolism without tying to the requested ceRNA mechanism and the two specified examples)."}
{"query": "Explain why long-term control of ovine Johne’s disease (OJD) with Gudair® vaccination can still be at risk even when clinical cases become rare, and identify two distinct negative consequences that may result if farmers reduce or cease vaccination.", "response": "Rubric (Total Score: 1.0 point; Minimum: 0 points)  \n- 0.5 points: States the core reason control can remain at risk despite few clinical cases: vaccinated flocks may still have animals that shed *Mycobacterium avium* subspecies *paratuberculosis* (Mptb) in faeces (i.e., vaccination reduces clinical disease but does not necessarily eliminate infection/shedding; risk of resurgence if vaccination stops).  \n- 0.25 points: Correctly identifies one consequence of reduced/ceased vaccination: increased risk of OJD resurgence/re-emergence on the farm due to ongoing Mptb shedding and delayed onset masking infection.  \n- 0.25 points: Correctly identifies a second, distinct consequence: broader loss of control beyond the individual farm (jeopardizing regional/national control) and/or compromised disease management for producers.\n\nDeductions (Max 0.25 points; final score not below 0):  \n- Deduct 0.05–0.25 points for excessive irrelevant content that obscures the required points (e.g., lengthy unrelated vaccine manufacturing details or unrelated diseases)."}
{"query": "In ovine footrot, explain how *Dichelobacter nodosus* serogroup diversity and virulence classification complicate immunity and disease control, including (i) the number of serogroups and their cross-protection status, (ii) the possibility of multiple serogroups infecting a single foot, and (iii) the molecular basis used to categorize strains as virulent versus benign.", "response": "Rubric (Total Score: 1.0 Point; Max deduction for excess irrelevant content: 0.25 Point):  \n- **Serogroups and cross-protection (0.4 points):**  \n  - 0.2 points: States there are **10 serogroups** of *D. nodosus*.  \n  - 0.2 points: States **no cross-protection** occurs between serogroups (i.e., different host antigens with no cross protection).  \n- **Co-infection on a foot (0.2 points):**  \n  - 0.2 points: States **several serogroups can be present on a single foot**.  \n- **Virulence classification basis (0.4 points):**  \n  - 0.4 points: States strains are categorized as **virulent vs benign based on the amino acid sequence of an extracellular protease**.  \n\n**Deductions (up to -0.25 points):**  \n- Deduct **0.05–0.25** for adding substantial irrelevant material not asked for (e.g., detailed descriptions of studies’ geographic findings, extensive discussion of unrelated microbes/community research) depending on severity.  \n- Final score floor: **0 points**."}
{"query": "Explain the key mechanical and biochemical mechanisms that establish functional residual capacity (FRC) during the first breaths after birth, and describe how these initial ventilatory events simultaneously promote increased pulmonary blood flow.", "response": "Rubric (Total Score: 1.0 Point; Minimum: 0 Points)\n\nScoring points (award up to 1.0 total):\n- 0.35 points: States that strong initial inspiratory efforts generate a large negative intrathoracic pressure (≈ −90 cmH₂O) that creates an airway pressure gradient driving air into liquid-filled lungs, opening alveoli and aiding liquid movement across the alveolar epithelium.\n- 0.25 points: Identifies repetitive active expiratory laryngeal closure as a mechanism for air-stacking that helps maintain end-expiratory air volume (FRC).\n- 0.20 points: Explains surfactant’s role in lowering distal airway surface tension, reducing elastic recoil, and decreasing expiratory emptying, thereby supporting FRC.\n- 0.20 points: Describes that lung inflation/ventilation increases pulmonary blood flow via pulmonary endothelial release of vasodilators nitric oxide (NO) and prostacyclin, enabling effective alveolar-capillary gas exchange.\n\nDeductions (max 0.25 points):\n- Deduct 0.05–0.25 points for excessive irrelevant content that is not needed to answer the question (e.g., unrelated neonatal conditions, unrelated cardiovascular shunts, detailed clinical management steps).  \n- Final score cannot be below 0."}
{"query": "Explain two major sources of complexity in the milk allergenome and describe how genetic polymorphisms and post-translational modifications can alter milk proteins in ways that may change their allergenicity, including at least two specific functional properties that can be affected.", "response": "Rubric (Total Score: 1.0 point; Minimum: 0 points)\n\n- Sources of complexity (0.4 points total)  \n  - 0.2: Identifies genetic polymorphisms across individuals/breeds as a source of complexity (e.g., different variants of caseins or whey proteins).  \n  - 0.2: Identifies post-translational modifications as a source of complexity.\n\n- Mechanisms linking changes to allergenicity (0.4 points total)  \n  - 0.2: Explains that polymorphisms can change amino-acid sequence and/or cause deletion of peptide fragments, affecting protein structure/function and potentially allergenicity.  \n  - 0.2: Explains that post-translational modifications (must name at least one: glycosylation, phosphorylation, acetylation, proteolytic cleavage) can change protein structure/function and potentially allergenicity.\n\n- Functional properties affected (0.2 points total)  \n  - 0.2: Correctly names at least two affected functional properties from: micelle stability, solubility, digestibility.\n\nDeductions (max 0.25 points)  \n- Deduct 0.05–0.25 for excessive irrelevant content that is not responsive (e.g., extended discussion of unrelated allergy epidemiology or non-milk allergens). Maximum total deduction is 0.25, and the final score cannot go below 0."}
{"query": "In an animal model of high-fat-diet–induced metabolic dysfunction, what metabolic and tissue-level changes are expected when goat’s milk is added to the diet, and what is the estimated equivalent daily intake for a 60-kg adult human when scaled by body-surface-area normalization?", "response": "Rubric (Total = 1.0 point; Minimum = 0.0 points):  \n- **0.75 points:** Correctly states the key expected changes with goat’s milk supplementation (must include at least **three** of the following, in substance):  \n  1) decreased body weight and/or body fat mass;  \n  2) improved glucose tolerance;  \n  3) prevention of adipose tissue hypertrophy;  \n  4) prevention of hepatic steatosis;  \n  5) increased energy expenditure;  \n  6) increased/augmented oxidative muscle fibers;  \n  7) reduced inflammatory markers.  \n- **0.25 points:** Correctly gives the human-equivalent intake estimate: **~1.4 to 2.8 glasses/day**, where **1 glass = 250 mL**, for a **60-kg adult**.  \n\nDeductions (max 0.25 points):  \n- Deduct **0.05–0.25** for excessive irrelevant content that goes beyond answering the question (e.g., extended discussion of goat feed types or lists of bioactive compounds without tying to the asked outcomes).  \n- Final score floor: **0.0 points**."}
{"query": "Explain why drug detection times (DTs) in horses derived from classic pharmacokinetic studies at rest may not generalize to field conditions during training, and identify two specific exercise-related physiological changes (one hepatic and one renal) that could plausibly alter drug clearance, including the direction of change for each.", "response": "Rubric (Total = 1.0 point; Minimum = 0.0):  \n- 0.5 points: States the core rationale that DTs from resting, laboratory pharmacokinetic studies may differ in real training/exercise conditions because exercise can change drug disposition/elimination (e.g., via cardiovascular/organ function changes affecting clearance), leading to different DTs than at rest.  \n- 0.25 points: Correct hepatic change and implication: hepatic blood flow decreases during submaximal exercise, which can decrease hepatic clearance for drugs with high hepatic extraction.  \n- 0.25 points: Correct renal change and implication: glomerular filtration rate (GFR) decreases (reported >40% during mild exercise in humans), which would tend to reduce renal clearance.  \n\nDeductions (max 0.25 points):  \n- Deduct 0.1–0.25 points for substantial irrelevant additions that go beyond the asked elements (e.g., extended discussion of specific drug studies or detailed mechanisms not needed), proportional to severity. Final score cannot go below 0.0."}
{"query": "Describe the etiological agent responsible for peste des petits ruminants (PPR) by naming the virus and stating its taxonomic placement (genus and family), and summarize the typical outbreak infection rate and the approximate case fatality rates in goats versus sheep.", "response": "Rubric (Total = 1.0 point; Minimum = 0.0):  \n- **Virus identification and taxonomy (0.5 points total):**  \n  - **0.25**: Correctly names the etiological agent as **small ruminant morbillivirus (SRMV)**.  \n  - **0.25**: Correctly states **Morbillivirus** as the genus and **Paramyxoviridae** as the family.  \n\n- **Epidemiologic severity metrics (0.5 points total):**  \n  - **0.20**: States outbreak infection rates are typically **high, about 50–90% (or above 50–90%)** in endemic areas.  \n  - **0.20**: States case fatality in **goats is about 55–85%**.  \n  - **0.10**: States case fatality in **sheep is less than ~10%**.  \n\n- **Deductions for excessive/irrelevant content (max −0.25):**  \n  - Deduct **0.05–0.25** if substantial extraneous material is added (e.g., lengthy clinical signs, treatment protocols, unrelated virology) that is not asked and obscures the required points.  \n  - Total score cannot fall below **0.0**."}
{"query": "Why can histopathological examination alone fail to reliably distinguish *Neospora caninum* infection from *Toxoplasma gondii* infection in cases of ovine abortion, and what additional evidence supports the possibility that *N. caninum* can cause clinical disease in adult sheep?", "response": "Rubric (Total Score: 1.0 point; Minimum: 0 points)\n\n- Similarity limiting histopathology (0.5 points)  \n  - 0.5: States that *N. caninum* and *T. gondii* are morphologically similar and induce similar lesions, so histopathology cannot accurately differentiate them.  \n  - 0.0: Does not mention both morphological and lesion similarity as the reason histopathology cannot distinguish them.\n\n- Supporting evidence for adult-sheep clinical disease (0.5 points)  \n  - 0.5: Identifies evidence that *N. caninum* DNA was detected in the brain of an adult ewe with encephalitis, supporting that it may cause clinical neosporosis in adult sheep.  \n  - 0.0: Fails to cite DNA detection in the brain of a ewe with encephalitis (or gives incorrect/irrelevant evidence).\n\nDeductions for excessive irrelevant content (max 0.25 points)  \n- Deduct up to 0.25 if the answer includes substantial off-topic material (e.g., extensive discussion of global prevalence, cattle economics, or general reproductive failure causes) that is not needed to address the two required elements.  \n- Final score cannot be below 0."}
{"query": "Design an integrated, field-practical control program for haemonchosis in sheep caused by *Haemonchus contortus* that addresses (i) why blanket anthelmintic treatment is no longer sufficient, and (ii) which complementary management and genetic strategies should be combined to reduce parasite impact while limiting further drug resistance.", "response": "Rubric (Total = 1.0 point; Minimum = 0.0 point):  \n- 0.25 points: Explains why indiscriminate/blanket anthelmintic use is insufficient by correctly stating it has led to widespread drug resistance against most conventional anthelmintics.  \n- 0.25 points: Identifies targeted selective treatment (TST) as a core control element (treat selected animals rather than the whole flock).  \n- 0.25 points: Specifies at least two correct complementary strategies from the following list (0.125 each, max 0.25): selective breeding for resistance, culling more susceptible animals, maintaining good body condition score via a balanced diet.  \n- 0.25 points: Demonstrates integrated reasoning by explicitly linking the combined approach (TST + breeding/culling + nutrition/body condition) to lowering production losses/parasite burden while reducing selection pressure for resistance (must mention both impact reduction and resistance-limitation).  \n\nDeductions (max 0.25 points):  \n- Deduct 0.10–0.25 points for excessive irrelevant content that is not asked for (e.g., detailed vaccine development history, extensive descriptions of medicinal plants or molecular tools without tying them to the requested practical program), proportional to severity.  \n- Final score cannot go below 0.0."}
{"query": "Explain how cationic host defence peptides (CHDP) are induced during an innate immune response and identify the two major CHDP families in humans along with at least four human cell types known to express these peptides.", "response": "Rubric (Total Score: 1.0 point; Minimum: 0.0 points):  \n- Induction mechanism (0.4 points total)  \n  - 0.2: States that infection is detected via recognition of pathogen-associated molecular patterns (PAMPs).  \n  - 0.2: States that PAMP recognition occurs through pattern recognition receptors (PRRs), specifically mentioning Toll-like receptors (TLRs) and/or NOD receptors (NOD-like receptors/NLRs), and that this leads to increased CHDP expression/release.  \n- Human CHDP families (0.3 points total)  \n  - 0.3: Correctly names both families: cathelicidins and defensins. (0.15 each; both required for full 0.3.)  \n- Cell types (0.3 points total)  \n  - 0.3: Correctly lists at least four of the following as CHDP-expressing cell types: neutrophils, macrophages, lymphocytes, eosinophils, epithelial cells, placental trophoblasts. (0.075 each up to 0.3.)  \n\nDeductions (max 0.25 points):  \n- Deduct 0.05–0.25 for excessive irrelevant content beyond what is needed (e.g., detailed biochemical mechanisms, extensive history of CHDP discovery, unrelated immune pathways). Deduction magnitude depends on severity. Final score cannot go below 0.0."}
{"query": "In small animal periodontal disease, distinguish gingivitis from periodontitis in terms of (1) reversibility, (2) the tissues primarily affected, and (3) the role of plaque microorganisms, including the significance of the genus *Porphyromonas*.", "response": "Rubric (Total Score: 1.0 Point; Min Score: 0.0 Points)\n\n- **Gingivitis vs. periodontitis—reversibility (0.3 points)**  \n  - 0.3: Correctly states gingivitis is the initial **reversible** stage (reversible with professional cleaning and home care) and periodontitis is a later stage with **inflammation-induced tissue destruction** (not described as reversible).  \n  - 0.0: Does not correctly distinguish reversibility/destruction.\n\n- **Tissues affected (0.4 points)**  \n  - 0.2: Correctly identifies gingivitis inflammation is restricted to the **gingiva**.  \n  - 0.2: Correctly identifies periodontitis affects deeper supporting structures: **periodontal ligament and alveolar bone**.  \n  - 0.0–0.3: Partial/unclear identification of tissues.\n\n- **Microbial/plaque role and *Porphyromonas* significance (0.3 points)**  \n  - 0.15: States gingivitis inflammation is initiated by **plaque bacteria** (and periodontitis is also caused by microorganisms).  \n  - 0.15: States *Porphyromonas* is a major periodontopathic genus in humans/companion animals and its numbers increase with plaque accumulation and are directly related to gingivitis development.  \n  - 0.0–0.2: Mentions bacteria/plaque but misses *Porphyromonas* relationship or misstates it.\n\n- **Deductions for excess irrelevant content (max −0.25 points)**  \n  - Deduct 0.05–0.25 if the response adds substantial unrelated material (e.g., detailed prevalence statistics, unrelated systemic effects, treatment regimens beyond “professional cleaning and home care”) that obscures the required distinctions.  \n  - Final score cannot be below 0.0."}
{"query": "Explain what makes scrapie a transmissible spongiform encephalopathy (TSE) by describing the core pathogenic molecular event involving prion proteins, and identify two other TSEs in different species; also state which host species scrapie is most commonly associated with and name the atypical form first identified in 1998.", "response": "Rubric (Total = 1.0 point; Minimum = 0.0 points):\n\n- Pathogenic molecular event (0.40 points)  \n  - 0.40: Clearly states that TSEs (including scrapie) involve accumulation of the abnormal prion isoform PrP^Sc derived from/converted from the normal cellular prion protein PrP^C (conversion/misfolding/abnormal isoform accumulation must be explicit).  \n  - 0.0: Does not mention PrP^Sc and PrP^C relationship/accumulation.\n\n- Two other TSEs in different species (0.25 points)  \n  - 0.125: Correctly names bovine spongiform encephalopathy (BSE).  \n  - 0.125: Correctly names human Creutzfeldt–Jakob disease (CJD).  \n  - 0.0: Names neither correctly.\n\n- Main host association (0.20 points)  \n  - 0.20: Correctly states scrapie is long known primarily in sheep (may also note goats are less frequent).  \n  - 0.0: Incorrect or missing host association.\n\n- Atypical form identified in 1998 (0.15 points)  \n  - 0.15: States that an atypical type of scrapie (atypical scrapie) was identified in sheep in 1998 and is distinct from classical scrapie.  \n  - 0.0: Does not identify atypical scrapie / confuses with classical only.\n\nDeductions for excessive irrelevant content (max deduction 0.25 points):  \n- Deduct 0.05–0.25 if the response adds substantial unrelated material (e.g., detailed clinical signs, control policies, unrelated prion diseases, or extensive history) that obscures the required points. Total score after deduction cannot go below 0.0."}
{"query": "Describe the cellular expression pattern and subcellular localization of amyloid precursor protein (APP) in the central nervous system, and explain two distinct ways in which APP is linked to physiological stress responses, including a mechanistic reason for its upregulation after neurotrauma.", "response": "Rubric (Total Score: 1.0 point; Minimum: 0 points)\n\n1) Expression pattern and CNS cell types (0.25 points)  \n- 0.25: States that APP is constitutively expressed and highly conserved, and that it is most abundantly expressed in CNS neurons and glia.  \n- 0: Missing/incorrect.\n\n2) Subcellular localization/trafficking (0.25 points)  \n- 0.25: Correctly identifies localization in neuronal somatodendritic and axonal compartments AND notes presence in the presynaptic zone, reached by fast axoplasmic transport.  \n- 0: Missing/incorrect.\n\n3) Stress-response role (0.25 points)  \n- 0.25: Identifies APP as an acute phase protein that promotes survival under metabolically challenging cellular stress, with at least two correct examples (e.g., ischaemia-hypoxia, traumatic brain injury, inflammation).  \n- 0: Missing/incorrect or fewer than two correct stress examples.\n\n4) Mechanistic basis for neurotrauma upregulation (0.25 points)  \n- 0.25: States that APP upregulation after neurotrauma is due to increased mRNA expression.  \n- 0: Missing/incorrect.\n\nDeductions for excess/irrelevant content (max 0.25 points)  \n- Deduct 0.05–0.25 if the response adds substantial unrelated material (e.g., unrelated APP processing pathways, Alzheimer’s pathology details, or non-CNS tissue expression claims) that is not needed to answer the question.  \n- Total score cannot go below 0."}
{"query": "In equine populations, how do the typical clinical manifestations and disease course of equine influenza A virus differ between immunologically naïve horses and primed horses, and what complication can increase mortality despite generally low fatality?", "response": "Rubric (Total = 1.0 point; Minimum = 0 points):  \n- **0.4 points:** Correctly describes clinical signs in **naïve** horses (must include at least three of: pyrexia/fever, lethargy, anorexia, harsh dry cough, serous nasal discharge).  \n- **0.3 points:** Correctly contrasts **primed** horses as having **milder signs and shorter duration** than naïve horses.  \n- **0.3 points:** Identifies **secondary bacterial infection** as the complication that can increase mortality, and characterizes it with at least one hallmark (mucopurulent nasal discharge and/or extended fever).  \n\nDeductions (max 0.25 points):  \n- Deduct **0.05–0.25 points** (severity-based) if the response adds substantial irrelevant material (e.g., extensive transmission-route discussion, numeric morbidity values, or aerosol distance) that is not needed to answer the question.  \n- Final score cannot be below **0 points**."}
{"query": "Goat pox can be hard to diagnose and can cause severe outbreaks in small ruminant production systems. Describe (i) the key clinical features and typical mortality/morbidity ranges, (ii) why serology is insufficient for differentiating it from sheep pox virus (SPPV) infection and what diagnostic approach can distinguish it, (iii) the major enzootic regions where it commonly occurs, and (iv) how virus strain and host breed influence disease severity, including which breeds tend to be more resistant.", "response": "Rubric (Total Score: 1.0 point; Minimum: 0.0 points)\n\n- Clinical features + impact (0.30 points)  \n  - 0.10: Mentions pyrexia (fever).  \n  - 0.10: Mentions generalized pock lesions with lymphadenopathy.  \n  - 0.10: Gives outbreak severity ranges: morbidity up to 100% and mortality about 50%–100%.  \n\n- Diagnosis and differentiation from SPPV (0.25 points)  \n  - 0.15: States goat pox is not distinguishable from SPPV serologically (serology cannot differentiate).  \n  - 0.10: Identifies molecular techniques as the way to diagnose/distinguish.  \n\n- Enzootic distribution (0.20 points)  \n  - 0.20: Correctly lists enzootic regions: Africa, the Middle East, and southern Asia.  \n\n- Determinants of severity / breed resistance (0.25 points)  \n  - 0.15: States severity depends on virus strain and host breed.  \n  - 0.10: States indigenous sheep/goat breeds are more resistant than European breeds.  \n\nDeductions for excess/irrelevant content (max 0.25 points)  \n- Deduct 0.05–0.25 if the response adds substantial unrelated information (e.g., extensive census figures, unrelated diseases, treatment protocols not asked for) that obscures the required points.  \n- Total score cannot go below 0.0."}
{"query": "Describe the infectious agent responsible for classical scrapie in sheep and goats, explaining the key molecular hallmark of infection (including the specific abnormal prion forms and their proteinase K property), and identify the main tissues in which the disease-associated prion progressively accumulates during infection.", "response": "Rubric (Total Score: 1.0 Point; Minimum: 0.0 Points)\n\n- Infectious agent identification (0.25 points)  \n  - 0.25: States that the transmissible agent is a prion.  \n  - 0.0: Does not identify a prion (or identifies a virus/bacterium/parasite).\n\n- Molecular hallmark: conversion event (0.25 points)  \n  - 0.25: Explains conversion of normal cellular prion protein into a misfolded disease-associated form.  \n  - 0.0: No conversion described or incorrect mechanism.\n\n- Molecular hallmark: named abnormal forms + proteinase K feature (0.30 points)  \n  - 0.15: Correctly names the misfolded form as PrP^Sc.  \n  - 0.15: States that it has a proteinase K–resistant core termed PrP^res (or explicitly notes proteinase K resistance of the core).  \n  - 0.0: Names are missing/incorrect and/or proteinase K resistance not mentioned.\n\n- Sites of progressive accumulation (0.20 points)  \n  - 0.10: Identifies peripheral lymphoid tissues as an accumulation site.  \n  - 0.10: Identifies the brain as an accumulation site.  \n  - 0.0: Incorrect tissues or only vague/unsupported locations.\n\nDeductions (Max 0.25 points)  \n- Deduct 0.05–0.25 for excessive irrelevant content that obscures the required points (e.g., long discussion of EU case counts, economics, or unrelated clinical signs).  \n- Total score cannot go below 0.0."}
{"query": "In equine biomechanics, identify the vertebral formula of the horse’s spinal column (give the number of vertebrae in each region), and specify which thoracolumbar segment is described as the most mobile.", "response": "Rubric (Total Score: 1.0 point; Minimum: 0 points)  \n- Vertebral formula (0.6 points total):  \n  - 0.1: States there are 7 cervical vertebrae.  \n  - 0.1: States there are 18 thoracic vertebrae.  \n  - 0.1: States there are 6 lumbar vertebrae.  \n  - 0.1: States there are 5 sacral vertebrae.  \n  - 0.2: States there are 15–21 coccygeal vertebrae (must be a range; “15 to 21” or equivalent).  \n- Most mobile thoracolumbar segment (0.4 points total):  \n  - 0.4: Identifies the most mobile area as between T14 and T18 (fourteenth to eighteenth thoracic vertebrae).  \n\nDeductions (maximum -0.25 points):  \n- Deduct 0.05 to 0.25 for excessive irrelevant content that is not asked for (e.g., extended discussion of visceral mass inertia, sports performance, or rider weight effects), depending on severity."}
{"query": "In a horse with peracute Clostridioides difficile colitis complicated by severe SIRS and concurrent renal compromise, which standard treatment classes are commonly used for C. difficile colitis/SIRS, and which specific components of these treatments may be limited due to nephrotoxicity? Include the reported case fatality rate range for this condition.", "response": "Rubric (Total Score: 1.0 Point; Minimum: 0.0 Points)\n\nScoring points (award up to 1.0 total):\n- 0.25 points: States the case fatality rate range as 37%–79%.\n- 0.25 points: Lists standard treatment classes used for C. difficile colitis and secondary severe SIRS in horses: NSAIDs, antimicrobials, anti-LPS therapy, and fluid therapy.\n- 0.25 points: Identifies NSAIDs as potentially nephrotoxic and therefore limited in horses with renal compromise.\n- 0.25 points: Identifies aminoglycosides and polymyxin B as potentially nephrotoxic and therefore limited in horses with renal compromise.\n\nDeductions (max 0.25 points):\n- Deduct 0.05–0.25 points for excessive irrelevant content beyond what is needed to answer (e.g., detailed mechanisms of SIRS, unrelated antibiotic regimens, or extensive discussion of other equine colitis causes).  \n- Total deduction cannot exceed 0.25 points; final score cannot be below 0.0 points."}
{"query": "In equine metabolic syndrome (EMS), what is the most important risk factor predisposing to endocrinopathic laminitis, and what are the main pillars of long-term management used to reduce laminitis risk?", "response": "Rubric (Total Score: 1.0 point; minimum 0):  \n- 0.5 points: Correctly identifies insulin dysregulation (ID) as the most important EMS-related risk factor for endocrinopathic laminitis.  \n- 0.5 points: Correctly states that long-term management is primarily based on dietary strategies and an exercise program aimed at improving insulin regulation and reducing obesity (where present).  \n\nDeductions (max 0.25 points):  \n- Deduct 0.1–0.25 points for substantial irrelevant or excessive additional content that is not asked for (e.g., extended discussion of unrelated diseases, detailed test methodologies beyond noting that lab testing exists), with deduction magnitude proportional to severity. The final score cannot be below 0."}
{"query": "In sheep pre-implantation development, explain the maternal-to-embryonic transition by stating (i) what molecular control dominates the earliest cleavage cycles, (ii) when full embryonic genome activation occurs, and (iii) how E-cadherin–mediated compaction at the morula stage mechanistically contributes to blastocyst formation (include the key cellular reorganization and the resulting main blastocyst cell lineages).", "response": "Rubric (Total Score: 1.0 Point)\n\n- Early cleavage control (0.25 points)  \n  - 0.25: States that the first cleavage cycles are controlled by maternal RNAs and proteins synthesized/stored during oogenesis.  \n  - 0.0: Does not identify maternal RNAs/proteins as the primary early drivers (or claims embryonic transcripts dominate immediately).\n\n- Timing of full embryonic genome activation in sheep (0.25 points)  \n  - 0.25: Correctly states full activation occurs at the 8–16 cell stage.  \n  - 0.0: Gives an incorrect stage or omits a clear timing.\n\n- Compaction mechanism: adhesion and polarization (0.25 points)  \n  - 0.15: Identifies E-cadherin as mediating blastomere adhesion during compaction (localized at contact regions).  \n  - 0.10: States that morula compaction induces polarization with membrane reorganization into apical and basolateral domains.  \n  - 0.0: Misses both adhesion role and polarization/apical–basolateral reorganization, or describes unrelated mechanisms.\n\n- Blastocyst outcome: structure and lineages (0.25 points)  \n  - 0.15: Names the trophectoderm (TE) and inner cell mass (ICM) as the main resulting cell lineages.  \n  - 0.10: Notes formation of a fluid-filled cavity as part of the blastocyst structure.  \n  - 0.0: Fails to identify TE and ICM, or does not connect compaction/polarization to blastocyst formation.\n\nDeductions for excess/irrelevant content (max 0.25 points)  \n- Deduct 0.05–0.25 if the response adds substantial extraneous material that obscures the required points (e.g., detailed implantation endocrinology, unrelated species comparisons, or extended clinical discussion).  \n- Total score cannot be below 0."}
{"query": "How do two observations about equine-lineage influenza A viruses undermine the long-held view that horses are a “dead-end” host and that equine influenza is genetically static?", "response": "Rubric (Total Score: 1.0 point; Minimum: 0 points):  \n- 0.5 points: States that equine influenza viruses, while more genetically stable than human-lineage influenza viruses, still undergo evolutionary change (i.e., are not in evolutionary stasis).  \n- 0.5 points: States that equine-lineage influenza viruses have been transmitted from horses to dogs, demonstrating cross-species spread and challenging the “dead-end host” assumption.\n\nDeductions (max 0.25 points):  \n- Deduct up to 0.25 points for excessive irrelevant content that goes beyond answering the two required observations (e.g., detailed influenza taxonomy, clinical signs, vaccination strategies, or unrelated host species discussions). The deduction amount should be proportional to severity. The final score cannot be below 0."}
{"query": "A horse presents with a suspected inherited bleeding disorder, but no validated genetic test is available for the condition. What laboratory diagnostic approach should be used to evaluate the disorder, and how can genetic testing (when available) be applied to reduce the risk of producing affected foals in autosomal recessive bleeding diseases?", "response": "Rubric (Total Score: 1.0 point; Minimum: 0 points)\n\n- Diagnostic approach without a genetic test (0.6 points total)  \n  - 0.2: States that diagnosis relies on measuring platelet function (e.g., platelet function testing).  \n  - 0.2: States that von Willebrand factor should be measured (level and/or activity).  \n  - 0.2: States that other coagulation protein levels and/or activities should be measured.\n\n- Use of genetic testing to reduce risk in autosomal recessive diseases (0.4 points total)  \n  - 0.4: Explains that genetic testing can be used to identify carriers and prevent breeding two carriers (carrier × carrier), thereby reducing affected foals.\n\n- Deductions for excessive/irrelevant content (max 0.25 points)  \n  - Deduct 0.1–0.25 if the response adds substantial unrelated detail (e.g., extensive discussion of exercise-induced pulmonary haemorrhage or naming multiple disorders without tying them to the asked diagnostic strategy), obscuring the required points.  \n  - Final score cannot be below 0."}
{"query": "Explain the physiological mechanism by which saddle pressure can progress from vascular occlusion to tissue necrosis in a horse’s back, and identify (i) the mean capillary pressure value relevant to occlusion risk and (ii) the proposed mean-pressure threshold that indicates increased risk of saddle-induced back pain; also state one reason mean pressure is preferred over maximal pressure as a metric.", "response": "Rubric (Total Score: 1.0 point; minimum 0.0):  \n- 0.35 points: Correct mechanism described: pressure exceeding mean capillary pressure can cause vascular occlusion; prolonged occlusion leads to ischemia with oxygen/nutrient deprivation and can progress to tissue necrosis; muscle noted as particularly vulnerable.  \n- 0.20 points: Correctly states the mean capillary pressure value: 4.7 kPa.  \n- 0.20 points: Correctly states the proposed mean-pressure risk threshold for back pain: mean pressure > 11 kPa.  \n- 0.25 points: Provides one valid reason mean pressure is preferred over maximal pressure, such as: mean pressure shows the largest differences between saddle variants, is more reliable than maximal pressure, and/or differentiates more clearly between horses with vs. without back pain.  \n\nDeductions (max 0.25 points):  \n- Deduct 0.05–0.25 points (severity-based) if the response includes substantial irrelevant material beyond what is needed (e.g., unrelated saddle-fitting advice, unrelated equine anatomy/rehab discussion). The total score cannot go below 0."}
{"query": "In a quadruped modeled as a heavy beam supported at the forelimbs and hindlimbs, describe where compressive versus tensile stresses occur (i) in the head-and-neck “anterior cantilever” and (ii) in the trunk segment between the supports when the body sags ventrally, and identify the main anatomical structures primarily associated with resisting compression versus producing/handling tension.", "response": "Rubric (Total = 1.0 point; Minimum = 0):  \n- (0.25) Anterior cantilever (head/neck) stress pattern correctly stated: lower margin in compression AND upper margin in tension.  \n- (0.25) Trunk-between-supports stress pattern correctly stated: upper margin in compression AND lower margin in tension (due to ventral sagging).  \n- (0.25) Compression-resisting structures correctly identified as the skeleton, specifically including vertebral column and sternum (pelvis acceptable as additional correct detail).  \n- (0.25) Tension-handling structures correctly identified as musculature (e.g., neck and cranial thoracic dorsal/shoulder muscles) AND/or strong connective-tissue strands that can take over part of tensile forces.  \n\nDeductions (max 0.25):  \n- Deduct up to 0.25 for excessive irrelevant content that obscures the required stress patterns/structures (e.g., lengthy digressions into unrelated biomechanics), scaled by severity. Final score cannot be below 0."}
{"query": "Explain how equine back pain or experimentally induced limb lameness can biomechanically contribute to abnormal saddle movement, and identify a downstream consequence of that saddle movement for the horse.", "response": "Rubric (Total = 1.0 point; Minimum = 0 points):\n\n- 0.4 points: States that back pain/stiffness and/or forelimb/hindlimb lameness alters spinal biomechanics.  \n  - Correct content: altered biomechanics of the spine (any clear equivalent phrasing).\n\n- 0.3 points: States that these conditions shift the horse’s centre of gravity (or weight distribution) in a way that can destabilize the saddle.  \n  - Correct content: explicit mention of centre of gravity shift/changed weight distribution.\n\n- 0.2 points: Identifies an abnormal saddle movement outcome such as consistent saddle slip to one side.  \n  - Correct content: “saddle slip consistently to one side” or an unambiguous equivalent.\n\n- 0.1 points: Identifies a downstream consequence for the horse: focal areas of increased pressure beneath the saddle.  \n  - Correct content: increased focal pressure under the saddle (pressure points).\n\nDeductions for excess/irrelevant content (max 0.25 points):  \nDeduct 0.05–0.25 if the response adds substantial unrelated material (e.g., prevalence statistics, extensive discussion of rider skill/training/saddle fit without linking to the biomechanical chain asked). Deduction magnitude depends on how much it obscures the required causal pathway. Final score cannot go below 0."}
{"query": "Define complementary and alternative veterinary medicine (CAVM) and distinguish between “complementary veterinary medicine” and “alternative veterinary medicine” by explaining how each relates to conventional veterinary treatment; then name three example modalities and give two common equine use-cases, noting the core evidence/safety concern associated with these practices.", "response": "Rubric (Total = 1.0 point; Minimum = 0.0):  \n- **Definitions and distinction (0.45 points)**  \n  - 0.25: Correctly defines CAVM as a heterogeneous group of preventive/diagnostic/therapeutic philosophies and practices not part of the traditional veterinary curriculum.  \n  - 0.20: Correctly distinguishes: *complementary* = used **in addition to** conventional treatments; *alternative* (AVM) = used **instead of** conventional treatments.  \n- **Examples (0.20 points)**  \n  - 0.20: Provides any **three** correct examples (e.g., acupuncture, homeopathy, manual therapy, chiropractic, phytotherapy, nutraceutical medicine).  \n- **Equine use-cases (0.20 points)**  \n  - 0.20: Provides any **two** correct reported indications in horses (e.g., behavioural problems; musculoskeletal problems/lameness; optimising performance; injury prophylaxis; enhancing recovery; chronic conditions in geriatric horses).  \n- **Evidence/safety concern (0.15 points)**  \n  - 0.15: States the key concern that evidence is lacking/efficacy is uncertain and that efficacy and safety for several therapies remain unclear (not evidence-based).  \n\n**Deductions for excess/irrelevant content (max 0.25 points):**  \n- Deduct **0.05–0.25** if the response adds substantial material beyond what is asked (e.g., detailed mechanisms, extensive history, unrelated regulatory or ethical debates), with deduction scaled to severity.  \n- Final score floor: **0.0**."}
{"query": "Describe the typical clinical presentation of alopecia areata (including lesion characteristics and scarring/inflammation status), name the recognized human subgroups based on extent of hair loss, and list at least five non-human species in which alopecia areata has been reported.", "response": "Rubric (Total Score: 1.0 point; Minimum: 0 points)\n\n- Clinical presentation (0.35 points total)\n  - 0.20: States that lesions are well-circumscribed, nonscarring alopecia.\n  - 0.15: States that alopecia may be sudden or insidious and is visually noninflammatory.\n\n- Human subgroups by extent (0.30 points total)\n  - 0.15: Correctly identifies alopecia totalis as complete loss of scalp hair.\n  - 0.15: Correctly identifies alopecia universalis as loss of entire body hair.\n\n- Non-human species reported (0.35 points total)\n  - 0.35: Lists at least five correct non-human species from the following: nonhuman primates, dogs, cats, cattle, chickens, laboratory rodents, horses.  \n  - 0.20: Lists exactly four correct non-human species from the list above.\n  - 0.10: Lists exactly three correct non-human species from the list above.\n  - 0.00: Lists fewer than three correct non-human species, or lists species not supported.\n\nDeductions for excess/irrelevant content (max 0.25 points)  \n- Deduct 0.05–0.25 if the response includes substantial extraneous material not asked for (e.g., detailed treatment protocols, speculative causes, unrelated epidemiology beyond what is necessary to answer), scaled by severity. The total score cannot go below 0."}
{"query": "Explain how the myostatin (MSTN) gene product GDF8 regulates muscle growth at the cellular level, and identify at least two specific signaling pathways through which MSTN is involved in broader regulation of muscle-related physiology.", "response": "Rubric (Total = 1.0 point; Minimum = 0 points):  \n- **0.5 points:** Correctly states the core cellular mechanism that **GDF8 (from MSTN) negatively regulates muscle growth by decreasing proliferation of muscle precursor cells via inhibition of cell-cycle progression**.  \n- **0.5 points:** Correctly identifies **at least two** MSTN-involved signaling pathways from the following: **Notch**, **MAPK (Mitogen-Activated Protein Kinase)**, **Wnt (wingless-type MMTV integration site family)**. (Full credit only if two or more are correctly named.)\n\nDeductions (max 0.25 points):  \n- Deduct **0.05–0.25** points for excessive irrelevant content that goes beyond the asked mechanisms/pathways (severity-based), such as lengthy unrelated discussion of other genes/diseases or speculative claims not required for the answer.  \n- Final score cannot be below **0**."}
{"query": "In equine stringhalt, compare two treatment approaches—surgical transection/myotenectomy involving the lateral digital extensor versus botulinum toxin injections—by stating (1) a reported success/effectiveness figure or outcome for each approach and (2) the typical duration of improvement reported for the botulinum toxin treatment.", "response": "Rubric (Total Score: 1.0 point; Minimum: 0 points)\n\n- Surgical approach outcome (0.5 points)  \n  - 0.5: Correctly states that surgically cutting the digital extensors has an approximately 50% success rate, or that surgical myotenectomy of the lateral digital extensor tendon has been reported to show positive results.  \n  - 0.0: Does not provide a correct reported outcome for the surgical approach.\n\n- Botulinum toxin (Botox) outcome and duration (0.5 points)  \n  - 0.25: Correctly states that Botox injections (into extensor digitorum lateralis and lateral vastus) decreased hyperflexion/hyperabduction.  \n  - 0.25: Correctly states the improvement lasted up to 12 weeks.  \n  - 0.0: Does not provide the correct Botox effect and/or duration.\n\nDeductions for extraneous content (max 0.25 points)  \n- Deduct 0.1–0.25 if the response includes substantial irrelevant material (e.g., unrelated pathology details like myelin sheath findings, broad prognosis or recovery-time ranges, or medication effects on trot vs walk/turn) that obscures the requested comparison.  \n- Total score after deductions cannot be below 0."}
{"query": "African horse sickness is described as infectious but non-contagious in Equidae. Explain what this implies about its transmission dynamics, and identify (i) the virus type (genome and genus-level classification), (ii) the principal arthropod vectors involved (including the primary field vector and the important cooler-highland vector in South Africa), and (iii) the season and climatic conditions typically associated with peak incidence.", "response": "Rubric (Total = 1.0 point; Minimum = 0 points):  \n\n- **Transmission implication (0.25 points)**  \n  - 0.25: Clearly explains that “infectious but non-contagious” means animals become infected but it does **not** typically spread by direct animal-to-animal contact; transmission is primarily **vector-borne** (biting midges).  \n  - 0: Missing/incorrect explanation (e.g., claims direct contagion is typical).\n\n- **Virus type (0.25 points)**  \n  - 0.15: Identifies the agent as a **double-stranded RNA** virus.  \n  - 0.10: Identifies it as an **orbivirus** (genus-level classification).  \n\n- **Vectors (0.30 points)**  \n  - 0.15: Identifies **Culicoides** biting midges as the transmitting vectors.  \n  - 0.10: Names **Culicoides imicola** as the principal **field vector**.  \n  - 0.05: Names **Culicoides bolitinos** as an important vector in the **cooler upper highlands of South Africa**.\n\n- **Peak incidence conditions (0.20 points)**  \n  - 0.10: States peak incidence is usually in **late summer and early autumn**.  \n  - 0.10: Links peak incidence to **climatic conditions that favor abundant Culicoides midges** (i.e., conditions increasing midge abundance).\n\n**Deductions for extraneous content (max −0.25 points):**  \n- Deduct **0.05–0.25** if the response includes substantial irrelevant material beyond what is asked (e.g., detailed outbreak history, unrelated diseases, or extensive clinical signs) that obscures the required elements. The total score cannot go below 0."}
{"query": "In horses, describe the primary infectious unit and main transmission route for *Clostridium difficile*, identify two major adult-horse risk factors and name at least three antibiotic classes commonly associated with disease, explain how intestinal lesion distribution differs between foals under 1 month versus older foals/adults, and state the most reliable diagnostic criterion.", "response": "Rubric (Total Score: 1.0 point; Minimum: 0 points)\n\n- **Transmission unit and route (0.20 points)**\n  - 0.10: Correctly identifies the **highly resistant spore** as the infectious unit.\n  - 0.10: Correctly states **fecal–oral transmission** as the primary route.\n\n- **Adult-horse risk factors (0.20 points)**\n  - 0.10: Correctly identifies **hospitalization** as a major risk factor.\n  - 0.10: Correctly identifies **antimicrobial treatment** as a major risk factor.\n\n- **Antibiotics commonly associated (0.15 points)**\n  - 0.15: Names **at least three** of the following: **erythromycin**, **trimethoprim/sulfonamides**, **β-lactams**, **clindamycin**, **rifampicin**, **gentamicin**.  \n  - 0.00: Fewer than three correct antibiotics/classes or mostly incorrect.\n\n- **Age-related lesion distribution (0.25 points)**\n  - 0.10: For **foals < 1 month**, states **small intestine is invariably affected**.\n  - 0.15: Correctly contrasts that **older foals/adults** have a more **aboral** distribution: primarily **colon** (and sometimes **cecum**) with **small intestine rarely affected**.\n\n- **Most reliable diagnostic criterion (0.20 points)**\n  - 0.20: States that the most reliable criterion is **detection of toxin A, toxin B, or both in intestinal contents or feces**.\n\n- **Deductions for extraneous content (max −0.25 points)**\n  - Deduct **0.05–0.25** if the response includes substantial irrelevant material (e.g., extended discussion of unrelated pathogens, treatment regimens, or general diarrhea pathophysiology) that obscures the required elements.  \n  - Total score cannot go below **0.00**."}
{"query": "Explain the “bow-and-string” mechanical model of the equine thoracolumbar spine by identifying which structures function as the bow and the string, describing how concentric contraction of the abdominal and sublumbar muscles changes intervertebral joint position and back shape, and stating why strengthening hypaxial musculature is emphasized in conditioning or rehabilitation (including a case where it is especially needed).", "response": "Rubric (Total Score: 1.0 point; minimum 0.0):  \n- 0.25 points: Correctly identifies the bow as the thoracolumbar spine and the string as the abdominal and sublumbar muscles (hypaxial musculature) providing tension.  \n- 0.25 points: Correctly explains that concentric contraction of these muscles flexes the intervertebral joints, rounding/arching the back (more “rounded” posture).  \n- 0.25 points: Correctly explains that insufficient muscular tension allows viscera weight to extend the intervertebral joints, producing a more lordotic back contour.  \n- 0.25 points: States why strengthening/recruiting hypaxial musculature is emphasized: to promote/maintain a rounded working posture that helps maintain separation of the dorsal spinous processes; includes at least one appropriate scenario where targeted rehab is needed (e.g., poor natural posture/weak inactive hypaxials after colic surgery or after foaling) and/or notes that ground-based core training and specific locomotor exercises are appropriate.  \n\nDeductions (max 0.25 points):  \n- Deduct 0.05–0.25 for excessive irrelevant content that is not asked for (e.g., detailed unrelated anatomy, unrelated diseases, or training philosophies) that obscures the required mechanical explanation. Final score cannot go below 0.0."}
{"query": "Describe the taxonomy and key virion properties of African swine fever virus (ASFV), and explain how its encoded proteins support immune evasion by naming at least two host pathways or components it can inhibit or modulate.", "response": "Rubric (Total = 1.0 point; Min = 0.0):  \n- **Taxonomy (0.25 points):**  \n  - 0.25 if the answer correctly states that ASFV is the only member of **family Asfarviridae** and belongs to **genus Asfivirus** (must include both).  \n- **Virion properties (0.25 points):**  \n  - 0.25 if the answer correctly describes ASFV as a **large, complex, icosahedral, multi-enveloped DNA virus** (must include DNA virus plus at least two of: large/complex/icosahedral/multi-enveloped).  \n- **Protein repertoire (0.20 points):**  \n  - 0.20 if the answer correctly includes that the particle contains **54 structural proteins** *and/or* that the genome encodes numerous **enzymes/transcription factors/immune homologues** (full credit if at least one of these is stated correctly; no extra credit for both).  \n- **Immune evasion mechanisms (0.30 points):**  \n  - 0.15 for correctly naming inhibition/modulation of **host transcription factors**.  \n  - 0.15 for correctly naming inhibition/modulation of the **interferon response** *or* modulation of **immune cell subsets** (either one acceptable for the second 0.15).  \n- **Deductions for excess irrelevant content (max −0.25 points):**  \n  - Deduct 0.05–0.25 if the response adds substantial unrelated details (e.g., symptoms, epidemiology, control measures) that are not asked and materially obscure the required points."}
{"query": "Explain how the three structural regions of gram-negative bacterial lipopolysaccharide (LPS) relate to (i) strain-specific immune recognition, (ii) membrane anchoring and toxicity, and (iii) activation of the TLR4/MD-2 receptor complex; include the typical EC₅₀ range for equine monocyte responses to *E. coli* LPS.", "response": "Rubric (Total = 1.0 point; Min = 0):  \n\n- **O antigen and strain-specific recognition (0.20 points)**  \n  - 0.20: States that the **O antigen** is an **outer, repetitive glycan/polysaccharide** that **varies between strains** and is a **target for host antibody recognition**.  \n  - 0: Missing or incorrect.\n\n- **Core oligosaccharide role/position (0.10 points)**  \n  - 0.10: Identifies the **core domain** as **less variable oligosaccharides** connecting O antigen to lipid A.  \n  - 0: Missing or incorrect.\n\n- **Lipid A: anchoring + toxicity (0.25 points)**  \n  - 0.25: Describes **lipid A** as the **innermost** component that **anchors LPS in the bacterial membrane** and is responsible for **many toxic effects** of gram-negative bacteria.  \n  - 0: Missing or incorrect.\n\n- **TLR4/MD-2 ligand specificity and signaling consequence (0.25 points)**  \n  - 0.25: States that **lipid A is the smallest ligand recognized by TLR4/MD-2**, and that **LPS binding to TLR4 initiates signaling cascades leading to cell activation and inflammatory mediator synthesis**.  \n  - 0: Missing or incorrect.\n\n- **Equine sensitivity (EC₅₀) (0.20 points)**  \n  - 0.20: Provides the EC₅₀ range for equine monocytes responding to *E. coli* LPS as **0.013–0.030 ng/mL** (for TNFα release and tissue factor expression).  \n  - 0: Missing or incorrect.\n\n**Deductions for excess/irrelevant content (max −0.25 points):**  \nSubtract **0.05–0.25** if the response adds substantial material not needed to answer (e.g., extended discussion of unrelated TLRs, detailed downstream pathway components not requested, or broad sepsis management), with deduction magnitude proportional to how much it obscures the required points. Final score cannot be below 0."}
{"query": "African swine fever virus is often genotyped by sequencing a specific region of a particular viral protein. Identify the protein and the sequenced region used for this genotyping, state how many genotypes this method discriminates, and describe the historical geographic association of Genotype I versus the overall genotype diversity observed in southern/eastern Africa.", "response": "Rubric (Total Score: 1.0 point):  \n- **0.25 points:** Correctly identifies the protein as **p72**.  \n- **0.25 points:** Correctly specifies the sequenced region as the **C-terminus of the p72 protein**.  \n- **0.25 points:** Correctly states that this method discriminates **22 genotypes**.  \n- **0.25 points:** Correctly describes geographic patterns: **Genotype I** is historically associated with **western Africa**, while **southern and eastern Africa** show **higher heterogeneity with all 22 genotypes recorded**.  \n\nDeductions (max 0.25 points):  \n- Deduct **0.05–0.25 points** if the response includes substantial irrelevant content beyond what is asked (e.g., extended discussion of transmission, 2007 Caucasus spread details, or endemicity by country) that obscures the required elements."}
{"query": "Explain the genome segmentation and protein-coding strategy of African horse sickness virus (AHSV), including which genome segments encode both a structural and a non-structural protein, and describe how the three capsid layers are organized with specific proteins and their roles in host interaction.", "response": "Rubric (Total = 1.0 point; Min = 0 points):\n\n- Genome type and segmentation (0.20): States that AHSV has 10 linear double-stranded RNA genome segments.  \n  - Correct answer element: “10 linear dsRNA segments.”\n\n- Encoded protein sets (0.20): Identifies that the segments code for seven structural proteins (VP1–VP7) and at least five non-structural proteins (NS1–NS4 and S10-ORF2).  \n  - Correct answer elements: “VP1–VP7” and “NS1–NS4 plus S10-ORF2 (at least five non-structural proteins).”\n\n- Dual-coding segments (0.25): Correctly specifies BOTH of the following:  \n  - Segment 9 (VP6) also encodes NS4. (0.125)  \n  - Segment 10 encodes NS3/3A and S10-ORF2. (0.125)\n\n- Capsid layer organization + host-interaction role (0.35): Describes the three concentric capsid layers with correct protein placement and at least one correct functional role tied to host interaction:  \n  - Outer capsid: VP2 and VP5. (0.15)  \n  - Outer capsid role: cell attachment and/or inducing apoptosis. (0.10)  \n  - Inner capsid: VP7 and VP3; notes that it encloses VP1, VP4, VP6 (replication complex) and the genome. (0.10)\n\nDeductions for excess/irrelevant content (max 0.25):  \n- Deduct up to 0.25 if the response adds substantial off-target material (e.g., extended discussion of vaccination policy, epidemiology, or cure/control issues) that is not asked and obscures the required genome/capsid details.  \n- Final score cannot be below 0."}
{"query": "Explain how African swine fever virus (ASFV) infection can simultaneously impair haemostasis and cause severe lymphopenia, identifying the key infected cell type, the mediators released, and the proposed mechanism driving lymphocyte loss; also describe one debated mechanism proposed for thrombocytopenia in acute/subacute infection.", "response": "Rubric (Total = 1.0 point; Min = 0.0):  \n- **0.35 points**: Identifies **macrophages** as the major infected/destructed cell type central to pathogenesis.  \n- **0.25 points**: States that impaired haemostasis is linked to release of **active substances from destroyed/infected macrophages**, including at least **two** of the following correctly: **cytokines**, **complement factors**, **arachidonic acid metabolites**.  \n- **0.25 points**: Explains severe lymphopenia as due to **apoptosis of lymphocytes**, and links this to **pro-inflammatory cytokines produced by infected macrophages** inducing apoptosis.  \n- **0.15 points**: Provides one debated thrombocytopenia mechanism: either (a) **infection/destruction of megakaryocytes** may contribute, **or** (b) notes that some researchers report **no evidence of impaired thrombocytopoiesis** (no structural/ultrastructural correlates).  \n\nDeductions (max 0.25 points):  \n- Deduct **0.05–0.25** for excessive irrelevant content (e.g., detailed clinical signs, transmission routes, vaccine discussions) that is not needed to answer the question; apply larger deductions as irrelevant material becomes more dominant. Final score cannot go below 0."}
{"query": "Explain why laboratory confirmation is necessary for Classical Swine Fever (CSF) and describe (1) the types of diagnostic approaches used, (2) the epidemiological importance of wild boar, and (3) how control strategies differ between CSF-free countries facing outbreaks and endemically infected regions.", "response": "Rubric (Total = 1.0 point; Min = 0 points):  \n- **0.25 points:** States that laboratory confirmation is required because CSF shows a wide range of clinical syndromes influenced by virus and host factors (clinical signs alone are insufficient).  \n- **0.25 points:** Correctly identifies that **both direct and indirect** diagnostic methods are used (credit only if both are mentioned).  \n- **0.25 points:** Explains that **wild boar act as a reservoir host** and can **sporadically transmit** CSFV to domestic pig farms.  \n- **0.25 points:** Correctly contrasts control approaches: **CSF-free countries** mainly use **quarantine and strict culling**, with **vaccination only as an emergency option**; **endemic regions** use **live vaccines** for control.\n\nDeductions (max 0.25 points):  \n- Deduct **0.05–0.25 points** for substantial irrelevant or excessive content that obscures the required elements (e.g., lengthy discussion of viral genotypes/virulence relationships or detailed clinical presentations beyond the need to justify lab confirmation).  \n- Final score cannot be below **0**."}
{"query": "Describe the three independent epidemiologic cycles of African swine fever (ASF) by naming the key host/vector components in each cycle and explaining which cycle involves natural reservoirs without disease in the reservoir host, and which cycle can transmit infection via pig-derived products.", "response": "Rubric (Total = 1.0 point; Minimum = 0 points):  \n- 0.35 points: Correctly identifies the **sylvatic cycle** as involving **warthogs and soft Ornithodoros spp. ticks**, with **no disease in warthogs** (natural reservoir setting).  \n- 0.35 points: Correctly identifies the **tick–pig cycle** as involving **soft Ornithodoros spp. ticks and domestic pigs**.  \n- 0.20 points: Correctly identifies the **domestic cycle** as transmission **among domestic pigs and/or from pig-derived products (e.g., pork) to domestic pigs**, and states that it **does not involve natural reservoirs**.  \n- 0.10 points: Correctly matches the prompt’s functional distinctions:  \n  - **Natural reservoirs without disease** = **sylvatic cycle**  \n  - **Pig-derived products as a transmission route** = **domestic cycle**\n\nDeductions (max 0.25 points):  \n- Deduct 0.05–0.25 points for excessive irrelevant material (e.g., detailed clinical signs, unrelated control policies, molecular virology) that substantially obscures the required cycle descriptions.  \n- Final score cannot be below 0."}
{"query": "Feral swine (Sus scrofa) have expanded across much of the United States; identify two biological/ecological traits that help explain this rapid spread, and name one specific pathogen for which feral swine in Texas have shown serologic evidence of exposure.", "response": "Rubric (Total = 1.0 point; Minimum = 0 points):\n- (0.4 points) Trait 1: Correctly states that females can begin breeding at about 1 year of age (early reproductive maturity).\n- (0.4 points) Trait 2: Correctly states either (a) high reproductive output (up to ~10 piglets per year) OR (b) lack of predation (predator release) as a contributor to expansion.\n- (0.2 points) Pathogen: Correctly names Bacillus anthracis (anthrax agent) as the organism indicated by antibodies in Texas feral swine.\n\nDeductions (max 0.25 points; score floor = 0):\n- Deduct up to 0.25 points for substantial extraneous or irrelevant content that goes beyond answering the question (e.g., long lists of additional diseases, extensive history of introductions, or unrelated management details)."}
{"query": "Explain the taxonomic classification of classical swine fever virus (CSFV), name three other pestiviruses to which it is genetically and serologically related, and list two policy approaches currently used to control classical swine fever in pigs.", "response": "Rubric (Total = 1.0 point; Minimum = 0 points):  \n- **Virus taxonomy (0.3 points):**  \n  - 0.15: Identifies the pathogen as **classical swine fever virus (CSFV)**.  \n  - 0.15: Classifies CSFV as **genus Pestivirus, family Flaviviridae**.  \n- **Related pestiviruses (0.4 points):**  \n  - 0.4: Correctly names **three** of the following: **BVDV-1**, **BVDV-2**, **border disease virus (BDV)**. (If only two are correct: 0.25; if only one is correct: 0.1; if none: 0.)  \n- **Control approaches (0.3 points):**  \n  - 0.15: States **non-vaccination stamping-out policy** (or equivalent wording indicating culling/eradication without vaccination).  \n  - 0.15: States **prophylactic vaccination**.  \n\n**Deductions (max 0.25 points):**  \n- Deduct **0.05–0.25** for excessive irrelevant content beyond what is asked (severity-based). Final score cannot be below **0**."}
{"query": "Explain why detection of the human-associated norovirus genotype GII.4 in swine is epidemiologically significant, and describe how the typical presence of species-specific P-types in swine complicates interpretation of swine as a reservoir with zoonotic potential.", "response": "Rubric (Total Score: 1.0 point; minimum 0.0):  \n- (0.5 points) Epidemiological significance: Clearly states that finding human-associated GII.4 in swine suggests possible cross-species transmission and/or that swine could serve as a reservoir that might contribute to zoonotic spillover to humans.  \n- (0.5 points) Complicating factor (P-types): Correctly explains that swine usually have species-specific P-types, which implies host-adapted polymerase lineages; therefore, detecting GII.4 alone does not definitively prove sustained circulation in swine or clear zoonotic risk without additional evidence (e.g., compatible human-like P-type, recombination context, transmission data).  \n\nDeductions (max 0.25 points):  \n- Deduct 0.05–0.25 points for excessive irrelevant content that goes beyond the asked epidemiologic interpretation (e.g., long digressions on norovirus clinical symptoms, global case counts, or unrelated virology details).  \n- Final score cannot be below 0.0."}
{"query": "Explain why sequencing a Quarter Horse genome is scientifically and practically valuable by addressing (1) its population/registry significance in the United States, (2) how selective breeding goals differ from Thoroughbreds and what phenotypic consequences follow, and (3) how the presence of both single-gene disorders and complex traits motivates variant discovery for future equine genomic research.", "response": "Rubric (Total = 1.0 point; Minimum = 0.0):  \n\n- **Population/registry significance (0.30 pts)**  \n  - 0.30: States that Quarter Horses constitute the largest U.S. breed registry/population contribution (e.g., ~3 million registered in 2010 and even larger when including related/unregistered populations).  \n  - 0.0: Does not identify the breed’s major registry/population significance.\n\n- **Selective breeding differences + phenotypic consequences (0.35 pts)**  \n  - 0.35: Correctly contrasts breeding aims: Thoroughbreds selected for speed over longer distances (about 3/4 to 2 miles) while Quarter Horses selected for short-distance speed plus compliant disposition for ranch/cattle work; explicitly notes these choices produced phenotypic differences with an underlying genetic component.  \n  - 0.0: Missing or incorrect comparison of breeding goals and/or no link to genetically influenced phenotypic differences.\n\n- **Genetic architecture motivation (0.35 pts)**  \n  - 0.35: Mentions that Quarter Horses have notable **single-gene disorders** (credit if at least one correct example such as PSSM, HYPP, GBED, or HERDA is named) and also that many traits/diseases are **complex/multigenic** and can be environmentally modulated; connects this to why identifying variants in one genome helps enable future equine genomic studies.  \n  - 0.0: Does not mention both single-gene and complex traits and/or does not connect variant discovery to future research utility.\n\n**Deductions for excess irrelevant content (max −0.25 pts):**  \n- Deduct **0.10–0.25** if the response adds substantial unrelated material (e.g., detailed clinical signs or treatments of disorders, long historical narratives about breeds) that obscures the requested three-part explanation.  \n- Final score cannot go below 0.0."}
{"query": "Explain how Classical swine fever virus (CSFV) genotype/sub-genotype classification has been refined in genotype 1 and genotype 2, including (i) what evidence justified creation of sub-genotype 1.4, (ii) why some proposed sub-grouping systems in genotype 2 have limited international usefulness, and (iii) identify two especially divergent genotype 3 reference strains and the proposed role of one of them in phylogenetic analysis.", "response": "Rubric (Total = 1.0 point; Minimum = 0.0 points):\n\n- (0.35 points) Genotype 1 refinement—sub-genotype 1.4:\n  - Correctly states that sub-genotype 1.4 was created for Cuban isolates previously placed in 1.2 (0.15).\n  - Correctly states the justification/evidence: phylogenetic analysis of full-length E2 sequences showed they form a separate, quite divergent clade/sub-genotype from other genotype 1 strains (0.20).\n\n- (0.35 points) Genotype 2 sub-grouping limitations:\n  - Correctly notes that additional sub-groupings were suggested for sub-genotypes 2.1 and/or 2.3 (0.15).\n  - Correctly explains the limitation: these sub-grouping systems (e.g., 2.1a–2.1c, 2.3.1/2.3.2, EU “Rostock”/regional lineages based on 5′-NTR trees) were not internationally harmonized/standardized, reducing comparability across studies/regions (0.20).\n\n- (0.30 points) Divergent genotype 3 strains and outgroup role:\n  - Correctly names both divergent genotype 3 strains: “Kanagawa” (Japan, 1974) and “Congenital Tremor” (UK, 1964) (0.20).\n  - Correctly states that “Kanagawa” was suggested as a harmonized outgroup strain for phylogenetic analyses (0.10).\n\nDeductions for excess/irrelevant material (max −0.25 points):\n- Deduct up to 0.10 for minor irrelevant additions that do not obscure required points.\n- Deduct up to 0.25 for substantial irrelevant content or speculation (e.g., detailed disease pathology, vaccine strategies, or unrelated genomic features) that dilutes or obscures the requested classification/refinement details.\n- Final score cannot go below 0.0 points."}
{"query": "Describe the genome organization of Classical swine fever virus (CSFV) and explain how its coding strategy yields its mature protein products, including the total number of mature proteins and the names of its structural versus nonstructural proteins.", "response": "Rubric (Total = 1.0 point; Minimum = 0 points):\n\n- **Genome type and overall organization (0.35 points)**\n  - 0.15: States CSFV is **single-stranded, non-segmented, positive-sense RNA**.\n  - 0.10: States the genome has **5′ and 3′ untranslated regions (UTRs)**.\n  - 0.10: States the genome contains **one long open reading frame (ORF)**.\n\n- **Coding/processing strategy (0.25 points)**\n  - 0.15: States the ORF is translated into a **single primary polyprotein**.\n  - 0.10: States the polyprotein is **processed by cellular and viral proteases** into mature proteins.\n\n- **Mature protein products: counts and correct lists (0.40 points)**\n  - 0.10: Gives the correct total: **12 mature proteins**.\n  - 0.15: Correctly lists the **4 structural proteins: C, Erns, E1, E2**.\n  - 0.15: Correctly lists the **8 nonstructural proteins: Npro, P7, NS2, NS3, NS4A, NS4B, NS5A, NS5B**.\n\n- **Deductions for excessive irrelevant content (max −0.25 points)**\n  - Deduct **0.05–0.25** if the response includes substantial extraneous material not asked for (e.g., detailed clinical signs like thrombocytopenia/DIC, global distribution, or farming impact) that distracts from genome organization and protein processing.  \n  - Total score cannot go below **0**."}
{"query": "Explain why agricultural fairs in North America can be particularly conducive to zoonotic transmission and amplification of influenza A virus between pigs and humans, and contrast this with the typical level of swine–human intersection in the United States.", "response": "Rubric (Total Score: 1.0 point; Min: 0 points):  \n- 0.5 points: States that agricultural fairs create a high-risk swine–human interface due to very large human attendance and direct contact opportunities between non-swine producers/attendees and pigs (i.e., many people interacting with pigs, enabling bidirectional transmission).  \n- 0.5 points: States that fairs facilitate within-swine spread/amplification because pigs from multiple sources are co-housed together for multiple days, allowing sufficient time for IAV transmission and amplification in pigs; and contrasts that, generally in the U.S., opportunities for large populations of pigs and humans to intersect are limited (with fairs/live animal markets being notable exceptions).  \n\nDeductions (Max 0.25 points):  \n- Deduct 0.1–0.25 points for excessive irrelevant content that is not required to answer the question (e.g., extended discussion of specific pandemic strains, case counts, or citations beyond what is needed to justify the mechanisms of risk).  \n- Final score cannot be below 0."}
{"query": "Explain how repeated human-to-swine spillovers of 2009 pandemic A(H1N1) influenza contributed to the emergence of genetically diverse swine influenza lineages, including the role of reassortment with North American swine viruses carrying the triple reassortant internal gene (TRIG) cassette and the resulting impact on genome constellations and genotype diversity.", "response": "Rubric (Total Score: 1.0 point; minimum 0):  \n- **Human-to-swine reintroduction frequency and consequence (0.35 points)**  \n  - 0.20: States that human A(H1N1)pdm09 viruses were repeatedly reintroduced from humans into swine many times globally (credit requires “at least 133 times” or an equivalent clear indication of very high repeated introductions).  \n  - 0.15: Explains that these repeated introductions established circulating swine-associated genetic clades/lineages of pdm09 origin.  \n\n- **Reassortment mechanism and partners (0.35 points)**  \n  - 0.20: Describes reassortment between human-origin A(H1N1)pdm09 and other swine influenza A viruses occurring in pigs.  \n  - 0.15: Specifically identifies reassortment with North American swine influenza viruses containing the **TRIG internal gene cassette**.  \n\n- **Outcomes: genome constellations, diversity, and uncertainty (0.30 points)**  \n  - 0.15: States that reassortment produced **numerous genome constellations** in pigs since 2009.  \n  - 0.10: States that onward reassortment increased **genetic variability** and generated **novel genotypes**.  \n  - 0.05: Notes that these novel genotypes have **unknown phenotypic and/or epidemiologic consequences**.  \n\n- **Deductions for excess/irrelevant content (max 0.25 points)**  \n  - Deduct 0.05–0.25 if the response adds substantial unrelated material (e.g., detailed influenza clinical symptoms, vaccine policy, molecular biology not tied to reassortment/TRIG, or unrelated pandemic history) that obscures the required points.  \n  - Final score cannot be below 0."}
{"query": "Describe the innate immune signaling cascade that leads from cellular detection of classical swine fever virus (CSFV) to expression of antiviral effector genes, and state the key immune-evasion outcome CSFV can achieve despite this pathway.", "response": "Rubric (Total = 1.0 point; Minimum = 0 points):  \n- **Pattern recognition → cytokines/IFNs (0.35 points):** States that host pattern recognition receptors detect viral molecules and trigger intracellular signaling that activates/translocates transcription factors to induce cytokines and interferons (IFNs).  \n- **IFNs → JAK-STAT → ISGs (0.35 points):** States that IFNs activate **JAK-STAT** signaling, which drives transcription of **interferon-stimulated genes (ISGs)** with antiviral roles.  \n- **CSFV outcome (0.30 points):** States that CSFV can **evade innate immune signaling/immune surveillance** and thereby **establish persistent infection** (or equivalent wording capturing both evasion and persistence).\n\nDeductions (max 0.25 points):  \n- Deduct **0.05–0.25** for excessive irrelevant content that goes beyond the asked pathway/outcome (e.g., detailed clinical signs, economic impact, or unrelated virology), proportional to severity.  \n- Final score cannot be below **0**."}
{"query": "A veterinarian suspects classical swine fever (hog cholera) in a pig herd. Describe the causative agent category, compare key clinical features and typical time course of acute versus chronic disease (including incubation ranges), and explain how prenatal exposure can alter infection status over an animal’s lifetime.", "response": "Rubric (Total Score: 1.0 Point; Minimum: 0 Points)\n\n- Causative agent (0.2 points)  \n  - 0.2: Identifies the cause as a pestivirus.  \n  - 0: Does not identify pestivirus.\n\n- Acute vs chronic clinical picture (0.3 points)  \n  - 0.3: Correctly distinguishes that acute CSF has typical severe signs (e.g., fever and systemic signs such as hyperaemia/cyanosis of extremities, anorexia, vomiting, abortions, convulsions and/or stiff gait, leading to death) and that chronic CSF is generally milder and persists ~3–4 weeks.  \n  - 0.15: Mentions severity difference (acute more severe, chronic milder) and gives at least one correct acute sign OR the chronic duration (3–4 weeks), but not both.  \n  - 0: Does not correctly distinguish acute vs chronic features.\n\n- Incubation period ranges (0.3 points)  \n  - 0.3: States postnatal incubation is 2–14 days and notes chronic cases can extend up to ~3 months.  \n  - 0.15: Provides only one correct incubation figure (either 2–14 days postnatal or up to 3 months in chronic cases).  \n  - 0: No correct incubation information.\n\n- Effect of prenatal exposure (0.2 points)  \n  - 0.2: States prenatal exposure can lead to persistent infection throughout life.  \n  - 0: Does not mention lifelong persistent infection from prenatal exposure.\n\nDeductions for excess/irrelevant content (max 0.25 points)  \n- Deduct 0.05–0.25 if the response adds substantial extraneous material not asked for (e.g., detailed control policies, unrelated differential diagnoses, unrelated virology details), proportional to severity.  \n- Final score cannot be below 0."}
{"query": "Identify three emerging or re-emerging swine viruses with zoonotic potential and describe (i) a high-risk human population for exposure and (ii) one documented route or scenario of human infection linked to one of these viruses.", "response": "Rubric (Total Score: 1.0 point; Minimum: 0 points)\n\n- Zoonotic viruses identified (0.6 points total)  \n  - 0.2 points: Names swine hepatitis E virus (swine HEV).  \n  - 0.2 points: Names Nipah virus (NiV).  \n  - 0.2 points: Names Menangle virus.  \n  (If fewer than three are correctly named, award only the corresponding portions.)\n\n- High-risk human population (0.2 points)  \n  - 0.2 points: Correctly identifies at least one high-risk group: swine veterinarians, swine producers, or other pig handlers.\n\n- Documented human infection route/scenario (0.2 points)  \n  - 0.2 points: States that swine HEV has been linked to acute hepatitis in humans who consumed raw or undercooked pork products.\n\nDeductions for extraneous content (max 0.25 points)  \n- Deduct up to 0.25 points if the response adds substantial irrelevant material (e.g., detailed descriptions of unrelated swine viruses’ molecular biology or vaccine protocols) that obscures the required items.  \n- Final score cannot be below 0."}
{"query": "Explain why developing an effective African swine fever virus (ASFV) vaccine is difficult, addressing (1) viral factors, (2) genotype-related protection issues, and (3) key features of the host immune response and why common vaccine strategies (inactivation/attenuation or subunit/DNA approaches) have not been fully protective.", "response": "Rubric (Total = 1.0 point; Minimum = 0 points):  \n- **Viral complexity and immune evasion (0.30 points):** States that ASFV is large/complex with many proteins and includes immune-evasion adaptations.  \n- **Genotypic variability and cross-protection limitation (0.25 points):** States that many ASFV genotypes exist and that there is limited or no cross-protection across genotypes.  \n- **Immune response requirements (0.25 points):** States that neutralizing antibodies provide only partial protection and that T-cell/cell-mediated immunity is an important complementary component.  \n- **Why typical vaccine approaches fall short (0.20 points):** States that inactivated/attenuated virus approaches do not produce sufficient protection and that recombinant protein and/or DNA vaccines have only produced partial protection.\n\nDeductions (max 0.25 points):  \n- Deduct **0.05–0.25** if the response includes substantial irrelevant material (e.g., outbreak history, transmission routes, or detailed clinical signs) that is not needed to answer the question, with deduction severity based on how much it obscures the required points. The final score cannot be below 0."}
{"query": "Explain why pigs are considered key intermediate hosts (“mixing vessels”) in the emergence of new influenza virus strains, and describe the immunopathological mechanism that can make such strains highly virulent in the lung, including the term used for this phenomenon.", "response": "Rubric (Total Score: 1.0 Point; Minimum: 0 Points):\n\n- Role of pigs in emergence of new strains (0.5 points)  \n  - 0.5: States that pigs can be infected by influenza viruses from different species (e.g., humans and birds), facilitating cross-species transmission and/or reassortment that helps generate new potentially virulent strains.  \n  - 0.0: Does not identify pigs as intermediate hosts enabling cross-species mixing and new strain emergence.\n\n- Virulence mechanism in the lung (0.5 points)  \n  - 0.25: Describes that severe virulence can involve an uncontrolled/excessive immune response in the lung.  \n  - 0.25: Specifies this is driven by massive release of proinflammatory cytokines and chemoattractants and names the phenomenon “cytokine storm.”  \n  - 0.0: Fails to describe the excessive cytokine/chemoattractant-driven immune overreaction and/or does not name “cytokine storm.”\n\nDeductions for excessive irrelevant content (max 0.25 points):  \n- Deduct 0.05–0.25 if the response includes substantial information not needed to answer the question (e.g., unrelated influenza history, treatment protocols, or detailed molecular virology beyond the asked mechanism) that obscures the required points. The total score cannot go below 0."}
{"query": "Describe how Porcine circovirus type 2 (PCV2) is genotyped and sub-clustered using the Cap gene, and explain the two major genotype shifts observed since its discovery (including approximate timing and regions), noting any newly identified genotype and its distinguishing sequence characteristic.", "response": "Rubric (Total Score: 1.0 point; Minimum: 0 points)\n\n1) Genotyping basis and main genotypes (0.25 points)  \n- 0.25: States that PCV2 genotypes are defined by the Cap gene sequence and lists PCV2a, PCV2b, PCV2c, PCV2d, and PCV2e.  \n- 0.0: Does not identify the Cap gene as the basis and/or omits most genotypes.\n\n2) Sub-clustering details (0.20 points)  \n- 0.20: Correctly states PCV2b has clusters 1A–1C and PCV2a is subdivided into clusters 2A–2F.  \n- 0.0: Incorrect or missing cluster assignments.\n\n3) Novel genotype and distinguishing feature (0.20 points)  \n- 0.20: Identifies PCV2f as a novel genotype found in a retrospective China study (1996–1999) and notes it has lower sequence identity than other known genotypes.  \n- 0.0: Missing PCV2f and/or its lower sequence identity characteristic.\n\n4) Two major genotype shifts with timing and geography (0.35 points)  \n- 0.15: Correctly describes the first shift as PCV2a → PCV2b around 2004/2005.  \n- 0.20: Correctly describes the second shift since ~2012 as PCV2d gradually replacing predominant PCV2b in North America, China, South Korea, and Uruguay.  \n- 0.0: Missing or incorrect shifts, timing, or regions.\n\nDeductions for excessive irrelevant content (max 0.25 points)  \n- Deduct 0.05–0.25 if the response adds substantial off-topic material (e.g., extensive clinical disease descriptions, unrelated virology, vaccine discussions) that obscures the requested genotyping/shifts information. Final score cannot be below 0."}
{"query": "In shrimp pond farming, what are the hallmark field signs and typical timing of White Faeces Disease (WFD), what gut pathological changes are associated with it, which biological agents have been proposed as potential causes (give at least three examples), and what specific water-quality thresholds have been linked to peak mortality during outbreaks?", "response": "Rubric (Total = 1.0 point; Minimum = 0 points):\n\n- Hallmark sign + timing (0.25 points total)  \n  - 0.15: Identifies the hallmark sign as white faecal strings floating in rearing water.  \n  - 0.10: States typical onset is after ~50 days of culture.\n\n- Pathology (0.20 points total)  \n  - 0.20: Describes gut pathology as loss of microvilli with subsequent lysis in the hepatopancreas and midgut.\n\n- Proposed causative agents (0.30 points total)  \n  - 0.10: Names Enterocytozoon hepatopenaei (EHP).  \n  - 0.10: Names “veriform bodies resembling protozoan gregarines.”  \n  - 0.10: Correctly provides at least one culturable Vibrio example (any one: V. parahaemolyticus, V. fluvialis, V. mimicus, V. alginolyticus, or Vibrio sp.).  \n  *(Max for this section is 0.30 even if more examples are listed.)*\n\n- Water-quality thresholds tied to peak mortality (0.25 points total)  \n  - 0.15: States dissolved oxygen below 3.0 mg/L.  \n  - 0.10: States alkalinity below 80 ppm.\n\nDeductions for excessive/irrelevant content (max 0.25 points):  \n- Deduct 0.05–0.25 if the response adds substantial content not asked for (e.g., extended discussion of profitability outcomes, broad disease-management advice, or speculation on definitive causation beyond noting it is inconclusive), with the deduction proportional to severity.  \n- Final score cannot be below 0."}
{"query": "In a swine-associated viral “perfect ecological storm,” explain the distinct roles of reservoir hosts and intermediary hosts in (1) generating/sustaining viral genetic diversity and (2) transmitting viruses to humans, and then apply this framework to contrast commercial swine and exhibition swine in the United States, including why occasional co-raising of these groups can elevate zoonotic risk at county fairs.", "response": "Rubric (Total Score: 1.0 Point; Min Score: 0):  \n- 0.5 points: Correctly distinguishes host roles  \n  - Identifies reservoir hosts as primarily generating/sustaining high viral genetic diversity with relatively low direct human contact.  \n  - Identifies intermediary hosts as harboring a subset of reservoir diversity but enabling transmission to humans via higher contact.  \n- 0.5 points: Correct application to U.S. swine systems and zoonotic pathway  \n  - Commercial swine: described as effectively reservoir-like due to year-round production conducive to diverse viral evolution/sustained transmission, but reduced zoonotic transmission due to higher biosecurity/less frequent human contact.  \n  - Exhibition swine: described as intermediary-like due to low biosecurity and high human contact, plus seasonal cohort turnover that purges diversity/immunity.  \n  - Explains that occasional co-raising allows diverse viruses from commercial swine to enter exhibition settings (e.g., county fairs), increasing chances of spillover to humans.\n\nDeductions (Max 0.25 points):  \n- Deduct up to 0.25 points for excessive irrelevant content that goes beyond the asked mechanisms and swine-system comparison (e.g., unrelated virus taxonomy, unrelated historical outbreaks, or extensive general discussion of pandemics without tying to the specific reservoir/intermediary framework and U.S. swine examples). The final score cannot be less than 0."}
{"query": "Describe the key virion morphology and capsid composition of betanodaviruses, including envelope status, symmetry, approximate particle size range reported across studies, and the capsid subunit copy number and protein mass.", "response": "Rubric (Total Score: 1.0 point; Minimum: 0 points)\n\n- Envelope status (0.2):  \n  - 0.2 = States betanodavirus virions are non-enveloped.  \n  - 0.0 = Incorrect or missing.\n\n- Shape and symmetry (0.2):  \n  - 0.1 = States virions are spherical.  \n  - 0.1 = States they have icosahedral symmetry.  \n  - 0.0 = Incorrect or missing.\n\n- Particle size (0.2):  \n  - 0.2 = Gives an appropriate size description that includes ~25 nm and acknowledges a reported range approximately 20–34 nm across detections.  \n  - 0.0 = Incorrect or missing.\n\n- Capsid composition: copy number and protein mass (0.4):  \n  - 0.2 = States the capsid is formed by 180 copies (subunits).  \n  - 0.2 = States the capsid is made of a single protein of ~42 kDa.  \n  - 0.0 = Incorrect or missing.\n\nDeductions for excess/irrelevance (max 0.25):  \n- Deduct up to 0.25 if substantial extra material not asked for is included (e.g., long lists of host species/outbreak history) that obscures the required morphological/compositional points. Final score floored at 0."}
{"query": "Explain why swine are considered “mixing vessels” for influenza A viruses, and identify (i) the specific receptor-related reason they can be infected by both avian- and human-origin IAVs and (ii) three enzootic swine influenza A subtypes that commonly circulate worldwide, including one potential public health concern arising from these enzootic swIAVs.", "response": "Rubric (Total = 1.0 point; Minimum = 0.0 points):  \n\n- Mixing-vessel mechanism (0.35 points)  \n  - 0.35: Clearly explains that co-infection in swine can enable reassortment between avian- and human-origin IAVs, generating new reassortant viruses.  \n  - 0.0: Does not mention reassortment/co-infection as the reason swine facilitate new virus generation.\n\n- Receptor-related reason (0.25 points)  \n  - 0.25: States that swine respiratory tracts express both sialic acid (SA) receptor types associated with avian and human IAV binding, enabling infection by both origins.  \n  - 0.0: Fails to identify the presence of both SA receptor types (or gives an incorrect receptor explanation).\n\n- Common enzootic subtypes (0.20 points)  \n  - 0.20: Correctly lists all three: H1N1, H1N2, and H3N2.  \n  - 0.10: Lists exactly two of these correctly.  \n  - 0.0: Lists one or none correctly, or lists only subtypes not supported here.\n\n- Public health concern (0.20 points)  \n  - 0.20: Identifies that enzootic swIAVs can sporadically transmit to humans causing subclinical/mild seasonal-like illness and may have pandemic potential (either element acceptable, both ideal).  \n  - 0.10: Mentions only sporadic zoonotic transmission to humans OR only pandemic potential, but not both.  \n  - 0.0: No valid public health concern described.\n\nDeductions for excessive irrelevant content (max −0.25 points):  \n- Deduct 0.05–0.25 if the response includes substantial unrelated material (e.g., detailed influenza molecular biology, vaccination programs, or historical outbreak narratives) that is not needed to answer the question.  \n- Total score after deductions cannot be below 0.0."}
{"query": "Explain why accurate species-level identification of *Aeromonas dhakensis* is critical in warm-water aquaculture and public health, and describe two downstream decisions or assessments that can be improved by using dependable molecular tools to discriminate it from *Aeromonas hydrophila* and other motile aeromonads.", "response": "Rubric (Total Score: 1.0 point; Minimum: 0 points):  \n- **0.5 points:** States why accurate identification is critical, including both of the following core ideas:  \n  - Misidentification has likely caused its importance/prevalence in aquatic disease events to be overlooked (confusion with *A. hydrophila*/other aeromonads).  \n  - Correct ID is needed because *A. dhakensis* may be more virulent and can also infect humans (zoonotic risk), including concerns about antibiotic-resistant strains.  \n- **0.5 points:** Provides **two** correct downstream decisions/assessments improved by dependable molecular discrimination, chosen from:  \n  - Prompt/accurate diagnosis in disease cases in aquatic hosts.  \n  - Distinguishing strains with heightened virulence (virulence risk profiling).  \n  - Better evaluation of zoonotic risk to humans.  \n  - Informing antibiotic-resistance concern/risk evaluation (e.g., recognizing resistant strains as part of risk assessment).  \n  - Retrospective screening of presumptive *Aeromonas* strain collections to determine true prevalence/impact across aquaculture/environment/healthcare.  \n\nDeductions (max 0.25 points):  \n- Deduct **0.05–0.25 points** for excessive irrelevant content that obscures the required points (e.g., long discussions of unrelated aquaculture management practices or detailed treatment regimens not asked for).  \n- Final score cannot be below **0 points**."}
{"query": "In cultured fish, why can field diagnosis of bacterial gill disease (BGD) be unreliable in identifying the true causative bacterial species, and what specific laboratory-developed diagnostic methods can be used to more specifically support identification of *Flavobacterium branchiophilum*?", "response": "Rubric (Total = 1.0 point; Min = 0):  \n- 0.5 points: Explains the core limitation of field diagnosis: it is typically based on light microscopy and/or clinical signs, so bacteria on gills are often identified by visual morphology (long, thin rods) and presumed to be *F. branchiophilum* rather than confirmed to species level.  \n- 0.5 points: Correctly names at least two *F. branchiophilum*-specific/supportive diagnostic approaches from the following list: ELISA, IFAT, PCR. (Full 0.5 only if ≥2 are correctly provided; otherwise 0.)  \n\nDeductions (max 0.25 points):  \n- Deduct 0.1–0.25 points if the response adds substantial irrelevant content (e.g., detailed treatment protocols, unrelated fish diseases, or extensive general discussion of aquaculture) that obscures the required points. Final score cannot go below 0."}
{"query": "Describe the genomic location and structural organization of the swine leukocyte antigen (SLA) complex, including (i) its size range and chromosome placement, (ii) how the class I, II, and III regions are positioned relative to the centromere and chromosomal arms, (iii) what distinguishes the swine MHC arrangement from other studied mammals, and (iv) the gene-content differences between the class III region and the class I/II regions.", "response": "Rubric (Total = 1.0 point; Minimum = 0.0 points):  \n\n- **Genomic location, size, and chromosome (0.25 points)**  \n  - 0.25: States that the SLA complex spans ~2.40–2.66 Mb (or equivalent) and maps to swine chromosome 7 (SSC7), spanning the centromere.  \n  - 0.0: Missing/incorrect size range and/or chromosome placement and/or centromere spanning.\n\n- **Regional organization and chromosomal arms (0.25 points)**  \n  - 0.25: Correctly places class I and class III on **7p1.1**, and class II on **7q1.1**, with the class III region located between class I and class II (i.e., flanking the centromere-split arrangement).  \n  - 0.0: Incorrect or incomplete mapping of regions to chromosomal arms/bands and their relative arrangement.\n\n- **Unique feature among mammals (0.25 points)**  \n  - 0.25: Explicitly identifies the **centromere splitting the MHC/SLA complex** as a feature unique among mammals studied to date.  \n  - 0.0: Does not identify this unique centromere split or states a different “unique” feature.\n\n- **Gene-content differences across regions (0.25 points)**  \n  - 0.25: States that class I and II regions contain MHC class I/II gene series plus many non-MHC genes, while the class III region contains **no MHC genes** but includes key immunity-related genes.  \n  - 0.0: Incorrectly describes gene content (e.g., claims class III has MHC genes) or omits the contrast.\n\n**Deductions for excess/irrelevant content (max −0.25 points):**  \nSubtract **0.05 to 0.25** if the response adds substantial material not asked for (e.g., detailed discussion of anchor genes or haplotype-definition mechanisms beyond brief mention), with the deduction scaled to how much it obscures the required points. Final score cannot go below 0.0."}
{"query": "Describe African swine fever virus (ASFV) in terms of (i) viral family and genome type, (ii) virion morphology and layered structure (including size), (iii) host range and clinical outcome differences among suids, and (iv) the sylvatic transmission cycle including the vector; also explain what primarily drives ASFV genome size variation.", "response": "Rubric (Total = 1.0 point; Minimum = 0 points):\n\n- (0.20) Taxonomy + genome type: States that ASFV belongs to the **Asfarviridae** family and is a **double-stranded DNA** virus.  \n- (0.20) Virion morphology/size/layers: Identifies **icosahedral** morphology, gives size **~180–200 nm diameter**, and names the **multi-layered structure** with at least **4 of 5** correctly listed: **nucleoprotein core, core shell, inner envelope, viral capsid, external envelope (on egress)**.  \n- (0.20) Hosts + clinical outcome contrast: Notes infection of **domestic pigs and wild boar** plus other **African suids**, and contrasts outcomes: **acute disease with up to 90–100% mortality** in domestic pigs/wild boar vs **inapparent infection** in **bushpigs and warthogs**.  \n- (0.20) Sylvatic cycle + vector: Describes a **sylvatic cycle** involving **bushpigs/warthogs** and a **soft tick vector, Ornithodoros spp.**  \n- (0.20) Genome size + driver of variation: Gives genome size **~170–193 kbp**, mentions **~151–167 ORFs**, and explains that genome size differences are mainly due to **gain/loss of multigene family (MGF) members**.\n\nDeductions (max 0.25 points):  \n- Deduct **0.05–0.25** for excessive irrelevant material (e.g., unrelated control policies, vaccine discussions, or detailed molecular pathways not requested). Deduction magnitude depends on how much it obscures the required points. Final score cannot go below **0**."}
{"query": "In aquaculture, enumerate at least six distinct disease-mitigation mechanisms attributed to probiotic *Bacillus* and name at least four different fish pathogens (bacterial genera or specific viruses) that these *Bacillus* probiotics have been shown to mitigate.", "response": "Rubric (Total Score: 1.0 point; Minimum: 0.0):  \n- **Mechanisms (0.6 points):** Award **0.1 points each** for up to **six** correct, distinct mechanisms from the following list (max 0.6):  \n  1) production of bacteriocins; 2) suppression of virulence gene expression; 3) competition for adhesion sites; 4) production of lytic enzymes; 5) production of antibiotics; 6) immunostimulation; 7) competition for nutrients and energy; 8) production of organic acids.  \n- **Pathogens mitigated (0.4 points):** Award **0.1 points each** for up to **four** correct pathogens from the following list (max 0.4): *Aeromonas*, *Vibrio*, *Streptococcus*, *Yersinia*, *Pseudomonas*, *Clostridium*, *Acinetobacter*, *Edwardsiella*, *Flavobacterium*, white spot syndrome virus, infectious hypodermal and hematopoietic necrosis virus.  \n- **Deductions (max 0.25 points):** Deduct **0.05–0.25** if the response includes substantial irrelevant material beyond listing mechanisms and pathogens (severity-based). Final score cannot go below 0."}
{"query": "Explain how the chicken hypothalamus maintains homeostasis by describing its roles in thermoregulation, feeding control (including a specific nucleus and its neuropeptide function), reproductive regulation via photoperiod, and water balance (including the hormone involved and its site of production).", "response": "Rubric (Total Score: 1.0 Point):  \n- Thermoregulation (0.25): States that the hypothalamus regulates body temperature via thermoregulatory mechanisms to maintain a stable internal temperature.  \n- Feeding control with nucleus + neuropeptides (0.25): Identifies the arcuate nucleus and explains that it produces neuropeptides that stimulate or suppress appetite depending on nutritional status (hunger/satiety regulation).  \n- Reproduction via photoperiod (0.25): Explains that photoperiod (day length/light) influences hypothalamic function to regulate reproductive activity and seasonal adaptation.  \n- Water balance with hormone + production site (0.25): States that the supraoptic nucleus produces vasopressin, which regulates water reabsorption in the kidneys (water balance/thirst/fluid intake control).\n\nDeductions (Max 0.25):  \n- Deduct 0.05–0.25 for excessive irrelevant material that is not asked for (e.g., detailed discussion of aggression/parental care pathways or unrelated anatomy), depending on severity. Final score cannot go below 0."}
{"query": "Aquaculture disease management often relies on antibiotics for bacterial infections, vaccination for viral infections, and chemical treatments for parasitic infections, yet each approach has important limitations. Explain why new sustainable control measures are needed in aquaculture, and identify at least two alternative strategies to antibiotics/vaccines/chemicals, including one reason oral vaccination is particularly challenging.", "response": "Rubric (Total = 1.0 point; Minimum = 0):  \n- 0.35 points: States why new sustainable control measures are needed, including antibiotic-resistance risk (development and/or transfer of resistance genes).  \n- 0.15 points: Mentions at least one of the additional concerns driving change: environmental impact and/or consumer safety concerns.  \n- 0.25 points: Correctly identifies at least two alternative sustainable strategies from: (i) breeding for disease resistance, (ii) plant extracts as prebiotics, (iii) augmentation/introduction of beneficial microorganisms. (Full 0.25 only if at least two are named.)  \n- 0.25 points: Gives at least one correct reason oral vaccination is challenging: antigen breakdown in the harsh gastric environment and/or high tolerogenic gut environment and/or inadequate vaccine design.\n\nDeductions (max 0.25 points):  \n- Deduct 0.05–0.25 points for excessive irrelevant material that goes beyond answering the prompt (e.g., extended discussion of unrelated diseases, detailed mechanisms not asked for).  \n- Total score cannot go below 0."}
{"query": "Describe the virion structure and genome organization of Salmonid alphavirus (SAV), including its taxonomic placement, genome type/size, the number and functional division of its open reading frames, the specific proteins encoded in each region, and the genetic basis used to define SAV subtypes.", "response": "Rubric (Total = 1.0 point; Min = 0.0):  \n- **Taxonomy (0.20 pts):** Correctly identifies SAV as an **Alphavirus** in the **family Togaviridae**.  \n- **Virion structure (0.15 pts):** States that SAV is **spherical and enveloped**, and is approximately **60–70 nm** in diameter.  \n- **Genome type and size (0.20 pts):** States that SAV has a **single-stranded positive-sense RNA genome** of about **12 kb**.  \n- **Genome organization—two ORFs and division (0.25 pts):** States there are **two open reading frames**, with the **5′ two-thirds** encoding **nonstructural proteins nsP1–nsP4** and the **3′ end** encoding structural proteins.  \n- **Structural proteins named (0.10 pts):** Names the structural proteins as **E1, E2, E3, and 6K** (capsid glycoproteins).  \n- **Subtype basis (0.10 pts):** States that SAV subtypes (1–6) are defined using nucleic acid sequences encoding **E2 and nsP3**.\n\nDeductions (max 0.25 pts):  \n- Deduct **0.05–0.25 pts** for excessive irrelevant material that is not requested (e.g., long discussions of country-by-country outbreak lists or disease names without tying them to the asked genomic/taxonomic details). The total score cannot go below **0.0**."}
{"query": "Question (Text-Generation):\nDescribe the taxonomy of swine hepatitis E virus, name the four swine HEV genotypes identified within its species, and distinguish which genotypes are zoonotic versus swine-only; additionally, state two major human exposure routes and identify one patient group at increased risk for chronic infection.", "response": "Rubric (Total Score: 1.0 point; Minimum: 0.0 points)\n\nScoring Points (award only if correct and explicitly stated):\n- 0.25 pts: Correct taxonomy: species Orthohepevirus A, genus Orthohepevirus, family Hepeviridae.\n- 0.25 pts: Correctly lists all four swine HEV genotypes: HEV-3, HEV-4, HEV-5, HEV-6.\n- 0.20 pts: Correct zoonotic vs swine-only distinction: HEV-3 and HEV-4 are zoonotic/infect humans; HEV-5 and HEV-6 are identified only from swine.\n- 0.15 pts: Gives two correct major human exposure routes: (1) consumption of raw/undercooked pork (foodborne) and (2) occupational/direct contact with infected pigs.\n- 0.15 pts: Identifies an at-risk group for chronic infection: immunocompromised patients, especially solid-organ transplant recipients.\n\nDeductions (Max 0.25 pts):\n- Deduct 0.05–0.25 pts for excessive irrelevant material that goes well beyond what is asked (e.g., lengthy discussion of neurological/kidney outcomes, broad HEV history, unrelated virology), proportional to severity.  \n- Final score cannot be below 0.0 points."}
{"query": "In an adult chicken, compare the brachial wing vein, the right jugular vein, and the medial metatarsal vein as venipuncture sites by specifying (1) the preferred anatomical point for sampling from the brachial wing vein, (2) which jugular side is preferred and why, and (3) which site is more prone to hematoma formation and which site has lower hematoma risk but may be harder to locate.", "response": "Rubric (Total = 1.0 point; Minimum = 0.0):  \n- 0.35 points: States that blood from the brachial wing vein should be collected at the bifurcation just proximal to (near) the elbow (acceptable wording: “at/near the elbow where it bifurcates”).  \n- 0.25 points: Identifies the right jugular vein as preferred for faster collection of larger volumes.  \n- 0.25 points: Correctly identifies the jugular site as more prone to hematoma formation (due to vein mobility and/or large subcutaneous space).  \n- 0.15 points: Correctly identifies the medial metatarsal vein as having minimized/less hematoma risk (because it is surrounded by muscles) but being difficult to locate, especially in adults.  \n\nDeductions (max 0.25 points):  \n- Deduct 0.05–0.25 points for including substantial extraneous material that is not asked for (e.g., detailed restraint methods, needle gauge recommendations, or unrelated anatomy) such that it obscures or contradicts the required comparisons."}
{"query": "Explain the transmission route that leads to fish-borne zoonotic trematode (FZT) infection in humans, and contrast the major chronic disease outcome associated with hepatobiliary FZT (naming at least one causative species) with two key clinical or pathological effects that can occur in intestinal FZT infections (including at least one representative intestinal taxon).", "response": "Rubric (Total Score: 1.0 point; Minimum: 0.0):  \n\n- Transmission route (0.25 points)  \n  - 0.25: States that humans acquire infection by ingesting raw or improperly cooked fish containing the metacercaria stage of zoonotic trematodes/flukes.  \n  - 0.0: Missing/incorrect transmission route or wrong infectious stage/source.\n\n- Hepatobiliary FZT chronic outcome + species (0.25 points)  \n  - 0.25: Identifies chronic hepatobiliary inflammation with potential progression to cholangiocarcinoma, and correctly names at least one liver fluke species (Opisthorchis viverrini, O. felineus, or Clonorchis sinensis).  \n  - 0.125: Gives the correct chronic outcome (cholangiocarcinoma risk via chronic hepatobiliary inflammation) but does not name a correct species (or species is too vague/incorrect).  \n  - 0.0: Outcome is incorrect and/or no valid species.\n\n- Intestinal FZT effects + representative taxon (0.50 points)  \n  - 0.25: Correctly names at least one representative intestinal FZT taxon (e.g., Haplorchis spp. (Heterophyidae), Echinochasmus spp. (Echinostomatidae), Metagonimus spp., Centrocestus spp., Stellantchasmus falcatus, or Procerovum varium).  \n  - 0.25: Correctly provides at least two intestinal FZT effects from the following: intestinal inflammation, diarrhea, and/or invasion of heart/brain/spinal cord by parasite eggs.  \n  - 0.0–0.25: Partial (only one correct effect, or taxon missing/incorrect).\n\nDeductions for excess/irrelevant content (max 0.25 points)  \n- Deduct 0.05–0.25 if the response includes substantial unrelated material (e.g., extensive life-cycle details beyond ingestion of metacercariae, unrelated parasites/diseases, treatment guidelines) that obscures the required elements.  \n- Final score cannot go below 0.0."}
{"query": "Explain two distinct mechanisms by which probiotics can increase growth performance in aquaculture animals, including (i) how they affect feed quality or safety and (ii) how they alter the animal’s digestion and nutrient uptake, and state the downstream production/economic outcome these changes can produce.", "response": "Rubric (Total = 1.0 point; Min = 0.0):  \n- 0.25 points: Correctly states a feed quality/safety mechanism: probiotics detoxify harmful feed compounds via hydrolytic enzymes.  \n- 0.25 points: Correctly states a second feed-related mechanism: probiotics produce vitamins (must include biotin and/or vitamin B12) that improve nutritional value.  \n- 0.25 points: Correctly explains a digestion/nutrient uptake mechanism: probiotics alter digestive enzyme synthesis/release and/or modify intestinal structure to increase nutrient digestion and absorption.  \n- 0.25 points: Correctly identifies the downstream outcome: improved feed utilization leading to higher growth/body weight gain and improved yields at lower production costs.\n\nDeductions (max 0.25 points):  \n- Deduct 0.1–0.25 points if the response contains substantial irrelevant content (e.g., unrelated disease treatment details, species-specific protocols not asked for) that obscures the required mechanisms/outcome.  \n- Final score cannot be below 0.0."}
{"query": "In veterinary medicine, what is the specific viral agent that causes infectious canine hepatitis in dogs, what are four typical clinical signs of this disease, and what is a common non-infectious cause of hepatitis in large domestic animals?", "response": "Rubric (Total Score: 1.0 point; Minimum: 0 points):  \n- **0.25 points:** Correctly identifies the causative agent as **Canine mastadenovirus A** (formerly **Canine adenovirus 1, CAV-1**).  \n- **0.50 points:** Lists **four** typical clinical signs of infectious canine hepatitis in dogs: **pyrexia (fever), jaundice, vomiting, encephalopathy (neurologic signs)**.  \n  - Award **0.125 points each** for each correctly stated sign, up to 0.50 points.  \n- **0.25 points:** States that in large domestic animals hepatitis is commonly due to **ingested plant toxins**, with an acceptable example being **ragwort**.\n\nDeductions (Max 0.25 points):  \n- Deduct **0.05–0.25 points** if the response includes substantial irrelevant content beyond what is asked (e.g., detailed vaccine schedules, unrelated liver diseases, or extensive pathophysiology) that obscures the required facts.  \n- Final score cannot be below **0**."}
{"query": "A food-safety protocol aims to minimize microbial contamination of table eggs during cleaning while preserving the egg’s natural barrier. Explain what the eggshell cuticle is, when it is deposited relative to oviposition, two key protective functions it serves, and the specific temperature relationship recommended between wash water and the egg to reduce pore-mediated contamination.", "response": "Rubric (Total Score: 1.0 Point; Min: 0):  \n- **0.25 points:** Correctly identifies the cuticle as an extremely thin proteinaceous layer that plugs shell pore openings and regulates permeability (to gases/liquids/particles).  \n- **0.25 points:** Correctly states deposition timing: by uterine epithelial cells during the last ~5 hours before oviposition.  \n- **0.25 points:** States **two** protective functions, specifically: (1) reduces water loss, and (2) helps prevent bacterial penetration by blocking pore entrances (both required for full credit on this component; only one function earns 0.125).  \n- **0.25 points:** Correctly states the wash-water guidance: water should be about **20°F (11°C) warmer than the egg** to prevent vacuum action drawing contaminants through pores.  \n\nDeductions (Max 0.25 points):  \n- Deduct **0.05–0.25** points if the response includes substantial irrelevant material (e.g., detailed cuticle composition percentages or unrelated egg-processing steps) that obscures or replaces the required points; severity-based.  \n- Final score cannot be below 0."}
{"query": "Explain how the pancreas’s endocrine cell types and exocrine secretions work together to regulate blood glucose and support digestion in the duodenum, including (i) which islet cell type secretes each major hormone and (ii) how pancreatic juice acidity/alkalinity is controlled and why.", "response": "Rubric (Total Score: 1.0 point; Minimum: 0.0 points)\n\n1) Endocrine hormones and islet cell sources (0.6 points total)  \n- 0.15: States that beta cells secrete insulin.  \n- 0.15: States that alpha cells secrete glucagon.  \n- 0.15: States that delta cells secrete somatostatin.  \n- 0.15: States that gamma cells secrete pancreatic polypeptide.\n\n2) Endocrine function (0.1 points)  \n- 0.1: States that these endocrine secretions mainly regulate blood sugar (blood glucose) levels.\n\n3) Exocrine digestive role (0.15 points)  \n- 0.15: States that pancreatic juice contains digestive enzymes acting on carbohydrates, proteins, and fats in the duodenum.\n\n4) Bicarbonate and alkalinity/neutralization (0.15 points)  \n- 0.15: States that bicarbonate maintains pancreatic juice alkalinity and neutralizes acidic gastric juice.\n\nDeductions (max 0.25 points)  \n- Deduct 0.05–0.25 for excessive irrelevant content that goes well beyond the requested mappings/functions (e.g., unrelated pancreatic diseases, detailed pathways not asked for), proportional to severity. Final score cannot go below 0."}
{"query": "In grass carp, what anatomical structure functionally replaces the true stomach, and what are three quantitative histomorphometric characteristics of this structure (include the correct measurements with units)?", "response": "Rubric (Total = 1.0 point; Minimum = 0.0 points):  \n- (0.4 points) Correctly identifies the structure replacing the true stomach as the anterior intestinal dilatation called the **intestinal bulb**.  \n- (0.6 points) Provides **exactly three** correct quantitative characteristics **with units** for the intestinal bulb, chosen from the list below (0.2 points each; maximum 0.6):  \n  - Mean diameter of the bulb: **65 ± 41.54 µm**  \n  - Mean wall thickness: **1598.03 ± 31.58 µm**  \n  - Mean thickness of tunica mucosa: **1109.80 ± 13.85 µm**  \n  - Approximate number of deep longitudinal folds: **about 52**  \n  - Mean height of folds: **1066.98 ± 42.40 µm**  \n  - Mean width of folds: **181.38 ± 5.58 µm**  \n  - Mean lumen diameter: **1952.59 ± 42.86 µm**  \n\nDeductions (Maximum deduction = 0.25 points):  \n- Deduct **0.10–0.25 points** if the response includes substantial extra material beyond identifying the intestinal bulb and giving three measurements (e.g., extended discussion of unrelated fish anatomy or non-requested tissue-layer descriptions), with the deduction scaled to severity.  \n- Final score cannot be below **0.0**."}
{"query": "Explain why most mammalian testes descend to an extra-abdominal location for normal spermatogenesis, name two mammals whose testes remain intra-abdominal, and describe the key developmental reason horses have delayed inguinal passage compared with ox, sheep, and pig (include approximate gestational timings).", "response": "Rubric (Total Score: 1.0 point; Minimum: 0.0 points)  \n- Temperature rationale (0.30): States that descent is needed to reduce testicular temperature by about 2–3°C below core body temperature to support spermatogenesis.  \n- Exceptions (0.20): Correctly names both elephant and hyrax as having intra-abdominal testes.  \n- Comparative timing (0.20): Provides correct approximate inguinal passage timings for ox (~120 days), sheep (~80 days), and pig (~90 days) of pregnancy. (Credit if all three are correct; otherwise 0 for this point.)  \n- Horse mechanism + timing (0.30): Explains that in the horse the foetal gonad enlarges rapidly around ~100–120 days, preventing passage through the inguinal canal until shrinkage allows passage at ~300 days (with testes typically through the canal by birth).  \n\nDeductions (max 0.25):  \n- Deduct 0.05–0.25 for excessive irrelevant content that obscures the required points (e.g., lengthy discussion of unrelated endocrine pathways or general reproductive anatomy beyond what is asked). The total score cannot go below 0.0."}
{"query": "In canine chronic hepatopathies, why is copper detected on liver biopsy not by itself diagnostic of primary copper-associated hepatopathy, and what histologic/staining features and interpretive challenges should be evaluated to help distinguish primary from secondary copper accumulation while still guiding therapy?", "response": "Rubric (Total Score: 1.0 Point; Minimum: 0 Points)\n\nScoring points (award up to 1.0 point total):\n- 0.25 points: States that copper accumulation can be primary or secondary to other hepatopathies, so copper presence alone is not diagnostic for primary disease.\n- 0.25 points: Identifies that quantity and distribution patterns (e.g., periportal vs centrilobular) are key discriminators and are assessed on special copper stains (e.g., rhodanine or rubeanic acid).\n- 0.25 points: Mentions evaluating which cells contain copper (hepatocytes and/or macrophages) and associated lesions (necrotic hepatocytes and/or small “copper granulomas”).\n- 0.25 points: Explains interpretive challenges that can prevent confident distinction (e.g., severe parenchymal change distorting lobular architecture and/or Tru-cut biopsies with few intact lobules).\n\nDeductions (max 0.25 points):\n- Deduct 0.05–0.25 points for excessive irrelevant content that is not needed to answer (e.g., lengthy breed lists, unrelated liver physiology, non-biopsy diagnostic tests), with deduction severity based on how much it obscures the required elements. Final score cannot be below 0."}
{"query": "Explain how fish habitat salinity is associated with variation in nephron structure by (i) defining an aglomerular kidney and naming at least two fish groups in which it is common, and (ii) identifying which nephron segment is absent in several marine teleost orders and giving at least two example taxa that show this shorter nephron pattern.", "response": "Rubric (Total = 1.0 point; Minimum = 0 points):  \n- 0.4 points: Correctly defines an aglomerular kidney as lacking renal corpuscles (RCs).  \n- 0.2 points: Names at least two correct example taxa/groups where aglomerular kidneys are predominantly found in marine species/euryhaline fishes in seawater (any two of: toadfish/Batracoididae, anglerfish/Lophiiformes, sea horses/Hippocampus, needlefish/Belonidae).  \n- 0.2 points: Correctly identifies the absent nephron segment in several marine teleosts as the distal segment.  \n- 0.2 points: Provides at least two correct example taxa/groups with the shorter nephron due to absence of the distal segment (any two of: percids/Percidae, killifish/Cyprinodontiformes, flounder/Pleuronectiformes, sticklebacks/Gasterosteidae).  \n\nDeductions (max 0.25 points):  \n- Deduct 0.05–0.25 points for excessive irrelevant material beyond what is needed to answer the two requested parts (severity-based), without reducing the final score below 0."}
{"query": "A dog presents with protein intolerance, hyperammonemia, and progressive neurologic signs consistent with hepatoencephalopathy. Explain why defects in any one of the five urea cycle enzymes can be life-threatening in mammals, identify a specific urea-cycle enzyme deficiency reported in dogs and its likely clinical outcome if untreated, and name two general treatment measures used to control the neurologic syndrome.", "response": "Rubric (Total Score: 1.0 point; Minimum: 0.0 points)\n\n- Essential biochemical rationale (0.35 points)  \n  - 0.35: Clearly states that mammals lack alternative pathways for urea biosynthesis, so a defect in any single urea-cycle enzyme can prevent effective ammonia detoxification (leading to hyperammonemia).  \n  - 0.0: Does not state the lack of alternative urea biosynthesis pathways and/or does not connect enzyme defects to failure of ammonia detoxification.\n\n- Specific deficiency in dogs + consequence if untreated (0.35 points)  \n  - 0.20: Identifies argininosuccinate synthetase deficiency as the reported defect.  \n  - 0.15: States that if untreated it can progress to severe hepatoencephalopathy with CNS depression leading to coma and death.  \n  - 0.0: Wrong/missing deficiency and/or wrong/missing untreated outcome.\n\n- Two treatment measures (0.30 points)  \n  - 0.15: Names a low-protein diet.  \n  - 0.15: Names oral antibiotics.  \n  - 0.0: Provides fewer than two correct measures or substitutes unrelated therapies.\n\nDeductions for excess/irrelevant content (max 0.25 points)  \n- Deduct 0.05–0.25 if the response includes substantial additional material not needed to answer (e.g., lengthy discussion of unrelated liver diseases, detailed pathophysiology beyond ammonia/urea-cycle relevance, or extensive treatment regimens beyond the two requested) such that it obscures the required points.  \n- Total score after deductions cannot be below 0.0."}
{"query": "In veterinary surgical pathology, what histologic and anatomic criteria define a subcutaneous mast cell tumor (subcutaneous MCT) as a distinct subtype rather than a dermal/cutaneous MCT, and which single assessed feature has the strongest association with clinical outcome?", "response": "Rubric (Total Score: 1.0 point; Minimum: 0 points)\n\n- **Subtype-defining location/invasion criteria (0.6 points)**\n  - **0.3**: States that the **bulk of the tumor is located within the subcutaneous fat/subcutis**.\n  - **0.3**: States there is **no invasion of the dermis** (i.e., it is restricted to subcutis rather than arising in dermis and extending downward).\n  - *Notes for full credit on this section:* Minor allowed findings (e.g., low numbers of mast cells around hair follicle bases or infiltrating panniculus musculature) may be mentioned but are **not required**.\n\n- **Strongest prognostic feature (0.4 points)**\n  - **0.4**: Correctly identifies **mitotic activity/mitotic count** as the feature with the strongest effect on clinical outcome.\n\n- **Deductions for excessive irrelevant content (max −0.25 points)**\n  - Deduct **0.1–0.25** if the response adds substantial unrelated material (e.g., extensive discussion of unrelated grading systems, treatment modalities beyond what is asked, epidemiology, or clinical signs) that obscures the required criteria and prognostic factor.  \n  - Final score cannot be below **0**."}
{"query": "Describe the developmental origin and layered structure of the greater omentum, identify the cavity it encloses and its sole opening, and state the anatomical location of that opening relative to the caudate lobe of the liver, the caudal vena cava, and the hepatic portal vein, including its approximate size in the dog.", "response": "Rubric (Total Score: 1.0 Point; Min Score: 0.0 Points)\n\n- Greater omentum origin and formation (0.25 points)  \n  - 0.25: States that the dorsal mesogastrium attaches to the greater curvature of the stomach and grows caudally as a net-like covering over the ventral intestines to become the greater omentum.  \n  - 0.0: Missing or incorrect.\n\n- Layered structure (0.15 points)  \n  - 0.15: Identifies the greater omentum as having two layers forming a pouch: parietal/superficial and visceral/deep parts.  \n  - 0.0: Missing or incorrect.\n\n- Enclosed cavity and sole entry (0.20 points)  \n  - 0.20: Names the enclosed cavity as the omental bursa and identifies the only entry as the epiploic foramen.  \n  - 0.0: Missing or incorrect.\n\n- Location relative to key structures (0.30 points)  \n  - 0.10: Places the epiploic foramen caudomedial to the caudate lobe of the liver.  \n  - 0.10: States it is dorsal to the caudal vena cava.  \n  - 0.10: States it is dorsomedial to the hepatic portal vein.  \n  - 0.0: Any of these relations missing or incorrect earns 0 for that subpoint.\n\n- Size/shape in the dog (0.10 points)  \n  - 0.10: States it is slit-like and about 4 cm in the dog.  \n  - 0.0: Missing or incorrect.\n\nDeductions for extraneous content (Max deduction: 0.25 points)  \n- Deduct 0.05–0.25 if the response includes substantial irrelevant material (e.g., unrelated peritoneal ligaments, detailed clinical pathology, or extensive anatomy not needed to answer the prompt) that obscures the required points.  \n- Total score after deductions cannot be below 0.0."}
{"query": "In paravertebral anaesthesia at T13, L1, and L2, explain which functional neuron types are directly blocked to produce body-wall analgesia (including parietal peritoneum) and localized muscle effects, and justify why autonomic function is generally maintained despite thoracolumbar involvement (include the role of parasympathetic absence and sympathetic pre-/postganglionic organization).", "response": "Rubric (Total = 1.0 point; Min = 0 points):  \n- **0.4 points:** Correctly identifies that **GSA (general somatic afferent) neurons** carrying **touch/pain from the body wall** are anaesthetised, producing analgesia (must clearly link GSA block to pain/touch loss in body wall/parietal peritoneum region).  \n- **0.3 points:** Correctly identifies that **GSE (general somatic efferent) neurons** in the **ventral rami (T13, L1, L2)** to **striated body-wall muscle** are anaesthetised, explaining localized motor/muscle effects.  \n- **0.2 points:** States that the **parasympathetic system has no neurons in thoracolumbar spinal nerves**, supporting why parasympathetic function is not impacted here.  \n- **0.1 points:** Explains that **sympathetic preganglionic neurons are in thoracolumbar ventral roots** but autonomic function is maintained because the **pre- to postganglionic ratio is ~1:20**, allowing **widespread compensation** and leaving sufficient **sympathetic GVA-related function** intact.\n\nDeductions (max 0.25 points):  \n- Deduct **0.05–0.25** for substantial irrelevant additions (e.g., unrelated anaesthetic drug pharmacology, unrelated spinal levels/species details, or extensive surgical technique discussion) that obscure the required points. Final score not below 0."}
{"query": "Explain the embryological origin and cellular contributions to the avian thymus, including (i) which pharyngeal pouches it derives from, (ii) how thymic primordium cells and mesenchymal cells contribute to distinct thymic components (stroma vs epithelial-reticular meshwork), and (iii) the key features of thymic migration and final gross arrangement in the neck, noting how age affects its apparent position.", "response": "Rubric (Total Score: 1.0 point; Minimum: 0 points)\n\nA. Pharyngeal pouch origin (0.25 points)  \n- 0.25: Correctly states the thymus originates from the 3rd, 4th, and 5th pharyngeal pouches.  \n- 0: Incorrect or missing pouches.\n\nB. Cellular contributions to thymic components (0.40 points)  \n- 0.20: States thymic primordium/epithelial-reticular component (reticulum/meshwork) is endodermal in origin (from pharyngeal endoderm).  \n- 0.20: States head mesenchymal cells migrate in (via vessels) and form the stroma (excluding the epithelial-reticular component).  \n- 0: Does not correctly distinguish origins and/or assigns them incorrectly.\n\nC. Migration pathway, gross arrangement, and age-related position (0.35 points)  \n- 0.15: Describes migration superficially along the cervical region near the external jugular vein and vagus nerve toward the thoracic inlet/entrance of the thoracic coelomic cavity.  \n- 0.10: States it is typically 6–8 completely separate lobes.  \n- 0.10: Explains age effect: in very young birds it appears higher in the cervical region and becomes lower (more caudal/distal) with advancing age due to continued migration.  \n- 0: Missing or incorrect description of migration, lobation, and/or age effect.\n\nDeductions for excess/irrelevant content (max 0.25 points)  \n- Deduct 0.05–0.25 if the response adds substantial irrelevant material beyond the asked elements (e.g., detailed thymic immune function, lymphocyte selection mechanisms, unrelated comparative anatomy), proportional to severity.  \n- Final score cannot be below 0."}
{"query": "During glycogen mobilization, explain the two distinct enzymatic reactions required to (i) shorten nonreducing-end α‑1,4 glycosidic chains and (ii) remove α‑1,6 branch points, including the key chemical difference in bond cleavage (Pi vs H₂O), the immediate products formed (with approximate proportions), how those products are converted to Glc‑6‑P, and the specific liver-only step that enables release of free glucose into the bloodstream.", "response": "Rubric (Total Score: 1.0 Point; Minimum: 0.0):  \n- **0.25 points:** Correctly identifies reaction (i) as **phosphorylase** acting on **nonreducing-end α‑1,4 linkages** and specifies that it uses **inorganic phosphate (Pi), not water**, to cleave the bond (phosphorolysis).  \n- **0.25 points:** Correctly identifies reaction (ii) as a **debranching enzyme** acting on **α‑1,6 branch points** and states that it yields **free glucose** (not Glc‑1‑P) from the branch-point removal step.  \n- **0.25 points:** Correctly states the **product proportions**: about **90%** of glycogen degradation yields **Glc‑1‑P** (from α‑1,4 phosphorolysis) and about **10%** yields **free glucose** (from debranching).  \n- **0.25 points:** Correctly describes conversion/handling: **Glc‑1‑P → Glc‑6‑P via phosphoglucomutase (PGM)**, and free glucose can be **rapidly phosphorylated to Glc‑6‑P**; additionally identifies the liver-specific step **Glc‑6‑phosphatase (Glu‑6‑Pase) dephosphorylates Glc‑6‑P to free glucose for blood release**.\n\nDeductions (Max 0.25 points):  \n- Deduct **0.05–0.25** for excessive irrelevant material (e.g., detailed regulation by hormones, full EMP pathway steps, or unrelated glycogen synthesis discussion) that obscures the required items.  \n- Final score cannot go below **0.0**."}
{"query": "A clinician uses a Wood’s lamp to screen a suspected dermatophyte infection and observes apple-green fluorescence on hairs. Explain (1) why this finding is not definitive for dermatophytosis, (2) what confirmatory microscopic findings should be sought (include organism location relative to the hair shaft and the typical spore morphology), and (3) how fluorescence can be used to monitor treatment response as hair regrows.", "response": "Rubric (Total Score: 1.0; Minimum: 0.0):\n- 0.30 points: States that Wood’s lamp fluorescence is not definitive because false positives can occur from lint, crust/debris, or topical medications (must mention at least one specific non-fungal cause of similar fluorescence).\n- 0.40 points: Describes confirmatory microscopy correctly: plucked hairs examined under mineral oil at ~100× for hyphae plus arthrospores, with typical ectothrix distribution (coccoid arthrospores surrounding the outside of the hair shaft) and hyphae within the hair shaft (both ectothrix + internal hyphae required).\n- 0.30 points: Explains monitoring response: treated hairs may continue to fluoresce, but only the infected portion glows; as hair grows out, loss of fluorescence along the new growth indicates improvement (must include “only infected portion fluoresces” and “loss of fluorescence as hair grows”).\n- Deductions (max 0.25 points): Deduct up to 0.25 for excessive irrelevant content that obscures the required points (e.g., extended discussion of unrelated dermatophyte species, treatment regimens, or disease epidemiology). Final score cannot be below 0.0."}
{"query": "How do the mucous secretions and epithelial/cellular organization of the guppy ampullary organ and canal neuromasts support electrosensory/mechanosensory function, and what structural difference in canal support distinguishes guppies from red-tail shark that could relate to adaptation to water pressure?", "response": "Rubric (Total Score: 1.0 point; Minimum: 0.0 points):  \n- 0.4 points: Correctly explains the functional role of mucous substances in the ampulla/canals (neutral mucosubstances filling the ampulla plus acidic mucosubstances from abundant mucous cells), including at least one correct function: modulation of receptor signal intensity and/or protection, and notes their excellent electrical conductivity.  \n- 0.4 points: Correctly describes key organization enabling sensation/transmission: ampullary pores lined by a single squamous cell layer leading to a sac/ampulla of fusiform receptor cells; and/or canal neuromasts in canals filled with fluid (water + mucus) that transmit vibrations via skin pores to neuromasts with sensory cells bearing apical microvilli and associated nerve fibers below.  \n- 0.2 points: Correctly states the interspecies structural support difference and adaptive implication: guppy canal neuromasts are surrounded by an osseous (bony) coat (and/or dermal bone involvement), whereas red-tail shark canals are supported by a fibrous coat; bony support helps resist compression/squeezing under high bottom water pressure.  \n\nDeductions (max 0.25 points):  \n- Deduct 0.05–0.25 if the response adds excessive irrelevant material (e.g., unrelated fish anatomy, staining theory not tied to the asked functions/structures) that obscures the required points.  \n- Final score cannot be below 0.0."}
{"query": "A clinical isolate carries the A2059G mutation in a macrolide ribosomal target site. Predict the resistance phenotype across erythromycin, azithromycin, clarithromycin, clindamycin, and streptogramins, and briefly name two other distinct mechanisms by which bacteria can become resistant to macrolides.", "response": "Rubric (Total Score: 1.0 point; Minimum: 0 points)  \n- Resistance phenotype from A2059G (0.7 points total)  \n  - 0.2: States high-level resistance to erythromycin (correct: high-level resistance).  \n  - 0.2: States high-level resistance to azithromycin (correct: high-level resistance).  \n  - 0.15: States moderate resistance to clarithromycin (correct: moderate resistance).  \n  - 0.15: States moderate resistance to clindamycin (correct: moderate resistance).  \n  - 0.0/0.2: States no resistance to streptogramins (correct: no resistance). Award 0.2 if explicitly correct; otherwise 0.  \n\n- Two other macrolide-resistance mechanisms (0.3 points total)  \n  - 0.15: Names efflux pumps (correct: efflux mediated by pumps, e.g., mef(A), proton motive force–driven).  \n  - 0.15: Names drug inactivation (correct: hydrolysis of the lactone ring and/or phosphorylation/modification).  \n  - Note: If the response instead lists another correct category explicitly distinct from target-site modification, efflux, or inactivation, score that element as 0.\n\nDeductions for excess/irrelevant content (max 0.25 points)  \n- Deduct up to 0.25 if the answer includes substantial unrelated material (e.g., detailed macrolide spectra against many organisms, long discussion of anti-inflammatory effects) that obscures the requested phenotype/mechanisms.  \n- Final score cannot be below 0."}
{"query": "A dog presents with acute non–weight-bearing lameness and strongly resists paw handling by withdrawing the limb. Describe an effective approach to palpating and examining the paw and digits to localize pain, and list at least four common paw/digit conditions that can cause lameness; also state what nail wear might indicate.", "response": "Rubric (Total = 1.0 point; Minimum = 0 points):\n\n- Handling/positioning technique (0.35):  \n  - 0.35 points: States that paw/digit palpation should be performed while other joints (carpal and elbow) are held in relatively flexed positions to facilitate examination in a withdrawal-prone dog.\n\n- Exam method to localize pain (0.25):  \n  - 0.25 points: Describes assessing each digit including the nail and nail bed, and using careful palpation plus joint manipulation through flexion and extension while watching for pain and/or swelling.\n\n- Causes of paw/digit lameness (0.30):  \n  - 0.30 points: Correctly lists at least four of the following: split nails; nail-bed tumors; phalangeal fracture or luxation; infection; penetrating foreign bodies; pad lacerations.  \n  - 0.15 points: Lists only three correct causes.\n\n- Interpretation of nail wear (0.10):  \n  - 0.10 points: States that nail wear can indicate digit dragging due to neurologic disorders.\n\nDeductions for excessive irrelevant content (max 0.25):  \n- Deduct 0.05–0.25 points if the response includes substantial extraneous material not needed to answer (e.g., extended discussion of unrelated orthopedic differentials, imaging protocols, or treatments), proportional to severity. Final score not below 0."}
{"query": "A dog has a penetrating wound of the 5th digit of the forepaw with inflammation tracking along the extensor tendons. Which specific lymph node group is most likely to receive the primary afferent lymphatic drainage from (a) the 5th digit region and (b) the tendons of the extensor digitorum and extensor carpi muscles, and list four additional anatomical regions that commonly send afferent lymph to the same node group.", "response": "Rubric (Total = 1.0 point; Min = 0 points):  \n- 0.6 points: Correctly identifies the **superficial cervical lymph nodes** as the primary drainage lymph node group for both (a) the 5th digit/forepaw digit region and (b) the relevant extensor tendons (extensor digitorum communis/lateralis, extensor carpi radialis/ulnaris, etc.).  \n  - Award 0.6 only if the node group name is clearly given (accept “superficial cervical” or “prescapular”).  \n- 0.4 points: Lists **four** additional correct regions that send afferents to the superficial cervical lymph nodes (any four of the following earn credit):  \n  - Pinna  \n  - Parotid/neck areas  \n  - Skin of caudal part of dorsal head region  \n  - Caudal half of cranial neck region  \n  - Metacarpus/carpus/forearm  \n  - Lateral upper shoulder/upper foreleg region  \n  - Medial side of humerus region  \n  - Anterior thorax / cranial part of ventral thorax  \n  - Masseter region skin (often)  \n  - Antebrachial fascia (often)  \n  - Shoulder muscles (e.g., deltoideus, supra-/infraspinatus, teres minor, subscapularis)  \n  - Trunk limb muscles (e.g., trapezius, omotransversarius, brachiocephalic, sternomastoid, rhomboid, serratus ventralis, pectorales)  \n  - Splenius, sternohyoideus, sternothyroideus, neck skin muscle  \n  - Bones of the forelimb; carpal joint; forepaw digit joints  \n  - Award 0.4 only if four distinct correct regions are provided. Fewer than four = 0 for this component.  \n\nDeductions (max 0.25 points):  \n- Deduct up to 0.25 points for substantial irrelevant or extraneous content that obscures the requested identification/list (e.g., unrelated lymph node groups, detailed pathophysiology not asked for).  \n- Final score cannot be below 0."}
{"query": "In horses, explain why the term hydrophthalmos is preferred over buphthalmos, describe how hydrophthalmos typically develops and presents in adult versus congenital glaucoma cases (including the expected visual prognosis), and state how it can be differentiated from exophthalmos in a unilateral case.", "response": "Rubric (Total = 1.0 point; Min = 0 points):\n- Terminology preference (0.25 points):\n  - 0.25: States that hydrophthalmos means an enlarged globe regardless of original size and is preferred in equids because “buphthalmos” implies cow-sized, which is actually smaller than a horse globe.\n  - 0: Incorrect or missing.\n\n- Adult-horse glaucoma course and signs + vision potential (0.25 points):\n  - 0.25: Describes slow globe enlargement in adult glaucoma and links it with other glaucoma signs (corneal edema and/or endothelial/Haab’s striae) and notes vision may be present/reduced/absent at diagnosis and may return if IOP is controlled (even if mild enlargement remains).\n  - 0: Incorrect or missing.\n\n- Congenital glaucoma differences + prognosis (0.25 points):\n  - 0.25: States enlargement is more rapid in congenital cases due to greater elasticity of young globes, and vision loss is more rapid and permanent.\n  - 0: Incorrect or missing.\n\n- Differentiation from exophthalmos (0.25 points):\n  - 0.25: Defines exophthalmos as displacement of a normal-sized globe and notes that in unilateral cases comparative ultrasound measurements can confirm enlarged globe vs displacement.\n  - 0: Incorrect or missing.\n\nDeductions for excess content (max 0.25 points):\n- Deduct 0.05–0.25 if the response includes substantial irrelevant material (e.g., detailed glaucoma treatment protocols, unrelated ophthalmic diseases) that obscures the required points. Final score cannot go below 0."}
{"query": "A dog with generalized Malassezia dermatitis needs both treatment and a plan to prevent recurrence. Specify (1) an evidence-based topical regimen for active infection (including acceptable active ingredients/concentrations and frequency/duration), (2) the preferred oral antifungal options with typical dosing and tolerability considerations, and (3) one oral option that is less reliable and one that is less effective for surface infections, explaining why each is suboptimal.", "response": "Rubric (Total = 1.0 point; Min = 0.0 points):  \n\n- Topical regimen for active infection (0.40 points)  \n  - 0.25: Correctly lists at least TWO acceptable topical active ingredient options with correct concentrations (any two):  \n    - 2% chlorhexidine + 2% miconazole or ketoconazole; OR  \n    - 3–4% chlorhexidine as sole ingredient; OR  \n    - 1–2% miconazole; OR  \n    - 2% climbazole.  \n  - 0.15: Correct frequency AND duration for active infection: two to three times per week for three to four weeks.\n\n- Preferred oral options + dosing + tolerability (0.35 points)  \n  - 0.20: Names ketoconazole AND itraconazole as most effective options.  \n  - 0.10: Provides typical dosing for either or both (5–10 mg/kg/day).  \n  - 0.05: Notes itraconazole is generally better tolerated, but GI upset (vomiting/inappetence/diarrhea) can occur with either.\n\n- Suboptimal oral options and why (0.25 points)  \n  - 0.125: Identifies fluconazole (5–10 mg/kg/day) as potentially fewer adverse effects/interactions but less reliable for Malassezia treatment.  \n  - 0.125: Identifies terbinafine (30 mg/kg/day) as less effective for surface infections because it does not achieve high stratum corneum or sebum concentrations.\n\nDeductions (max 0.25 points):  \n- Deduct 0.05–0.25 if the response includes substantial irrelevant material (e.g., unrelated diseases, non-requested pharmacology, or extensive anecdotal treatment plans) that obscures the required regimen details. Final score cannot go below 0."}
{"query": "A 10-week-old puppy with a history of frequent regurgitation is diagnosed with gastroesophageal intussusception. Describe what gastroesophageal intussusception is (including what may invaginate), identify the common signalment, explain the key predisposing esophageal disorder and a plausible mechanical reason it may predispose, and state why the condition requires immediate treatment.", "response": "Rubric (Total = 1.0 point; minimum = 0 points):  \n- Definition and contents of intussusception (0.25): States that the stomach invaginates into the esophagus, and may include other abdominal organs (e.g., spleen, duodenum, pancreas, omentum).  \n- Signalment (0.20): Identifies it as rare and typically affecting young dogs, most commonly < 3 months old.  \n- Predisposing disorder (0.25): Correctly identifies idiopathic megaesophagus as an important preexisting/predisposing esophageal disease.  \n- Plausible mechanical rationale (0.15): Explains that a dilated/enlarged-capacity esophagus can accommodate invagination of the stomach through the diaphragmatic hiatus.  \n- Emergency nature (0.15): States it is a true gastrointestinal emergency with potential for death if untreated, hence needs immediate intervention.\n\nDeductions (max 0.25 points):  \n- Deduct up to 0.25 for excessive irrelevant detail that is not asked for (e.g., extensive discussion of unrelated causes of regurgitation, unrelated neurologic syndromes, or treatment protocols not requested), scaled to severity. Final score cannot be below 0."}
{"query": "In a small ruminant with septic pedal arthritis where prolonged antibiotic therapy has failed, what management option is described as more humane than distal interphalangeal joint drainage with arthrodesis, and what specific preoperative check must be performed to avoid persistent postoperative pain?", "response": "Rubric (Total = 1.0 point; Min = 0.0):  \n- 0.5 points: States the more humane option is **surgical removal (amputation) of the digit**.  \n- 0.5 points: States the necessary preoperative check/criterion is to **rule out sepsis in the proximal joints** (e.g., by **radiography if in doubt**) because proximal joint sepsis would mean pain persists.  \n\nDeductions (max 0.25 points):  \n- Deduct up to 0.25 if the response includes substantial irrelevant procedural detail (e.g., exact wire placement, 45° sawing angle, bandage schedule) that is not asked and obscures the required two elements."}
{"query": "A dog presents with multiple white-to-yellow papules and plaques with surrounding erythema on the head and distal limbs; some lesions are painful and intermittently pruritic, and a few have ulcerated. Describe the most appropriate diagnostic workup to confirm cutaneous xanthomas and rule out important differentials, including the key histopathologic findings and any species-specific laboratory testing, and state the core treatment strategy needed to prevent recurrence.", "response": "Rubric (Total Score: 1.0 point; Min: 0):  \n- **0.4 points:** States that **histopathology/biopsy** is needed to confirm the diagnosis and gives the **key findings**: **foamy macrophages**, **multinucleated giant cells**, and **lipid lakes throughout the dermis** (must include foamy macrophages + either giant cells or lipid lakes for full credit; partial = 0.2).  \n- **0.3 points:** Identifies appropriate tests to help rule out differentials/complications: **submit nodular tissue for bacterial and fungal culture** and **address secondary infection if present** (both elements for full credit; one element = 0.15).  \n- **0.15 points:** Includes **deep skin scrapings and fungal culture** when lesions are **pruritic or spreading**.  \n- **0.15 points:** States treatment is **prescription low-fat diet** and **management of underlying lipid/metabolic disease (e.g., diabetes mellitus)** and notes that **surgery alone without correcting the underlying cause leads to recurrence** (all required for full 0.15; two elements = 0.1; one = 0.05).  \n- **Species-specific requirement (can earn within points above):** Mentions that in **cats**, **serum lipid levels should be checked on a chemistry panel** (if included, counts toward completeness; if omitted, no extra penalty unless the answer incorrectly generalizes it as mandatory for dogs).  \n\nDeductions (max 0.25 points):  \n- Deduct **0.05–0.25** for substantial irrelevant additions (e.g., lengthy discussion of unrelated skin diseases, drug regimens not indicated, or extensive pathogenesis beyond lipid abnormalities) that obscure the requested diagnostic/treatment plan. Final score cannot be below 0."}
{"query": "In a PRRSV-positive breeding herd, identify three key factors that sustain ongoing PRRSV circulation and describe one specific gilt-replacement strategy that reduces the presence of fully susceptible (seronegative) subpopulations before entry into the herd.", "response": "Rubric (Total Score: 1.0 point; Minimum: 0.0 points)\n\nScoring points (award up to 1.0 total):\n- 0.6 points (0.2 each) for correctly stating three sustaining factors:\n  - 0.2: Co-existence of genetically diverse PRRSV isolates due to entry of new viruses (e.g., poor biosecurity and/or introduction of contaminated animals or semen).\n  - 0.2: Presence of naïve, fully susceptible subpopulations.\n  - 0.2: Improper management of gilt replacement pools.\n- 0.4 points for correctly describing the gilt-replacement strategy:\n  - 0.4: Expose incoming naïve replacement gilts to the farm-specific resident PRRSV isolate before they enter the PRRSV-positive breeding herd, with the goal of reducing seronegative/susceptible subpopulations.\n\nDeductions (max 0.25 points):\n- Deduct 0.05–0.25 for excessive irrelevant content beyond what is needed to answer (e.g., extended discussion of PRRSV virology, clinical signs, vaccines, or unrelated control programs).  \n- Total deduction cannot exceed 0.25, and final score cannot be below 0.0."}
{"query": "In a pig with an intestinal obstruction suspected to be caused by a foreign body (e.g., a stone), what surgical approach can be used to both treat the obstruction and evaluate whether euthanasia may be warranted, and what are two intraoperative management options for the stone?", "response": "Rubric (Total Score: 1.0 Point; Minimum: 0.0 Points):  \n- 0.4 points: Identifies laparotomy/abdominal surgery as the approach that allows direct treatment and assessment of disease extent (for deciding on prompt euthanasia if necessary).  \n- 0.3 points: States that if a stone is palpated in the small intestine, it can be removed.  \n- 0.3 points: States that the stone can alternatively be milked/manipulated into the large intestine.  \n\nDeductions (Max 0.25 Points):  \n- Deduct 0.05–0.25 points for excessive irrelevant content that goes beyond the asked elements (e.g., detailed descriptions of unrelated causes, extensive post-op care not requested). The deduction magnitude depends on severity. Final score cannot go below 0.0."}
{"query": "In pigs, describe the typical clinical course and duration of illness following infection with *Mycoplasma hyorhinis* in nursery/grower animals, and explain how concurrent primary respiratory infection and systemic spread change the main clinical signs and lesions (include at least three specific systemic manifestations).", "response": "Rubric (Total Score: 1.0 point; Minimum: 0 points)\n\n- **0.35 points**: States early/typical presentation in nursery/growers as **sneezing and catarrhal nasal discharge**, with **reduced feed intake and depression**, and notes **recovery in ~10–14 days if uncomplicated**.  \n- **0.35 points**: Explains effect of **concurrent primary respiratory pathogen**: *M. hyorhinis* found in **lower airways**, **contributes to pneumonia pathogenesis**, increasing **coughing and dyspnoea**.  \n- **0.30 points**: Describes systemic spread consequences including **pleuritis** (worsens respiratory signs) **and at least three** of the following specific systemic manifestations: **peritonitis with arched/curved-back posture**, **pericarditis**, **lameness due to (poly)arthritis**, and/or notes **polyserositis/polyarthritis can last >6 weeks**.\n\nDeductions (Max 0.25 points):  \n- Deduct **0.05–0.25** for excessive irrelevant material (e.g., detailed treatment protocols, unrelated pathogens, or age-group epidemiology beyond what is needed), proportional to severity. Final score cannot go below 0."}
{"query": "Compare ruminants and South American camelids (SACs) by describing (1) their ovulatory/oestrus physiology and follicular dynamics, (2) copulation posture and ejaculation characteristics, (3) one male reproductive anatomical difference, and (4) one key placental/fetal-membrane difference.", "response": "Rubric (Total = 1.0 point; Minimum = 0 points):\n\n- Reproductive physiology & follicular dynamics (0.30 points)  \n  - 0.15: States ruminants have an oestrus cycle with spontaneous ovulation (and no follicular wave cycle).  \n  - 0.15: States SACs lack an oestrus cycle, are induced ovulators, and do have a follicular wave cycle.\n\n- Copulation posture & ejaculation (0.25 points)  \n  - 0.125: States ruminants copulate standing with ejaculation short and intense.  \n  - 0.125: States SACs copulate prone with prolonged ejaculation.\n\n- Male reproductive anatomy (0.20 points)  \n  - 0.20: Identifies that male SACs have a cartilaginous projection on the tip of the penis and that ruminants lack it.\n\n- Placenta/fetal membrane difference (0.25 points)  \n  - 0.125: States SACs have a diffuse placenta and the fetus is surrounded by an epidermal membrane.  \n  - 0.125: States ruminants lack the epidermal membrane and have placental cotyledons.\n\nDeductions for irrelevant/excess content (maximum deduction = 0.25 points):  \n- Deduct 0.05–0.25 if the response adds substantial unrelated details (e.g., breathing, kidneys, parasites, suburethral diverticulum) beyond what is asked, with deduction proportional to how much it obscures the required comparisons.  \n- Final score cannot be below 0."}
{"query": "Explain why bluetongue virus (BTV) outbreaks depend on Culicoides midges, describe the mechanism underlying clinical signs in cattle when they occur, and state the laboratory method used to confirm diagnosis and what it detects.", "response": "Rubric (Total Score: 1.0 point; minimum 0):  \n- **Vector dependence and requirement for replication (0.35 points):** States that Culicoides midges act as required vectors **and** that BTV must replicate in the vector for transmission/outbreaks to occur.  \n- **Pathogenesis of clinical signs in cattle (0.35 points):** Identifies **endothelial damage** and **disseminated intravascular coagulation (DIC)** as the basis of clinical disease in cattle (may optionally link to haemorrhage/ischaemia/oedema/inflammation, but those alone are insufficient without the mechanism).  \n- **Diagnostic confirmation (0.30 points):** Specifies **PCR** as the confirmatory test and that it detects **viral RNA** (accept “detects all 24 serotypes” only if PCR and viral RNA are also correctly stated).\n\nDeductions (max 0.25 points):  \n- Deduct **0.05–0.25** for excessive irrelevant material that is not asked for (e.g., lengthy vaccine schedules, detailed nursing advice, or geographic history) depending on severity.  \n- Final score cannot be below **0**."}
{"query": "Describe a humane enucleation procedure for a non-recoverable eye condition in an animal, including the preferred sedation drug, the local anaesthetic technique (location and volume), key surgical steps to remove the globe without entering the conjunctival sac, and essential postoperative medications and timing for suture removal.", "response": "Rubric (Total = 1.0 point; Minimum = 0 points):  \n- **0.25 points:** Correctly identifies **heavy sedation with xylazine**.  \n- **0.25 points:** Correctly describes local anaesthesia as **instilled around the orbit including deeper tissues**, specifically a **single very deep 5 ml injection behind the eye to block the optic nerve**.  \n- **0.25 points:** Correctly outlines key surgical steps: **eyelids sutured closed; aseptic clipping/prep; skin incision parallel to upper eyelid margin without entering conjunctival sac; blunt dissection to section extraocular muscles (upper then lower); curved scissors to cut optic nerve; remove eye; obliterate socket with absorbable subcuticular suture; close eyelids with non-absorbable suture**.  \n- **0.25 points:** Correct postoperative plan: **antibiotics + NSAIDs for at least 5 days**, and **remove sutures at 10 days**.  \n\nDeductions (max 0.25 points):  \n- Deduct **0.05–0.25** for excessive irrelevant content that obscures the required elements (e.g., unrelated ophthalmic diseases, alternative surgeries, detailed anatomy not needed).  \n- Final score cannot be below **0**."}
{"query": "A flock of sheep develops a highly contagious ocular condition progressing from scleral inflammation with blepharospasm and increased lacrimation to corneal opacity and sometimes vascularization, ending in corneal ulceration. Identify two primary causative agents, name two opportunistic bacterial contributors, and state the recommended core treatment approach including one antibiotic choice and one medication class to avoid using concurrently.", "response": "Rubric (Total Score: 1.0 Point; Min Score: 0.0 Points):\n\n- Primary causative agents (0.4 points total):\n  - 0.2 points: Correctly names *Mycoplasma conjunctivae* as a primary cause.\n  - 0.2 points: Correctly names *Chlamydophila psittaci* as a primary cause.\n\n- Opportunistic bacterial contributors (0.2 points total):\n  - 0.1 points: Names any one of the following: *E. coli*, *Moraxella (Branhamella) ovis*, *Staphylococcus aureus*.\n  - 0.1 points: Names a second, different organism from the same list.\n\n- Treatment and contraindication (0.4 points total):\n  - 0.2 points: States treatment includes antibiotic eye ointment (topical antibiotics) and/or parenteral antibiotics.\n  - 0.1 points: Specifies oxytetracyclines as an appropriate antibiotic choice (acceptable: “oxytetracycline/long-acting oxytetracycline”).\n  - 0.1 points: Correctly states corticosteroids should not be used at the same time (avoid instilling corticosteroids concurrently).\n\nDeductions (Max 0.25 points):\n- Deduct 0.05–0.25 points for excessive irrelevant content that obscures the required items (e.g., extensive discussion of reservoirs, abortion outbreaks, or differential diagnoses beyond what is asked).  \n- Final score cannot be below 0.0 points."}
{"query": "Explain why non-virulent *Haemophilus parasuis* typically fails to cause systemic disease in healthy pigs, and contrast this with the key immune-evasion and persistence mechanisms that enable virulent strains to survive in the lung and potentially establish ongoing infection.", "response": "Rubric (Total = 1.0 point; minimum = 0.0):  \n\n- **0.5 points (Non-virulent strain control and lack of dissemination):** The answer correctly states BOTH of the following:\n  - Non-virulent strains are effectively recognized, phagocytosed, and killed by porcine alveolar macrophages (PAM), leading to clearance from the lungs.  \n  - Non-virulent strains are serum-sensitive and therefore cannot survive in blood to disseminate systemically.  \n\n- **0.5 points (Virulent strain mechanisms in lung and persistence):** The answer correctly states at least TWO of the following virulence-associated features (at least one must be immune-evasion related):\n  - Resistance to phagocytosis and delayed/limited activation of PAM during lung infection.  \n  - Use of capsule and/or the trimeric autotransporter surface proteins VtaA8 and VtaA9 to promote phagocytosis resistance.  \n  - Formation of biofilm-like structures on respiratory mucosa (e.g., tracheal mucosa) after colonization.  \n  - Intracellular/close association in the lung with host cells (neutrophils/macrophages and especially pneumocytes), with pneumocyte localization serving as a reservoir for persistent infection.  \n\n- **Deductions for excess/irrelevant content (max deduction = 0.25 points):**  \n  - Deduct **0.10–0.25** if the response adds substantial unrelated material (e.g., treatments, unrelated pathogens, extensive clinical signs not needed to answer the mechanism question) such that the core mechanisms are obscured.  \n  - Final score cannot be below **0.0**."}
{"query": "A dog presents with pink-to-red urine. Explain how centrifugation/settling and urine sediment findings can be used to distinguish hematuria from hemoglobinuria/myoglobinuria, and state approximately how many RBC per high-power field (hpf) are associated with light pink versus dark pink urine in dogs.", "response": "Rubric (Total = 1.0 point; Minimum = 0 points):  \n- **0.50 points:** Correctly states the centrifugation/settling distinction:  \n  - Hematuria (intact RBC) **clears in the supernatant** after centrifugation/settling because RBC pellet/sediment.  \n  - Hemoglobinuria/myoglobinuria **does not clear** and **persists in the supernatant** because pigment is dissolved.  \n- **0.50 points:** Correctly provides the approximate RBC/hpf thresholds in dogs:  \n  - **Light pink** urine at about **600 RBC/hpf**.  \n  - **Dark pink** urine at about **800–950 RBC/hpf**.  \n\nDeductions (max 0.25 points):  \n- Deduct **0.05–0.25** for excessive irrelevant content (e.g., extended discussion of beet pigments/HPLC/porphyrinuria without linking to the question’s requested differentiation and RBC/hpf thresholds), proportional to severity.  \n- Final score floor: **0 points**."}
{"query": "Explain the pathophysiologic mechanism by which pneumothorax reduces cardiac output, and list four distinct causes of pneumothorax in small animals, including at least one iatrogenic cause and one species-associated cause that is more typical in cats than dogs.", "response": "Rubric (Total = 1.0 point; minimum = 0):  \n- 0.5 points: Mechanism correctly explained: air in the pleural space makes intrapleural pressure positive → lung collapse, leading to decreased venous return and therefore decreased cardiac output. (Must include the venous return link and the cardiac output consequence.)  \n- 0.5 points: Causes listed (any four), with these requirements met:  \n  - At least one iatrogenic cause correctly named (e.g., barotrauma during anesthesia/mechanical ventilation; post-thoracocentesis; post fine-needle lung aspiration).  \n  - At least one cause identified as more typical in cats than dogs: inflammatory lower airway disease.  \n  - The remaining causes can be any correct distinct items (e.g., blunt force trauma from car accident/fall; penetrating trauma from inhaled foreign body; esophageal perforation; rupture of emphysematous bulla/pleural bleb; neoplasm; Paragonimus cyst; abscessed lung lobe; lung necrosis due to embolization with heartworm disease; pulmonary thromboembolic disease; porcupine quills).  \n\nDeductions (max 0.25 points):  \n- Deduct 0.05–0.25 points for excessive irrelevant material that obscures the required mechanism/causes (e.g., extended treatment protocols, unrelated cardiopulmonary diseases, or lengthy anatomy review). Final score cannot go below 0."}
{"query": "Design a helminth-control and deworming program for a commercial pig herd that includes (1) schedules for adults, growing pigs, and outdoor vs. indoor management, (2) at least two acceptable drug-delivery options with correct example doses/regimens, and (3) concrete steps to minimize anthelmintic resistance and ensure food-safety compliance.", "response": "Rubric (Total Score: 1.0 point; Min Score: 0 points)\n\n- **0.35 points — Correct treatment schedules and management actions**\n  - **0.15**: Adults treated **every 6 months**.  \n  - **0.10**: Growing pigs treated at **8 weeks of age**, then **every 2 months until maturity**.  \n  - **0.10**: Environmental management included: **outdoor pigs moved to clean pasture** and/or **indoor accommodation steam cleaned**.\n\n- **0.35 points — Correct medication options with accurate example regimens**\n  - Award full **0.35** if the answer correctly gives **at least two** of the following options (must include correct drug + route/form + dose/regimen):\n    - In-feed **ivermectin or fenbendazole** at **6-monthly intervals** (counts as one option if clearly stated).  \n    - **Doramectin i.m.** at **3 mg/10 kg**.  \n    - **Ivermectin s.c.** at **300 μg/kg**.  \n    - In-water **flubendazole 1 mg/kg for 5 days**.  \n    - **Fenbendazole oral pellets 5 mg/kg single dose**.\n\n- **0.30 points — Resistance reduction and food-safety compliance**\n  - **0.15**: Resistance mitigation includes **treating animals up to weight** (correct dosing by weight).  \n  - **0.10**: States **only licensed medicines for pigs** should be used.  \n  - **0.05**: Mentions following **meat withdrawal periods**.\n\nDeductions (Max 0.25 points)  \n- Deduct **0.05–0.25** for excessive irrelevant content that obscures the requested program (e.g., lengthy parasite life cycles, extensive discussion of non-pig species, or detailed clinical pathology not needed for the plan).  \n- Total score after deductions cannot be below **0.0**."}
{"query": "In fracture management, what is meant by closed reduction, what are the essential manipulation steps used to accomplish it, and what clinical fracture features make a case most suitable for attempting closed reduction?", "response": "Rubric (Total Score: 1.0 Point; Minimum: 0.0 Points):  \n\n- Definition of closed reduction (0.25 points)  \n  - 0.25: States that closed reduction is fracture reduction performed without incising the skin and without exposing the bone, using external manipulation.  \n  - 0.0: Missing or incorrect definition.\n\n- Key manipulation steps (0.40 points)  \n  - 0.15: Mentions holding/stabilizing the major bone segments through the skin.  \n  - 0.15: Mentions separating impacted/overridden ends using traction when needed.  \n  - 0.10: Mentions aligning the segments to near-normal anatomical position.  \n  - 0.0: Steps largely missing or incorrect.\n\n- Indications / suitable fracture features (0.35 points)  \n  - 0.15: Identifies fresh fractures (especially fresh lower limb fractures) as typical candidates.  \n  - 0.10: Specifies two-piece fractures with little or no overriding/displacement.  \n  - 0.10: Notes that segments should be easily palpable with minimal muscular coverage.  \n  - 0.0: Indications not provided or incorrect.\n\nDeductions for extraneous content (max 0.25 points):  \n- Deduct up to 0.25 if the response contains excessive unrelated material (e.g., detailed discussion of open reduction, internal fixation device types, or postoperative nursing not asked for) that substantially obscures the required elements. The final score cannot be below 0.0."}
{"query": "Compare *Salmonella* serovars with respect to (1) their primary animal reservoirs and (2) their likelihood of causing human enteritis, and then propose two specific on-farm exposure-prevention measures that reduce human infection risk when livestock are known to be shedding *Salmonella*.", "response": "Rubric (Total Score: 1.0 point; minimum 0.0):  \n- **0.6 points (Serovars: reservoir + human enteritis risk; all must be correct):**  \n  - **0.2**: Identifies **S. typhimurium** as found in multiple livestock species worldwide (e.g., cattle/sheep/goats/pigs; poultry rare) **and** notes it **causes human enteritis**.  \n  - **0.2**: Identifies **S. enteritidis** as mainly associated with **poultry** **and** notes it **causes human enteritis**.  \n  - **0.2**: Identifies **S. enterica serovar Dublin** as mainly associated with **cattle** **and** notes it **rarely causes human enteritis**.  \n\n- **0.4 points (Two prevention measures; must be specific and applicable on farms):**  \n  - **0.2**: Provides one correct measure, such as **excluding vulnerable people (children/elderly/immunocompromised/pregnant) from contact with infected animals**, **not bringing infected animals into food prep/eating areas**, **not drinking raw milk**, **not eating undercooked eggs**, or **seeking medical care for diarrhoea/vomiting/flu-like illness while informing the doctor of livestock salmonella**.  \n  - **0.2**: Provides a second **distinct** correct measure from the list above.\n\n- **Deductions (max 0.25 points):**  \n  - Deduct **0.1–0.25** for substantial irrelevant/additional content that obscures the requested comparison and measures (e.g., long discussions of unrelated *Salmonella* taxonomy, treatment regimens, or detailed disease pathology beyond “enteritis”).  \n  - Final score cannot go below **0.0**."}
{"query": "A urine sample is uniformly red-brown and remains discolored after centrifugation; the dipstick pad is positive for occult blood but no intact erythrocytes are seen in the urinary sediment. Describe a practical stepwise approach to differentiate myoglobinuria from hemoglobinuria using serum appearance and ammonium sulfate precipitation, and state which pigment is definitively identified by urinary protein electrophoresis.", "response": "Rubric (Total = 1.0 point; Minimum = 0 points):\n- 0.4 points: Correctly states the serum color distinction:\n  - Hemoglobinuria: serum can be pink (hemoglobin bound to haptoglobin).\n  - Myoglobinuria: serum typically not discolored (no carrier; rapidly cleared).\n- 0.4 points: Correctly states the ammonium sulfate (80% saturation) result:\n  - Myoglobin stays largely in solution.\n  - Hemoglobin is completely precipitated.\n- 0.2 points: Correctly states the definitive test:\n  - Definitive differentiation requires urinary protein electrophoresis (identifies whether the pigment is myoglobin vs hemoglobin by electrophoretic pattern).\n\nDeductions (max 0.25 points):\n- Deduct 0.05–0.25 for excessive irrelevant additions (e.g., extensive discussion of porphyrias, species anecdotes, or unrelated urine color causes) that are not needed to answer the question. Final score cannot be below 0."}
{"query": "A cat suspected of heartworm disease has negative antigen and antibody tests. Explain at least two plausible diagnostic reasons for these negative results in feline heartworm disease, and identify one echocardiographic finding that would support the diagnosis despite negative serology.", "response": "Rubric (Total Score: 1.0 point; Minimum: 0.0):\n- 0.4 points: States a correct reason antibody tests can be negative in cats (any one earns full 0.4):\n  - Antibody positivity indicates exposure only (so lack of antibodies does not rule out disease), and/or\n  - False-negative antibody tests are common in cats.\n- 0.4 points: States a correct reason antigen tests can be negative in cats (any one earns full 0.4):\n  - No female worms present (e.g., only males), and/or\n  - Only a few live males are present (low worm burden), and/or\n  - Antigen–antibody complex formation can mask antigen (more problematic in cats), causing false negatives.\n- 0.2 points: Identifies the echocardiographic supportive finding:\n  - Two parallel hyperechoic lines in the right ventricle or pulmonary artery.\n\nDeductions (max 0.25 points):\n- Deduct 0.05–0.25 points for excessive irrelevant content that goes beyond the requested diagnostic explanations and echocardiographic sign (e.g., extensive discussion of unrelated treatments, life cycle details, or radiographic criteria not asked for). Final score cannot be below 0.0."}
{"query": "Explain how the normal dorsal cricoarytenoideus muscle and its innervation produce airway opening during inspiration, and describe the anatomic course of the recurrent laryngeal nerve on the right versus left side. Then, identify the broader neurologic syndrome associated with many older, large-breed dogs with acquired laryngeal paralysis and state one piece of evidence supporting that it is a generalized (not purely local) neurologic disorder.", "response": "Rubric (Total Score: 1.0 point; Minimum: 0 points)\n\n- (0.35) Normal function and action: States that contraction of the dorsal cricoarytenoideus abducts the corniculate processes of the arytenoids during inspiration, opening the rima glottidis.  \n- (0.25) Innervation and nerve course: Identifies the recurrent laryngeal nerve as a vagal branch and correctly distinguishes its course (loops around the right subclavian artery on the right; loops around the aorta on the left; then travels cranially to the larynx).  \n- (0.20) Syndrome identification: Names the syndrome “geriatric-onset laryngeal paralysis–polyneuropathy (GOLPP).”  \n- (0.20) Evidence of generalized neurologic disease: Provides one correct supporting item, such as:  \n  - EMG/nerve conduction findings in peripheral limb muscles suggesting axonal disease, OR  \n  - clinical signs consistent with broader deficits (e.g., esophageal dysfunction, decreased proprioceptive placing), OR  \n  - abnormal laryngeal sensation in the context of generalized deficits.\n\nDeductions (Max 0.25 points):  \n- Deduct 0.05–0.25 points for substantial irrelevant additions that dilute the required elements (e.g., extended treatment protocols, unrelated airway diseases, or breed lists not asked for). The total score cannot fall below 0."}
{"query": "In ferrets, how do Aleutian disease (parvovirus) and ferret epizootic coronaviral enteritis (alphacoronavirus) differ in typical mortality and in the characteristic pattern of gastrointestinal signs over the first few days of illness?", "response": "Rubric (Total = 1.0 point; Min = 0 points):  \n- 0.5 points: Correctly states the mortality pattern for both diseases: Aleutian disease in ferrets is rarely fatal; ferret epizootic coronaviral enteritis has low mortality (<5%) despite high morbidity.  \n- 0.5 points: Correctly contrasts the GI sign pattern: Aleutian disease can cause diarrhoea (may be melaena) among systemic signs; epizootic coronaviral enteritis typically causes 48–72 hours of lethargy/anorexia with vomiting that then stops, followed by profuse green bile-stained mucoid diarrhoea (“green slime disease”).  \n\nDeductions (max 0.25 points):  \n- Deduct 0.05–0.25 points for excessive extraneous content that is not asked for (e.g., extensive lab-value discussion, age-related course details, or unrelated differential diagnoses). Final score cannot go below 0."}
{"query": "A captive snake presents with intense pruritus, self-trauma, anaemia, and dysecdysis. On close inspection, tiny red-to-dark “pin-head” mites are found tucked under the overlapping edges of the scales and around the corners of the mouth, and additional mites are seen floating in the water bowl after bathing. Identify the most likely mite species and name one bacterial genus and one viral disease that it can transmit.", "response": "Rubric (Total Score: 1.0 point; Minimum: 0 points):  \n- (0.4 points) Correctly identifies the mite as **Ophionyssus natricis** (snake mite).  \n- (0.3 points) Correctly names the bacterial genus **Aeromonas** as transmissible by this mite.  \n- (0.3 points) Correctly names the viral disease **inclusion body disease (IBD)** as transmissible by this mite.  \n\nDeductions (max 0.25 points):  \n- Deduct up to **0.25 points** for excessive irrelevant content that goes beyond identification/transmission (e.g., lengthy discussion of unrelated mite species, detailed treatment protocols, or unrelated reptile diseases)."}
{"query": "A leopard gecko presents with dysecdysis. What husbandry adjustments and immediate interventions can help resolve the shedding problem, and what specific complication involving the digits must be checked for and why?", "response": "Rubric (Total Score: 1.0 Point; Minimum: 0 Points)  \n- 0.4 points: States an appropriate husbandry adjustment to improve shedding: increase cage humidity and/or temperature.  \n- 0.3 points: States an immediate intervention: soak the animal in a warm water bath.  \n- 0.3 points: Identifies the digit/toe complication and consequence: retained shed skin can constrict/wrap around digits, cutting off circulation and leading to necrosis (must include both constriction/circulation compromise and necrosis/tissue damage).  \n\nDeductions (Max 0.25 Points):  \n- Deduct 0.05–0.25 points (severity-based) if the response includes substantial irrelevant content beyond the asked husbandry measures and digit complication (e.g., extended discussion of unrelated diseases or treatments). The final score cannot be below 0."}
{"query": "A newly identified fish rhabdovirus is described as an enveloped, bullet-shaped virus with a non-segmented, single-stranded negative-sense RNA genome of 11,019 nucleotides encoding five proteins (N, P, M, G, L). It is classified in the genus *Vesiculovirus* (family *Rhabdoviridae*, order *Mononegavirales*) and lacks the non-virion (NV) gene found between the G and L genes in *Novirhabdovirus*. How would you (i) state its full taxonomic placement, (ii) summarize its key structural and genomic features, (iii) specify the missing gene difference relative to *Novirhabdovirus*, and (iv) describe how isolates are genotyped and what genotypes are associated with North America/Asia versus Europe?", "response": "Rubric (Total = 1.0 point; Min = 0 points):  \n\n- **Taxonomy (0.25 points)**  \n  - 0.25: Correctly states genus *Vesiculovirus*, family *Rhabdoviridae*, order *Mononegavirales*.  \n  - 0: Any missing/incorrect taxonomic level.\n\n- **Structural + genome features (0.35 points)**  \n  - 0.15: Correctly identifies “enveloped” and “bullet-shaped.”  \n  - 0.10: Correctly gives particle size range (≈80–180 nm length; ≈60–90 nm diameter).  \n  - 0.10: Correctly describes genome as non-segmented, ssRNA, negative-sense (all three required).  \n  - 0: If these elements are largely absent or incorrect (partial credit only as specified above).\n\n- **Specific genomic difference vs *Novirhabdovirus* (0.20 points)**  \n  - 0.20: Clearly states that the NV (non-virion) gene between G and L is missing.  \n  - 0: Does not mention NV gene absence and/or wrong location.\n\n- **Genotyping + geography (0.20 points)**  \n  - 0.10: States genotyping is based on partial G gene sequence and lists all four genotypes (1a, 1b, 1c, 1d).  \n  - 0.10: Correctly links North America/Asia to genotype 1a and Europe to 1b/1c/1d.  \n  - 0: If missing key parts (e.g., no geography mapping or incorrect genotype set).\n\n- **Deductions for excessive irrelevant content (max deduction = 0.25 points)**  \n  - Deduct **0.05–0.25** if the response adds substantial unrelated material (e.g., extended disease symptoms, treatment programs, or unrelated virology) that obscures the required points.  \n  - Cap total deduction so the final score cannot drop below 0."}
{"query": "Explain the primary physiological functions of the liver and describe how estrogen alters hepatic lipid metabolism in laying hens to increase the triacylglycerol (TAG) content available for egg formation.", "response": "Rubric (Total Score: 1.0 Point; Min Score: 0 Points)\n\n- Liver functions (0.6 points total)  \n  - 0.15: States blood detoxification as a liver function.  \n  - 0.15: States regulation of circulating hormones as a liver function.  \n  - 0.15: States carbohydrate metabolism as a liver function.  \n  - 0.15: States protein synthesis and/or secretion of bile salts as a liver function (either earns 0.15; both may be mentioned but no extra credit).\n\n- Estrogen effect in laying hens (0.4 points total)  \n  - 0.20: Identifies that de novo lipogenesis in chickens occurs primarily in the liver and involves conversion of glucose to triglycerides/neutral lipids.  \n  - 0.20: Explains that in laying hens estrogen causes a shift in hepatocytic lipoprotein production, making the liver a source of TAG that ends up in eggs.\n\nDeductions for excess/irrelevant content (max 0.25 points)  \n- Deduct up to 0.25 if the response adds substantial unrelated material (e.g., detailed anatomy, unrelated diseases, or mechanisms not asked for) that obscures the required points. Final score cannot go below 0."}
{"query": "Design a safe, minimally traumatic venipuncture protocol for collecting blood from (a) a salamander and (b) a frog/toad, specifying the appropriate skin preparation solution (including dilution), preferred venipuncture site(s), needle/syringe selection, key technique precautions to avoid sample/vascular compromise, anticoagulant handling for the sample, restraint/anesthesia considerations, and maximum allowable blood volume for healthy versus sick animals.", "response": "Rubric (Total Score: 1.0 point; minimum 0):  \n- **0.20**: Skin prep correctly states **do not use alcohol** and specifies **1:40 dilution of 2% chlorhexidine** for site cleansing.  \n- **0.20**: Salamander collection correctly specifies **caudal tail vein** as the typical venipuncture site.  \n- **0.20**: Frog/toad collection correctly identifies **ventral abdominal vein** as the easiest primary site (may also list femoral/lingual as options but not as the primary easiest site).  \n- **0.15**: Equipment correctly specifies **1 mL syringe with 25–27 gauge needle** (or **insulin syringe for very small patients**).  \n- **0.10**: Technique precaution correctly states **avoid applying strong negative pressure** because the vessel is small and can collapse.  \n- **0.05**: Sample handling correctly states blood should be placed in a **heparinized Microtainer tube**.  \n- **0.05**: Restraint/anesthesia considerations correctly include **avoid restraint without gloves** (to prevent epithelial damage/elevated WBC) and/or that **some amphibians require anesthesia with 2%–3% MS222**.  \n- **0.05**: Blood volume limits correctly state **≤1% body weight if healthy** and **≤5% if sick**.\n\nDeductions (max **0.25**):  \n- Deduct **0.05–0.25** for excessive irrelevant content that obscures the protocol (e.g., unrelated disease discussion, non-requested drug regimens, or extensive anatomy not tied to sites/technique). Final score cannot go below **0**."}
{"query": "Explain two distinct biological mechanisms by which plant-derived polysaccharides can improve intestinal health and immunity in intensively farmed chicks, including the role of gut microbiota and the specific downstream metabolites involved.", "response": "Rubric (Total Score: 1.0 Point; Min: 0 Points):  \n- 0.5 points: States that polysaccharides regulate/modulate the intestinal microbiota structure (i.e., change the composition/structure of gut flora in a way linked to improved gut function/immunity).  \n- 0.5 points: States that polysaccharides are fermented by gut flora to produce short-chain fatty acids (SCFAs), and that these SCFAs help alleviate intestinal dysfunction (or equivalently improve intestinal function/health).  \n\nDeductions (Max 0.25 Points):  \n- Deduct 0.1–0.25 points if the response adds substantial irrelevant material beyond the required mechanisms (e.g., lengthy discussion of anti-cancer effects or non-poultry applications) that obscures whether the two required mechanisms are correctly identified.  \n- Final score cannot be below 0."}
{"query": "Explain why chicken nucleated erythrocytes are a useful model for epigenomic studies of transcriptionally active chromatin, and describe two distinct biological roles of these erythrocytes that make them relevant for linking chromatin state to organismal physiology.", "response": "Rubric (Total Score: 1.0 point; minimum 0.0):\n- (0.4) Model usefulness for epigenomics: States that chicken erythrocytes are nucleated and readily isolated, enabling epigenomic profiling of chromatin features associated with expressed/poised genes in a generally repressive chromatin environment (must include nucleated + practical accessibility/isolation, plus the idea of studying active/poised chromatin organization).\n- (0.3) Role 1 (gas transport): Identifies oxygen delivery to tissues and/or carbon dioxide removal as a physiological function.\n- (0.3) Role 2 (immunity): Identifies support of the innate immune response/protection from pathogens as a function.\nDeductions (max 0.25):\n- Deduct 0.05–0.25 for excessive irrelevant content that is not requested (e.g., extended discussion of chicken vs human genome size/gene arrangement or broad epigenetics background without tying to the question). Final score cannot go below 0.0."}
{"query": "A snake presents with oral inflammation consistent with stomatitis (“mouth rot”). Explain three plausible initiating or predisposing causes and outline a diagnostic workup that distinguishes bacterial from viral involvement, including at least one option when PCR is unavailable.", "response": "Rubric (Total = 1.0 point; Minimum = 0 points):\n\n- Causes/predisposing factors (0.6 points total):\n  - 0.2 points: Identifies snout rubbing/trauma from vivarium glass as an initiating cause (or equivalent description of mechanical injury to the mouth/snout).\n  - 0.2 points: Identifies immunosuppression or stress/other disease (including overzealous force-feeding of anorectic reptiles) as a predisposing factor.\n  - 0.2 points: Identifies at least one additional correct factor such as:\n    - Gram-negative bacterial secondary infection,\n    - uric acid crystal deposition from visceral gout/renal failure enabling infection,\n    - herpesvirus or ranavirus in tortoises (oral ulceration/diphtheresis),\n    - Mycoplasma spp. association in tortoises,\n    - adenoviruses or IBD association (in snakes/lizards as noted).\n\n- Diagnostic workup (0.4 points total):\n  - 0.2 points: States impression smears and bacterial swab with culture for bacterial assessment.\n  - 0.2 points: States viral diagnostic approach including PCR as an option, AND at least one correct alternative when PCR is not accessible (virus isolation using reptile cell lines OR electron microscopy of samples).\n\nDeductions for excessive/irrelevant content (max 0.25 points):\n- Deduct up to 0.25 points if the response adds substantial unrelated material (e.g., extended discussion of mite species, bedding-associated harvest mites, or detailed treatment protocols) that is not needed to answer the question. The final score cannot be below 0."}
{"query": "Explain why birds are particularly susceptible to diet-induced hepatic fat accumulation in commercial poultry systems, and identify one specific pathological condition that can result from high-energy (especially high-carbohydrate) feeding regimes in broilers.", "response": "Rubric (Total Score: 1.0 Point; Minimum: 0.0 Points)\n\n- Avian vs. mammalian site of lipogenesis (0.4 points)  \n  - 0.4: Clearly states that in birds, lipogenesis occurs primarily in the liver, whereas in mammals it occurs mainly in adipose tissue.  \n  - 0.0: Does not state this distinction correctly.\n\n- Mechanistic link to diet (0.4 points)  \n  - 0.4: States that high-energy/high-carbohydrate diets stimulate hepatic de novo lipogenesis (conversion of non-lipid precursors, commonly carbohydrates, into triglycerides), promoting fat accumulation in the liver.  \n  - 0.0: Does not connect high-carbohydrate/high-energy feeding to increased hepatic de novo lipogenesis/triglyceride synthesis.\n\n- Pathological condition in broilers (0.2 points)  \n  - 0.2: Correctly names “fatty liver and kidney syndrome” as a possible outcome.  \n  - 0.0: Names a different condition or none.\n\nDeductions for excess/irrelevant content (max 0.25 points)  \n- Deduct 0.05–0.25 if the response adds substantial unrelated material (e.g., detailed liver anatomy, unrelated diseases, treatment protocols) that obscures the required points.  \n- Total score after deductions cannot be below 0.0."}
{"query": "Explain how chicken type I interferons are induced and how they establish an antiviral state, and identify the known chicken type I interferon subtypes.", "response": "Rubric (Total Score: 1.0 Point; Minimum: 0.0 Points):\n\n- Induction pathway (0.35 points):  \n  - 0.35: States that viral pathogens are recognized by pattern recognition receptors (PRRs), which induces expression of chicken type I IFNs.  \n  - 0.0: Does not mention PRR-mediated recognition leading to type I IFN expression (or gives an incorrect induction mechanism).\n\n- Signaling/effector mechanism establishing antiviral state (0.40 points):  \n  - 0.20: States that type I IFNs act by binding/interacting with IFN receptors.  \n  - 0.20: States that this signaling induces interferon-stimulated antiviral proteins/effectors that create an antiviral state in neighboring cells (helping protect against infection).  \n  - 0.0: Fails to describe receptor interaction and/or fails to connect it to induction of IFN-stimulated antiviral proteins establishing an antiviral state.\n\n- Subtypes (0.25 points):  \n  - 0.25: Correctly lists all three subtypes: chIFN-α, chIFN-β, and chIFN-κ.  \n  - 0.10: Lists only one or two correct subtypes without adding incorrect ones.  \n  - 0.0: Lists none correctly or includes incorrect subtype claims that undermine correctness.\n\nDeductions for excessive irrelevant content (max 0.25 points):  \n- Deduct 0.05–0.25 if the response includes substantial off-topic material (e.g., detailed adaptive immunity pathways, unrelated cytokines, species comparisons not asked for) that obscures the required elements. Final score cannot go below 0.0."}
{"query": "Describe the virological features of salmonid alphavirus (SAV) relevant to pancreas disease/sleeping disease by specifying its virion structure and size, genome type and approximate length, the full set of proteins it encodes (by category and names), the viral antigen that is a prime vaccine target and why, and the molecular basis used to divide SAV into six genotypes.", "response": "Rubric (Total Score: 1.0 point; Min: 0 points):\n\n- Virion structure and size (0.2 points)  \n  - 0.2: States SAV is an enveloped spherical virus approximately 60–70 nm in diameter.  \n  - 0.0: Missing/incorrect structure or size.\n\n- Genome type and length (0.2 points)  \n  - 0.2: States the genome is positive-sense, single-stranded RNA of ~12 kb.  \n  - 0.0: Missing/incorrect genome type or length.\n\n- Encoded proteins (0.3 points)  \n  - 0.3: Correctly identifies 8 proteins total: non-structural nsP1–nsP4 and structural/capsid glycoproteins E1, E2, E3, and 6K.  \n  - 0.0: Incorrect count, missing categories, or incorrect/missing names.\n\n- Vaccine-target antigen and rationale (0.2 points)  \n  - 0.2: Identifies glycoprotein E2 as inducing neutralizing antibodies and therefore an ideal subunit/DNA vaccine candidate.  \n  - 0.0: Wrong antigen or missing/incorrect rationale.\n\n- Genotyping basis (0.1 points)  \n  - 0.1: States SAV genotypes (SAV1–SAV6) are defined using sequences of protein E2 and nsP3.  \n  - 0.0: Missing/incorrect basis.\n\nDeductions for excess/irrelevant content (max 0.25 points):  \n- Deduct 0.05–0.25 if substantial irrelevant detail is added (e.g., extensive clinical pathology, portals of entry, shedding routes, temperature effects) beyond what is needed to answer the specified virology points. Final score cannot go below 0."}
{"query": "Explain two distinct antiviral mechanisms attributed to viperin—one involving effects on viral macromolecule production and one involving its subcellular localization—and describe how the localization-related mechanism interferes with influenza virus protein trafficking.", "response": "Rubric (Total Score: 1.0 Point; Minimum: 0 Points)\n\n- (0.4 points) Viral macromolecule production mechanism: States that viperin inhibits viral protein and/or viral RNA biosynthesis (must mention inhibition of protein synthesis and/or RNA biosynthesis).  \n- (0.5 points) Localization-related mechanism and consequence: States that viperin localizes to the ER and disrupts lipid rafts, thereby inhibiting trafficking of soluble virally encoded proteins during influenza infection (must include ER localization + lipid raft disruption + inhibited trafficking in influenza).  \n- (0.1 points) Integration/clarity: Clearly distinguishes these as two separate mechanisms rather than repeating the same idea.\n\nDeductions (Max 0.25 points):  \n- Deduct 0.1–0.25 points for excessive irrelevant content that is not asked for (e.g., detailed descriptions of unrelated immune pathways, viperin structure, or viruses not referenced), depending on severity. Final score cannot be below 0."}
{"query": "Explain how the adaptor proteins TRIF and MAVS lead to interferon-β (IFN-β) production, specifying the role of TBK1 and IRF3, and contrast TBK1’s downstream transcription factor targets and functional outcome with those of canonical IKKs.", "response": "Rubric (Total Score: 1.0 point; Minimum: 0.0 points):  \n- (0.35) TRIF and MAVS are identified as adaptor proteins that activate/recruit TBK1 in the IFN-induction pathway.  \n- (0.35) TBK1 is correctly described as phosphorylating IRF3, and this is linked to IFN-β production (IRF3 is required/indispensable for driving IFN-β).  \n- (0.20) IRF activation consequences are correctly stated: phosphorylation leads to IRF (IRF3) dimerization and cytoplasm-to-nucleus translocation with DNA binding to stimulate IFN transcription.  \n- (0.10) Correct contrast with canonical IKKs: canonical IKKs activate NF-κB (inflammatory response), whereas TBK1 targets IRFs to drive IFN transcription.\n\nDeductions (max 0.25 points):  \n- Deduct 0.05–0.25 for excessive irrelevant or speculative content (e.g., naming unrelated receptors/kinases not in scope, detailed pathway branches not asked for) that obscures the required elements.  \n- Final score cannot be below 0.0."}
{"query": "Describe how human β-defensin 3 (hBD-3) modulates immune responses by (i) inducing costimulatory molecule expression, (ii) recruiting leukocytes, (iii) neutralizing LPS, and (iv) reducing inflammation, explicitly naming the relevant receptors and signaling adaptors involved in each function.", "response": "Rubric (Total = 1.0 point; Minimum = 0 points):  \n- **Costimulatory molecule induction (0.25 points):** States that hBD-3 induces **CD80, CD86, and CD40** expression via **TLR1 and TLR2**.  \n- **Chemotaxis (0.25 points):** States that hBD-3 is chemotactic to leukocytes via **CCR2 and CCR6**.  \n- **LPS neutralization (0.25 points):** States that hBD-3 **binds TLR4** and thereby **inhibits LPS binding / neutralizes LPS**.  \n- **Anti-inflammatory mechanism (0.25 points):** States that hBD-3 targets **TLR signaling** through **MyD88 and TRIF**, leading to **downregulation of proinflammatory genes**.  \n\nDeductions (maximum deduction: 0.25 points):  \n- Deduct **0.05–0.25 points** if the response includes substantial irrelevant or speculative material (e.g., unrelated defensins, detailed disease examples, or pathways/receptors not asked for), with the deduction scaled to severity. The final score cannot be below 0."}
{"query": "Newcastle disease virus (NDV) is considered a single serotype yet shows substantial genetic and antigenic diversity. Explain how NDV is genetically classified at the highest level and within the more variable group, and identify the two notable wild-bird reservoir exceptions where virulent NDV is endemic, including the host bird groups, the common name used for one of these reservoir-associated variants, and the geographic association for the other.", "response": "Rubric (Total Score: 1.0 point; Minimum: 0 points):  \n- (0.25) Correctly states the two major genetic groups: class I and class II.  \n- (0.25) Correctly describes the within-class II genotype system: at least 18 genotypes designated I–XVIII.  \n- (0.25) Correctly identifies the Columbidae (pigeons) reservoir exception and names the common variant designation: pigeon paramyxoviruses 1 (PPMV-1).  \n- (0.25) Correctly identifies the second reservoir exception as Phalacrocorax (cormorants) and links it to North America (and/or periodic mortality events).  \n\nDeductions (max 0.25 points):  \n- Deduct 0.05–0.25 for substantial irrelevant or speculative material beyond what is asked (e.g., lengthy discussion of poultry outbreak history, detailed pathogenesis, or unrelated taxonomy) that obscures the required points.  \n- Final score cannot be below 0."}
{"query": "How are Newcastle disease virus (NDV) strains classified by pathotype, and which laboratory workflow and specific in vivo indices are used to determine the pathogenicity/virulence of an NDV isolate?", "response": "Rubric (Total Score: 1.0 point; Min: 0 points)  \n- Pathotype classification (0.4 points)  \n  - 0.4: Correctly states the three pathotypes: velogenic, mesogenic, and lentogenic.  \n  - 0.0: Missing or incorrect pathotype list.\n\n- Pathogenicity determination workflow (0.2 points)  \n  - 0.2: States that pathogenicity determination involves virus isolation followed by in vivo testing.  \n  - 0.0: Does not mention this sequence/workflow.\n\n- Correct in vivo indices/tests (0.4 points)  \n  - 0.2: Correctly identifies ICPI (intracerebral pathogenicity index).  \n  - 0.1: Correctly identifies the intravenous pathogenicity index.  \n  - 0.1: Correctly identifies mean death time (MDT) in SPF chicken embryos/birds (SPF context must be included at least once).  \n  - 0.0–0.3: Partial credit only for the correctly named items above.\n\nDeductions for excess/irrelevant content (max 0.25 points)  \n- Deduct 0.05–0.25 if the response includes substantial irrelevant material (e.g., clinical signs, control measures, vaccine strains, unrelated diagnostics) that is not needed to answer the question.  \n- Total score after deductions cannot be below 0."}
{"query": "Explain why chicken-derived recombinant antibody libraries allow relatively simple PCR amplification of the full immunoglobulin variable-region repertoire, and contrast how antibody diversity is generated and sampled in (i) naïve chickens versus (ii) antigen-immunized chickens, specifying the key organ(s)/tissue sources and the relevant time window.", "response": "Rubric (Total Score: 1.0 Point; Max Deduction: 0.25 Points):  \n\n- PCR amplification rationale (0.35 points)  \n  - 0.35: States that all chicken \\(V_H\\) and \\(V_L\\) variable-region sequences share identical 5′ and 3′ ends, enabling amplification with only two primer sets.  \n  - 0: Does not identify shared 5′/3′ ends and/or does not connect this to using only two PCR primer sets.\n\n- Diversity generation mechanism + site + timing for naïve repertoire (0.35 points)  \n  - 0.35: Identifies gene conversion using pseudogene variable regions occurring in the bursa of Fabricius during the first ~4 months, and that naïve repertoire can be accessed from avian bursal cells.  \n  - 0: Missing or incorrect mechanism (gene conversion/pseudogenes), organ (bursa of Fabricius), time window (first 4 months), or sampling source (bursal cells).\n\n- Sampling sources for immunized chickens (0.30 points)  \n  - 0.30: States that after immunization, immunoglobulin mRNA can be sourced from spleen and/or blood lymphocytes and/or bone marrow.  \n  - 0: Does not name these tissue sources for immunized birds.\n\nDeductions for excess/irrelevant content (up to −0.25 points)  \n- Subtract 0.05–0.25 if the response includes substantial extra material beyond what is asked (e.g., unrelated antibody engineering methods, detailed immunization protocols, or molecular biology steps not needed), proportional to severity. Final score cannot go below 0."}
{"query": "In poultry production, compare the major impacts and transmission routes of *Salmonella enterica* serovars Pullorum/Gallinarum versus serovar Enteritidis, and explain why bacteriophages have been proposed as a control strategy instead of antibiotics.", "response": "Rubric (Total Score: 1.0 point; Minimum: 0 points)\n\n- **0.4 points (Pullorum/Gallinarum—impact in poultry):** States that *S. Pullorum* and *S. Gallinarum* are major poultry pathogens with severe economic impact due to high mortality, including that death can reach **up to ~90%** of affected birds.  \n- **0.4 points (Enteritidis—public health + spread):** States that *S. Enteritidis* can infect **humans via contaminated meat/eggs** and that infected poultry can **transmit to healthy neighboring birds**, contributing to economic loss (and/or identifies it as a major foodborne/public health pathogen).  \n- **0.2 points (Why phages instead of antibiotics):** Explains that **indiscriminate antibiotic use** (e.g., as growth promoters) contributed to **antibiotic-resistant microorganisms**, leading to **restriction/prohibition** in poultry, so **bacteriophages** are used to **infect and lyse Salmonella** as a biocontrol/phage therapy approach.\n\nDeductions (max 0.25 points):  \n- Deduct **0.05–0.25** for excessive irrelevant material (e.g., long descriptions of unrelated diseases, detailed molecular phage biology not asked for, unrelated regulatory history). Deduction magnitude depends on how much it obscures the required points. Final score cannot be below **0**."}
{"query": "FOXO3 can regulate cell-cycle arrest, apoptosis, and skeletal muscle atrophy through transcriptional control of downstream genes. Identify (i) two specific FOXO3-regulated genes that mediate cell-cycle retardation, (ii) two specific FOXO3-regulated genes that promote apoptosis, and (iii) two specific FOXO3-regulated genes involved in muscle atrophy/protein degradation, and explain one physiological outcome observed when FOXO3 expression is inhibited.", "response": "Rubric (Total Score: 1.0 point; Minimum: 0 points)\n\n- Cell-cycle retardation genes (0.3 points)  \n  - 0.15: Correctly names one FOXO3-regulated cell-cycle gene: p21, p27, p130 (RAB3GAP1 catalytic subunit 1), cyclin G2, or GADD45.  \n  - 0.15: Correctly names a second FOXO3-regulated cell-cycle gene from the same list (must be different from the first).\n\n- Apoptosis-promoting genes (0.3 points)  \n  - 0.15: Correctly names one FOXO3-regulated apoptosis gene: FasL, BNIP3, ATG8, TRAIL, or PTEN.  \n  - 0.15: Correctly names a second FOXO3-regulated apoptosis gene from the same list (must be different from the first).\n\n- Muscle atrophy/protein degradation genes (0.3 points)  \n  - 0.15: Correctly names one FOXO3 downstream gene involved in atrophy/protein degradation: FBXO32/atrogin-1, MURF, LC3, p62, or NBR1.  \n  - 0.15: Correctly names a second gene from the same list (must be different from the first).\n\n- Outcome of FOXO3 inhibition (0.1 points)  \n  - 0.1: States one correct physiological outcome of inhibiting FOXO3 expression: suppression of protein degradation and/or increased muscle fiber thickness and/or increased body weight.\n\nDeductions for excessive irrelevant content (max 0.25 points)  \n- Deduct 0.05–0.25 if the response includes substantial extra material beyond what is asked (e.g., long disease/aging discussions, unrelated pathways, or extensive citations), proportional to severity.  \n- Final score floor: 0 points."}
{"query": "Explain how hexavalent chromium (Cr(VI)) can generate reactive oxygen species via chromium intermediates and describe two distinct reasons the brain is particularly susceptible to the resulting oxidative damage.", "response": "Rubric (Total = 1.0 point; Min = 0):  \n- (0.5 points) Mechanism of ROS generation: Correctly states that Cr(VI) induces oxidative stress by increasing ROS production via formation of Cr(V) intermediates, and names at least one ROS produced (superoxide anion, hydroxyl radical, or singlet oxygen).  \n- (0.5 points) Brain susceptibility: Provides two correct reasons, chosen from:  \n  1) high lipid content/high polyunsaturated fatty acids (PUFAs) predispose to lipid peroxidation,  \n  2) low antioxidant levels reduce ROS control,  \n  3) high oxygen consumption (~20% of the body’s oxygen) increases oxidative burden.  \n\nDeductions (max 0.25 points):  \n- Deduct 0.05–0.25 for excessive irrelevant content that goes beyond the asked mechanism and brain-specific reasons (severity-based).  \n- Final score cannot be below 0."}
{"query": "Explain how Mycoplasma gallisepticum establishes long-term infection in poultry and describe two distinct pathogenic consequences: one at the host-cell interaction level and one at the population/industry level.", "response": "Rubric (Total = 1.0 point; Minimum = 0.0):\n- 0.35 points: States that M. gallisepticum adheres to mucosal epithelial cells and then colonizes host cells/tissues (both adhesion and colonization must be present).\n- 0.35 points: Describes immune dysregulation leading to chronic infection via excessive activation/recruitment of inflammatory cells infiltrating the chicken trachea, resulting in tracheal lesions (must include both inflammatory-cell recruitment/activation and lesions/chronicity).\n- 0.30 points: Provides a population/industry-level consequence by stating lifelong infection with persistent carrier status that enables transmission to other birds and/or notes serious economic losses (e.g., reduced egg production, reduced hatchability, low carcass quality). Either carrier/transmission or economic losses is sufficient, but it must be explicitly tied to M. gallisepticum infection.\n\nDeductions (max 0.25 points):\n- Deduct 0.05–0.25 points for excessive irrelevant content that is not asked for (e.g., detailed unrelated microbiology, treatment protocols, or speculative molecular pathways beyond “unknown mechanism”), scaled to severity. Final score cannot go below 0.0."}
{"query": "Explain why many human-infecting *Cryptosporidium* species and genotypes remain poorly characterized, and compare the main limitations of in vitro propagation with the practical constraints of in vivo propagation across different *Cryptosporidium* taxa. Include at least one example of an animal model used to propagate *C. parvum* and explain why that success does not generalize to many other human-pathogenic species/genotypes.", "response": "Rubric (Total = 1.0 point; minimum = 0.0 points):\n\n- Poor characterization rationale (0.25 points)  \n  - 0.25: States that many human-pathogenic species/genotypes are poorly characterized primarily because only a few isolates are available for study.  \n  - 0.0: Does not state this, or gives an incorrect primary reason.\n\n- In vitro propagation limitation (0.25 points)  \n  - 0.25: Clearly states that there is a lack of in vitro methods to propagate *Cryptosporidium* oocysts.  \n  - 0.0: Fails to mention the lack of in vitro propagation methods or claims effective in vitro propagation exists.\n\n- In vivo propagation—*C. parvum* animal model example (0.25 points)  \n  - 0.25: Names at least one correct animal model used to propagate *C. parvum* in vivo (mouse/mice, piglets, calves, or gerbils).  \n  - 0.0: No animal model is provided or the model given is not one of these.\n\n- Why in vivo success does not generalize (0.25 points)  \n  - 0.25: Explains that many other human-pathogenic species/genotypes have narrow host specificity and/or produce low numbers of oocysts in their typical hosts, limiting in vivo propagation.  \n  - 0.0: Omits this explanation or provides an incorrect reason.\n\nDeductions for excessive irrelevant content (max −0.25 points):  \n- Deduct 0.05–0.25 if the response includes substantial extraneous material (e.g., detailed life-cycle steps, clinical symptom lists, or unrelated comparisons to multiple other protozoa) that is not needed to answer the question, with the deduction scaled to severity. The final score cannot go below 0.0."}
{"query": "A clinical microbiology lab isolates *Staphylococcus aureus* with an oxacillin MIC of 4 µg/mL and susceptibility to cefoxitin, and PCR is negative for both **mecA** and **mecC**. What resistance phenotype best fits this isolate, what MIC range defines it, and what biological mechanism has been proposed to explain it?", "response": "Rubric (Total = 1.0 point; Min = 0):  \n- **0.4 points**: Correctly identifies the phenotype as **borderline oxacillin-resistant *S. aureus* (BORSA)**.  \n- **0.3 points**: Correctly states the defining **oxacillin MIC range is 1–8 µg/mL**.  \n- **0.3 points**: Correctly states the proposed mechanism is **hyperproduction of β-lactamase**.  \n\nDeductions (max 0.25 points):  \n- Deduct **0.05–0.25** if the response includes substantial irrelevant material (e.g., extended discussion of MRSA epidemiology/virulence or unrelated antibiotic classes) that obscures the required items.  \n- Final score cannot be below **0**."}
{"query": "In the regulation of the chicken lysozyme gene, identify which DNase I hypersensitive sites function as hormone-responsive enhancers in the oviduct versus macrophage-specific enhancers, and explain how lipopolysaccharide (LPS) stimulation transiently increases lysozyme transcription in macrophages through changes at the −2.4 kb silencer.", "response": "Rubric (Total Score: 1.0 point; Minimum: 0.0 points):  \n\n- **Enhancer site identification (0.6 points total):**  \n  - **0.3 points**: Correctly identifies the **oviduct hormone-responsive enhancers** as DHSs at **−0.1 kb and −1.9 kb**.  \n  - **0.3 points**: Correctly identifies the **macrophage-specific enhancers** as DHSs at **−3.9 kb, −2.7 kb, and −0.7 kb**.\n\n- **LPS/CTCF silencer mechanism (0.4 points total):**  \n  - **0.4 points**: States that **LPS stimulation induces transient non-coding RNA synthesis**, which **evicts/removes CTCF from the −2.4 kb silencer**, thereby **up-regulating/increasing lysozyme transcription** in macrophages.\n\n- **Deductions for excessive irrelevant content (max deduction: 0.25 points):**  \n  - Deduct **0.05–0.25 points** if the response adds substantial unrelated material (e.g., detailed lysozyme protein function, general steroid hormone biology, or unrelated chromatin concepts) that obscures the required enhancer/silencer mechanism.  \n  - Total score cannot go below **0.0 points**."}
{"query": "Describe the developmental origin and migratory route of chicken primordial germ cells (PGCs) from their initial segregation to their final destination, and explain why these properties make PGCs especially suitable for generating transgenic chickens compared with embryonic stem cells (ESCs) and spermatogonial stem cells (SSCs).", "response": "Rubric (Total = 1.0 point; Minimum = 0):  \n\n- **Origin and early location (0.2 points)**  \n  - 0.2: States that PGCs first separate in the **epiblast** of **EGK stage X** embryos.  \n  - 0.0: Missing/incorrect.\n\n- **Stepwise migration route (0.5 points total)**  \n  - 0.1: Movement down the **hypoblast of the area pellucida**.  \n  - 0.1: Subsequent localization to the **germinal crescent**.  \n  - 0.15: Entry into the **bloodstream/circulatory system**.  \n  - 0.15: Final arrival at the **genital ridges**.  \n  - 0.0–0.5: Award only for correctly described steps.\n\n- **Transgenesis rationale and comparative advantage (0.3 points total)**  \n  - 0.15: Explains that because PGCs **circulate in the bloodstream**, genetically manipulated PGCs can be **injected into recipient egg blood vessels** to generate transgenic birds.  \n  - 0.15: States that **germline-competent PGC lines** enable **germline chimeras/transgenic chickens** with **higher germline transmission efficiency** than **ESCs and SSCs**.  \n  - 0.0–0.3: Award only for these specific advantages.\n\n- **Deductions for excess irrelevant content (max 0.25 points)**  \n  - Deduct **0.05–0.25** if the response includes substantial unrelated material (e.g., detailed molecular pathways, unrelated gene-editing methods, or chicken embryology not tied to the PGC route/transgenesis rationale).  \n  - Total score cannot go below **0.0**."}
{"query": "Explain the shared domain architecture of TRAF family proteins and describe how the N-terminal and C-terminal regions contribute to signaling; then identify what is unique about TRAF6 among TRAF1–7 in terms of which receptor-superfamily signaling pathways it participates in.", "response": "Rubric (Total Score: 1.0 point; minimum 0.0):  \n- **0.35 points:** Correctly states the **common TRAF architecture**: an **N-terminal region** plus a **C-terminal TRAF domain**.  \n- **0.25 points:** Correctly describes **N-terminal functional domains**: includes a **RING-finger** and **five Zn-finger domains**, and links these to **protein ubiquitylation and downstream signaling activation**.  \n- **0.25 points:** Correctly describes the **C-terminal TRAF domain composition and functions**: contains **TRAF-N (coiled-coil)** and **conserved TRAF-C**; involved in **self-association** and **interactions with upstream regulators/downstream effectors**.  \n- **0.15 points:** Correctly identifies **TRAF6’s unique pathway participation**: it is the **only** TRAF member involved in **both** **TNFR superfamily** signaling and **TLR/IL-1R (IL-1/TLR)** superfamily signaling.\n\nDeductions (max 0.25 points):  \n- Deduct **0.05–0.25** for excessive irrelevant content that obscures the required points (e.g., lengthy discussion of experimental methods like yeast two-hybrid details beyond simply identifying TRAF6, or broad inflammatory biology not tied to the asked domains/pathways). Final score cannot go below **0.0**."}
{"query": "Explain how the N-terminal Yxxφ (tyrosine-based lysosomal targeting) motif influences IFITM3 late-endosomal localization and antiviral activity, and contrast the functional importance of this motif in mammals versus ducks; also state how this motif is used to distinguish IFITM1 from IFITM3.", "response": "Rubric (Total Score: 1.0 point; Minimum: 0.0 points)\n\n- Motif identity, location, and role (0.45 points)  \n  - 0.15: Correctly identifies Yxxφ as a tyrosine-based lysosomal targeting/sorting motif.  \n  - 0.15: States it is located in the N-terminal domain (NTD) of IFITM3.  \n  - 0.15: Explains it promotes entry into the endosomal/late-endosomal pathway supporting IFITM3’s antiviral function by helping prevent viral invasion.\n\n- Mammals vs ducks contrast (0.45 points)  \n  - 0.25: States that in mammals, mutating/disrupting Yxxφ causes IFITM3 mislocalization and reduces antiviral capacity.  \n  - 0.20: States that in ducks, Yxxφ is not essential for correct IFITM3 localization and does not affect antiviral capacity.\n\n- Classification use (0.10 points)  \n  - 0.10: States the conserved Yxxφ motif is used as a criterion to distinguish/classify IFITM1 vs IFITM3 because their sequences are highly similar.\n\nDeductions (maximum deduction: 0.25 points)  \n- Deduct 0.05–0.25 for excessive irrelevant content that obscures the required points (e.g., long discussions of unrelated immune pathways, other IFITM family members not asked about, or detailed literature summaries).  \n- Final score cannot be below 0.0."}
{"query": "Describe a genome-wide inferred phylogeny for the genus *Gallus* that includes (i) which two junglefowl species are sister taxa, (ii) which lineage is inferred to be the oldest, and (iii) the approximate divergence times for the sister-pair split, for the split joining Red junglefowl with that pair, and for the oldest lineage’s divergence.", "response": "Rubric (Total = 1.0 point; Minimum = 0.0 point):\n\n- Sister relationship identified (0.25 points)  \n  - 0.25: States that Grey junglefowl and Ceylon junglefowl are sister taxa.  \n  - 0.0: Any other sister pairing (e.g., Grey+Red or Green+Red).\n\n- Oldest lineage identified (0.25 points)  \n  - 0.25: States that Green junglefowl is the oldest *Gallus* lineage (basal/earliest diverging in this phylogeny).  \n  - 0.0: Names a different lineage as oldest or omits.\n\n- Divergence time for Grey–Ceylon split (0.15 points)  \n  - 0.15: Gives ~1.8 mya (accept ~1.6–2.0 mya).  \n  - 0.0: Incorrect or missing.\n\n- Divergence time for Red vs (Grey+Ceylon) split (0.20 points)  \n  - 0.20: Gives ~2.6–2.9 mya (accept ~2.5–3.0 mya).  \n  - 0.0: Incorrect or missing.\n\n- Divergence time for Green lineage (oldest) split (0.15 points)  \n  - 0.15: Gives ~4 mya (accept ~3.5–4.5 mya).  \n  - 0.0: Incorrect or missing.\n\nDeductions for excess/irrelevant content (max 0.25 points):  \n- Deduct 0.05–0.25 if the response includes substantial extra material beyond the requested phylogeny/times (e.g., long discussion of competing topologies, detailed citation lists, or methodological debate) that obscures the required items. Final score cannot go below 0."}
{"query": "Explain how Chicken infectious anemia virus (CIAV) affects the hematopoietic and immune systems of young chickens and identify two distinct transmission routes by which it spreads within and between chicken populations.", "response": "Rubric (Total Score: 1.0 point; Minimum: 0 points)\n\n- Pathogenesis in hematopoietic tissue (0.4 points)  \n  - 0.4: States that CIAV causes atrophy/damage of bone marrow hematopoietic tissue leading to anemia.  \n  - 0.0: Does not mention bone marrow hematopoietic atrophy/damage and anemia linkage.\n\n- Pathogenesis in lymphoid/immune tissue (0.3 points)  \n  - 0.3: States that CIAV causes atrophy/damage of lymphatic/lymphoid tissue such as the thymus, resulting in immunosuppression.  \n  - 0.0: Does not mention lymphoid tissue involvement (e.g., thymus) and immunosuppression linkage.\n\n- Transmission routes (0.3 points)  \n  - 0.15: Identifies horizontal transmission.  \n  - 0.15: Identifies vertical transmission.  \n  - 0.0: Mentions neither route correctly (or replaces with incorrect routes only).\n\nDeductions for excessive irrelevant content (max 0.25 points)  \n- Deduct 0.05–0.25 if substantial extraneous information is included that is not asked for (e.g., extensive history of discovery, vaccine contamination narrative, or unrelated clinical details) and obscures the required points.  \n- Total score after deductions cannot be below 0."}
{"query": "Explain how chromosomal sex is determined in chickens, including the number and types of chromosomes in somatic cells, the ZZ:ZW sex-chromosome system (which sex is ZZ vs. ZW), and the specific Z-linked gene whose expression is crucial for initiating sex determination.", "response": "Rubric (Total = 1.0 point; Minimum = 0.0 points):  \n- 0.25 points: States that chicken somatic cells have 39 chromosome pairs total.  \n- 0.25 points: Correctly specifies that these include 38 pairs of autosomes and 1 pair of sex chromosomes.  \n- 0.25 points: Correctly identifies the avian ZZ:ZW system and assigns sexes correctly (males = ZZ; females = ZW).  \n- 0.25 points: Names **Dmrt1** as the key Z-linked gene whose expression is crucial for sex determination in chickens.  \n\nDeductions (max 0.25 points):  \n- Deduct 0.05–0.25 points for excessive irrelevant material that goes beyond the asked elements (e.g., extended discussion of mammalian XY mechanisms, detailed citation lists, or unrelated developmental anatomy).  \n- Total score cannot go below 0.0 points."}
{"query": "Explain the antiviral mechanism used by IFITM1, IFITM2, and IFITM3 to inhibit viral replication, and name two pathogenic viruses specifically cited as being restricted by this mechanism.", "response": "Rubric (Total = 1.0 point; Minimum = 0 points):  \n- Mechanism (0.6 points):  \n  - 0.6 pts: States that IFITM1/2/3 inhibit viral replication by preventing fusion of viral and host-cell membranes (i.e., blocking virus–cell membrane fusion/entry).  \n  - 0 pts: Does not describe membrane-fusion prevention as the mechanism (or gives an unrelated/incorrect mechanism).  \n- Virus examples (0.4 points):  \n  - 0.2 pts: Correctly names influenza A virus.  \n  - 0.2 pts: Correctly names Ebola virus.  \n  - 0 pts for this section if neither virus is correctly named (partial credit if only one is correct as above).\n\nDeductions (max 0.25 points):  \n- Deduct 0.05–0.25 points if the response includes substantial irrelevant additions (e.g., extended discussion of chicken IFITM detection lists, unrelated in vitro study details, or viral vector methodology) that obscure the required mechanism-and-two-virus answer. The deduction depends on severity. Final score cannot go below 0."}
{"query": "Why are direct in-vivo measurements of cervical spinal loading typically avoided, and what specific anatomical and muscle-related information is necessary to build a reliable canine cervical spine biomechanical model that can assess surgical feasibility and potential side effects?", "response": "Rubric (Total Score: 1.0 point; Minimum: 0.0 points):  \n- 0.25 points: States that direct in-vivo spinal loading measurement is currently not feasible/impractical (explicitly identifies infeasibility as the key reason).  \n- 0.25 points: Identifies the need for accurate anatomical data of both soft tissues and bone (must include both categories).  \n- 0.25 points: Explains that muscles are essential because they provide most of the moments required for equilibrium/posture and movement, influencing stability/loading/locomotion (must link muscles to moment generation and functional role).  \n- 0.25 points: Specifies that the model requires canine muscle properties such as force estimation and muscle orientation (must include both force and orientation).\n\nDeductions (max 0.25 points):  \n- Deduct 0.05–0.25 points for excessive irrelevant content that is not asked for (e.g., extended discussion of human cervical models, detailed descriptions of specific spinal disorders, or unrelated surgical techniques), proportional to severity.  \n- Final score cannot be below 0.0."}
{"query": "Explain the primary wild progenitor of domestic chickens and summarize the genetic evidence (including mitochondrial DNA and microsatellite findings) that supports this ancestry, noting what the evidence implies about the number and geographic distribution of maternal origins.", "response": "Rubric (Total Score: 1.0 Point; Min: 0.0 Points):\n\n- Progenitor identification (0.35 points)  \n  - 0.35: Correctly identifies the red jungle fowl (Gallus gallus gallus) as the main wild progenitor/ancestor of domestic chickens.  \n  - 0.0: Incorrect progenitor or not stated.\n\n- mtDNA evidence (0.25 points)  \n  - 0.25: States that mitochondrial DNA evidence indicates domestic chickens descend from red jungle fowl populations in Southeast Asia.  \n  - 0.0: mtDNA evidence missing or incorrect.\n\n- Microsatellite evidence (0.25 points)  \n  - 0.25: States that microsatellite data show red jungle fowl were the main progenitor and major contributor to the domestic chicken gene pool.  \n  - 0.0: Microsatellite evidence missing or incorrect.\n\n- Maternal origins and geography (0.15 points)  \n  - 0.15: Clearly states there were multiple maternal origins in South and Southeast Asia and names at least two correct areas from: India, South China, Myanmar, Vietnam, Thailand.  \n  - 0.0: Claims single origin, wrong region, or provides no correct locations.\n\nDeductions for extraneous content (max 0.25 points):  \nDeduct 0.05–0.25 points if the response includes substantial irrelevant material (e.g., modern breeding practices, dietary traits, egg production statistics) that obscures or significantly outweighs the required genetic/biogeographic points. Final score cannot go below 0.0."}
{"query": "In chickens, what systemic immune changes have been observed after intravenous lipopolysaccharide (LPS) exposure, including (i) the short-term effects on monocytes/macrophages with the recovery timeframe, (ii) the effect on antibody titers after infectious bronchitis virus vaccination, and (iii) specific pro-inflammatory cytokine genes upregulated in heterophils in vitro?", "response": "Rubric (Total = 1.0 point; Minimum = 0.0 points):\n\n- **(0.40 points) Monocytes/macrophages + timeframe**\n  - 0.20: States that IV LPS **rapidly reduces peripheral blood monocytes**.\n  - 0.15: States that IV LPS **reduces splenic macrophages**.\n  - 0.05: States that these values **return to control levels by ~6–24 hours post-injection**.\n\n- **(0.30 points) Antibody titers after vaccination**\n  - 0.30: States that LPS-injected chickens show **lower antibody titers following infectious bronchitis virus vaccination** than controls.\n\n- **(0.30 points) Cytokine gene upregulation in heterophils (in vitro)**\n  - 0.10: Identifies **IL-1β** upregulation.\n  - 0.10: Identifies **IL-6** upregulation.\n  - 0.10: Identifies **IL-8** upregulation.\n\nDeductions (max 0.25 points):\n- Deduct **0.05–0.25** for excessive irrelevant content that is not asked for (e.g., extended discussion of human pulmonary diseases or farm environmental exposure routes beyond a brief mention).  \n- Final score cannot go below **0.0**."}
{"query": "Explain the etiological agent and transmission vector of Chagas disease, including the vector’s taxonomic classification and feeding behavior, and justify why dogs are routinely evaluated in endemic regions as sentinels for human infection risk.", "response": "Rubric (Total Score: 1.0 point; minimum 0):  \n- 0.25 points: Correctly identifies the causative agent as the protozoan *Trypanosoma cruzi*.  \n- 0.25 points: Correctly identifies the transmission vector as triatomine bugs and provides their taxonomy: order Hemiptera, family Reduviidae, subfamily Triatominae.  \n- 0.25 points: Correctly describes key vector behavior: hematophagous (blood-feeding) and primarily nocturnal, feeding on humans and domestic/wild animals.  \n- 0.25 points: Correctly justifies sentinel use of dogs in endemic areas: dogs are principal domestic hosts and are infected more frequently than humans, so routine evaluation helps estimate human infection risk.  \n\nDeductions (max 0.25 points):  \n- Deduct 0.05–0.25 points for excessive irrelevant content that is not asked for (e.g., lengthy clinical staging, treatment regimens, or detailed ecology beyond the vector classification/behavior and sentinel rationale), proportional to severity."}
{"query": "Explain the disease mechanism and epidemiological drivers of necrotic enteritis in chickens by (i) identifying the primary causative agent and describing its key microbiological traits, (ii) naming a major predisposing factor and a specific co-infecting species strongly linked to disease promotion, and (iii) summarizing why the disease can spread rapidly in modern poultry production and listing common environmental reservoirs where the causative bacterium is found.", "response": "Rubric (Total Score: 1.0 point; minimum 0.0):  \n\n- **Causative agent + traits (0.4 points)**\n  - 0.2: Correctly identifies **Clostridium perfringens** as the primary agent causing NE via abnormal intestinal overgrowth/colonization.\n  - 0.2: States key traits: **Gram-positive, anaerobic, spore-forming, rod-shaped** (credit requires at least three of these four traits).\n\n- **Predisposition/co-infection (0.3 points)**\n  - 0.15: Identifies **Eimeria spp.** as a predisposing factor.\n  - 0.15: Specifically names **Eimeria maxima** as a co-infection strongly implicated in promoting NE.\n\n- **Rapid spread + reservoirs (0.3 points)**\n  - 0.15: Explains rapid spread as linked to **high-intensity breeding/modern farming systems**.\n  - 0.15: Lists environmental/common reservoirs where C. perfringens is found (credit requires at least two): **soil, contaminated food, decaying vegetation, marine sediments**, and/or being a **normal bacterium in birds**.\n\n- **Deductions for excess/irrelevant content (max −0.25 points)**\n  - Deduct up to 0.25 if the response includes substantial unrelated material (e.g., detailed treatment regimens, unrelated pathogens, or extensive economic discussion) that obscures the required elements."}
{"query": "Explain why the chicken body louse is considered an obligate ectoparasite and describe how its on-host life cycle and feeding behavior can lead to measurable production losses in laying hens.", "response": "Rubric (Total Score: 1.0 point; minimum 0):  \n- **Obligate ectoparasite definition and application (0.35 points):**  \n  - 0.35 points: States that it lives on the outside of the host and depends on the chicken host to complete its life cycle (i.e., cannot complete the life cycle off-host).  \n- **Life-cycle detail (0.25 points):**  \n  - 0.25 points: Correctly gives that the entire life cycle occurs on the chicken and is completed in about **2–3 weeks**.  \n- **Feeding behavior (0.20 points):**  \n  - 0.20 points: States it feeds on **feathers** and may **occasionally feed on blood**.  \n- **Production-loss outcomes (0.20 points):**  \n  - 0.20 points: Identifies the linked losses as decreased **hen weight**, **egg production**, and **feed conversion** (all three must be present for full credit; 0.10 points if only two are correctly named).  \n- **Deductions for excessive irrelevant content (max 0.25 points):**  \n  - Deduct 0.05–0.25 points if substantial information unrelated to obligate ectoparasitism, on-host life cycle, feeding, or the specified production metrics is included (e.g., treatments, unrelated diseases, or extensive general poultry management). Final score cannot go below 0."}
{"query": "Explain how type I interferons can confer resistance to influenza A virus in mice, focusing on the role of the IFN-induced Mx1 protein and why different laboratory mouse strains vary in susceptibility.", "response": "Rubric (Total Score: 1.0 point; Minimum: 0 points)\n\n- **Mx1 as key IFN effector against influenza A (0.5 points)**\n  - 0.5: Clearly states that type I IFN induces an antiviral state in which **Mx1 is the main effector molecule** that inhibits/resists influenza A virus infection.\n  - 0: Does not identify Mx1 as the main IFN-induced effector against influenza A.\n\n- **Strain-dependent susceptibility explained by Mx1 gene functionality (0.5 points)**\n  - 0.5: Correctly explains that **mice with a functional Mx1 gene are highly resistant**, while **most laboratory mouse strains have a defective Mx1 gene and are therefore highly susceptible** to influenza A virus.\n  - 0: Does not link resistance/susceptibility differences to functional vs defective Mx1.\n\n- **Deductions for excessive irrelevant content (max 0.25 points)**\n  - Deduct **0.05–0.25** if the response adds substantial off-target material (e.g., detailed poultry economics/zoonosis discussions, unrelated immune pathways) that obscures the required points.  \n  - Total score cannot go below **0**."}
{"query": "Explain how dysregulation of the IGF-II/IGF2R axis can promote tumor growth and why IGF2R is considered a promising therapeutic target in osteosarcoma; include in your answer one genetic/epigenetic finding linked to osteosarcoma risk and one cross-species sequence feature relevant to targeting the IGF-II binding region.", "response": "Rubric (Total = 1.0 point; Minimum = 0 points):  \n\n- Tumor-growth mechanism via IGF-II/IGF2R dysregulation (0.45 points)  \n  - 0.25: Correctly states that IGF2R normally sequesters IGF-II for internalization/degradation (reducing IGF-II availability/signaling).  \n  - 0.20: Correctly links high circulating IGF-II plus IGF2R downregulation or IGF2R loss-of-function to increased tumor growth (i.e., more IGF-II activity and growth).\n\n- Why IGF2R is a therapeutic target in osteosarcoma (0.25 points)  \n  - 0.25: Correctly states that IGF2R is consistently overexpressed on the surface in human osteosarcoma, making it a suitable/accessible target (and/or notes its association/essential role in OS development).\n\n- Genetic/epigenetic OS-associated finding (0.15 points)  \n  - 0.15: Mentions the SNP that alters methylation in an IGF2R CpG island and that it is associated with increased osteosarcoma risk in humans.\n\n- Cross-species targeting-relevant sequence feature (0.15 points)  \n  - 0.15: States that the IGF-II binding region (Domains 11–FNII) is highly conserved across human/mouse/dog (~82% sequence identity), supporting cross-species relevance.\n\nDeductions for excessive/irrelevant content (max −0.25 points):  \n- Deduct 0.05–0.25 if the response adds substantial unrelated material (e.g., detailed osteosarcoma clinical management, unrelated IGF receptors/pathways not tied to IGF2R/IGF-II in the prompt) that obscures the required points. Final score floor: 0.0."}
{"query": "Explain why aging domestic dogs are considered a strong translational model for studying human brain aging and early Alzheimer’s-like decline, addressing (i) key shared neuropathologies, (ii) neuroanatomical and sociocognitive features that increase translational relevance compared with rodents, and (iii) how population diversity and selective breeding can support phenotype classification.", "response": "Rubric (Total = 1.0 point; Min = 0 points):  \n\n- **Shared neuropathology and aging outcomes (0.45 points total)**  \n  - 0.20: Identifies **beta-amyloid (Aβ) plaque** accumulation as a naturally occurring feature in aging dogs.  \n  - 0.15: Identifies **tauopathy** as also occurring in aging dogs (and noted as unlike common rodent models).  \n  - 0.10: Mentions at least one Alzheimer’s-relevant aging outcome in dogs (e.g., **cortical atrophy**, **cognitive decline with memory dysfunction**, or **cerebral degeneration/decreased cortical volume/CCD**).\n\n- **Translational features vs. rodents (0.35 points total)**  \n  - 0.20: States that dogs have a **gyrencephalic brain** (evolutionary intermediate vs. rodents) supporting improved translational relevance.  \n  - 0.15: Explains at least one **human-aligned environmental/sociocognitive factor** (e.g., shared social cues, diet/environmental stimuli, or convergent sociocognitive skills due to domestication).\n\n- **Utility of population diversity and selective breeding (0.20 points total)**  \n  - 0.20: Explains that **selective breeding and diverse canine features** enable **classification of specific neuropathology phenotypes** (i.e., variability can be leveraged for phenotype stratification).\n\n- **Deductions for excess/irrelevant content (max 0.25 points)**  \n  - Deduct **0.05–0.25** if the response adds substantial extraneous material not needed to answer the question (e.g., unrelated molecular pathways, treatment regimens, or lengthy discussion of non-neurological aging), with deduction magnitude proportional to severity.  \n  - Final score floor: **0 points**."}
{"query": "In evaluations of trained dogs used for medical scent detection of cancers, what factors can drive wide variability in reported diagnostic performance, and what ranges of sensitivity and specificity have been reported versus histopathology?", "response": "Rubric (Total = 1.0 point; Minimum = 0 points):\n\n- Variability factors (0.6 points total):\n  - 0.3 points: Identifies that different sample materials (e.g., urine, blood, breath, faeces) used for presentation can contribute to variability.\n  - 0.3 points: Identifies lack of standardisation of training and/or trainer bias as a major influence on variability.\n\n- Performance ranges (0.4 points total):\n  - 0.2 points: States the reported sensitivity range is 19% to 99%.\n  - 0.2 points: States the reported specificity range is 73% to 99%.\n\nDeductions for excess/irrelevant content (max 0.25 points):\n- Deduct up to 0.25 points if the response adds substantial extraneous material beyond what is asked (e.g., unrelated mechanisms of olfaction, detailed cancer biology, or claims about other diseases) that obscures the required points. The deduction depends on severity. Final score cannot go below 0."}
{"query": "Describe how alternative splicing at exon 9 of the human *c-kit* transcript generates KIT isoforms, and compare the GNNK⁻ and GNNK⁺ isoforms in (i) ligand (SCF) binding affinity, (ii) phosphorylation/internalization dominance, and (iii) at least two downstream signaling or cellular transformation phenotypes that are stronger in the GNNK⁻ isoform.", "response": "Rubric (Total = 1.0 point; min = 0.0):  \n- **Isoform generation mechanism (0.25):** States that alternative splicing creates KIT isoforms that **differ by presence vs absence of four amino acids at exon 9**, specifically the **GNNK** motif in humans.  \n- **SCF affinity comparison (0.20):** Correctly states **SCF binding affinity is identical** between GNNK⁻ and GNNK⁺.  \n- **Phosphorylation/internalization dominance (0.20):** Correctly states **GNNK⁻ dominates over GNNK⁺** in **phosphorylation and internalization**.  \n- **Stronger GNNK⁻ outcomes (0.35):** Provides **at least two** correct examples of stronger effects associated with **GNNK⁻**, such as:  \n  - **Loss of contact inhibition** (stronger/associated with GNNK deletion)  \n  - **Anchorage-independent growth**  \n  - **Potential tumourigenicity**  \n  - **Stronger ERK activation** (e.g., in transformed NIH3T3 fibroblasts)  \n  - **Higher Akt phosphorylation** (e.g., in Ba/F3 cells)  \n  - **Higher Gab2 phosphorylation** (e.g., in Ba/F3 cells)  \n  (Full 0.35 only if at least two are correctly named and clearly attributed to GNNK⁻.)\n\nDeductions (max 0.25):  \n- Deduct **0.05–0.25** for substantial irrelevant/additional material that obscures the required comparisons (e.g., extended discussion of unrelated KIT biology, other exons/mutations, or disease mechanisms not asked). The final score cannot go below **0.0**."}
{"query": "Explain why spontaneous canine lymphoma is considered a strong comparative model for human non-Hodgkin lymphoma, and identify one reason certain dog breeds are particularly suitable candidates for hematopoietic cell transplantation (HCT) research.", "response": "Rubric (Total Score: 1.0 Point)\n\n- Comparative model justification (0.6 points total)  \n  - 0.3 points: States that lymphoma occurs spontaneously in dogs at incidence rates comparable to or higher than in humans (acceptable if they cite the given range 13–100 per 100,000 or clearly indicate “comparable/greater”).  \n  - 0.3 points: Identifies at least one shared cancer feature between dogs and humans relevant to modeling (any one of: histologic appearance, tumor genetics, biological behavior, molecular target presentation, therapeutic response, or similar primary/metastatic microenvironments).\n\n- Breed suitability for HCT (0.4 points total)  \n  - 0.4 points: States that several dog breeds are genetically predisposed to spontaneous hematologic diseases, making them good candidates for HCT therapy/research.\n\nDeductions (max 0.25 points)  \n- Deduct 0.05–0.25 points for excessive irrelevant content that goes beyond answering the two requested elements (e.g., lengthy unrelated discussion of non-hematologic cancers, unrelated treatment protocols, or broad veterinary oncology history).  \n- Final score floor: 0 points."}
{"query": "Describe the taxonomic classification and genome organization of canine distemper virus (CDV), including the polarity and segmentation status of its RNA genome, the viral proteins it encodes (with emphasis on the surface glycoproteins), and identify the three proteins that form the paramyxovirus replicative complex targeted for antiviral chemotherapy.", "response": "Rubric (Total Score: 1.0 point; minimum 0 points):\n\n- Taxonomy (0.20 points)  \n  - 0.10: Identifies the pathogen as canine distemper virus (CDV).  \n  - 0.10: Correctly places CDV in genus *Morbillivirus*, family *Paramyxoviridae*.\n\n- Genome type and organization (0.30 points)  \n  - 0.15: States the genome is single-stranded RNA of negative polarity.  \n  - 0.15: States the genome is non-segmented (and may note it is within a lipid/enveloped virion).\n\n- Encoded proteins including surface glycoproteins (0.30 points)  \n  - 0.15: Correctly names both surface glycoproteins: hemagglutinin (H) and fusion (F).  \n  - 0.15: Lists the remaining encoded proteins: matrix (M), nucleocapsid (N), phosphoprotein (P), and large RNA-dependent RNA polymerase (L).\n\n- Replicative complex (0.20 points)  \n  - 0.20: Identifies the tripartite replicative complex as N–P–L.\n\nDeductions for excess/irrelevant content (max 0.25 points):  \n- Deduct 0.05–0.25 if the response includes substantial unrelated material (e.g., extensive clinical signs, host-range discussion, or treatment details beyond naming the antiviral target) that obscures the required items. Final score cannot go below 0."}
{"query": "Explain why infections caused by methicillin-resistant *Staphylococcus pseudintermedius* (MRSP) and *Pseudomonas aeruginosa* make canine pyoderma and otitis externa increasingly difficult to treat, and justify why an ideal new therapeutic agent for these cases should be veterinary-restricted and narrow-spectrum.", "response": "Rubric (Total Score: 1.0 point; Minimum: 0.0 points):\n\n- 0.4 points: States that MRSP contributes to treatment difficulty due to methicillin resistance and increasing multidrug resistance in *S. pseudintermedius*.\n- 0.3 points: States that *P. aeruginosa* contributes to treatment difficulty because it is resistant to most antibiotics used in veterinary medicine (especially in otitis externa/integumentary infections).\n- 0.2 points: Justifies “veterinary-restricted” as desirable due to limiting broader (e.g., human) antimicrobial use/impact given resistance concerns and zoonotic spillover risk (e.g., sporadic human infections in dog contacts).\n- 0.1 points: Justifies “narrow-spectrum” as desirable because it limits impact on the commensal microbiota (i.e., avoids unnecessary disruption of normal flora).\n\nDeductions (max 0.25 points):\n- Deduct 0.05–0.25 points for excessive irrelevant content that obscures the required elements (e.g., detailed unrelated microbiology, unrelated diseases/hosts, or extensive treatment guidelines not asked for). Final score cannot go below 0.0."}
{"query": "In clinical canine practice, why is rectal mucosa temperature commonly used as a proxy for core body temperature despite not being the “gold standard,” and what practical limitations of rectal thermometry motivate the use of non-contact infrared thermometry (include at least two alternative measurement sites)?", "response": "Rubric (Total = 1.0 point; Minimum = 0 points):  \n- 0.35 points: States why rectal temperature is commonly used (minimally invasive and provides insight/approximation of core temperature).  \n- 0.35 points: Identifies practical limitations of rectal thermometry (must include: difficulty using on aggressive dogs OR inability/unsuitability with anal mucosa infection/rupture; full credit if both are stated, partial credit if only one is clearly stated).  \n- 0.30 points: Names at least two alternative sites used with non-contact IR thermometers (any two of: axilla, auricular canal/ear canal, ocular regions/eye).  \n\nDeductions (max 0.25 points):  \n- Deduct 0.05–0.25 points for excessive irrelevant content that goes well beyond answering the question (e.g., lengthy discussion of unrelated thermoregulation physiology or treatment recommendations)."}
{"query": "Explain how myxomatous mitral valve degeneration in dogs produces mitral regurgitation by describing (1) the key components of the mitral apparatus involved in competence, (2) the principal histopathologic remodeling changes, and (3) the downstream structural and clinical consequences that can culminate in congestive heart failure.", "response": "Rubric (Total Score: 1.0 point; Minimum: 0 points):  \n- 0.25 points: Correctly identifies the components required for mitral valve competence, including at least four of the following: mitral annulus, mitral valve leaflets, chordae tendineae, papillary muscles, left atrial myocardium, left ventricular myocardium.  \n- 0.35 points: Correctly states at least two principal histopathologic changes of myxomatous remodeling: extracellular matrix expansion with glycosaminoglycans/proteoglycans; valvular interstitial cell alteration; attenuation or loss of the collagen-rich fibrosa layer.  \n- 0.30 points: Correctly links these changes to malformation/biomechanical dysfunction of the mitral apparatus causing mitral incompetence/mitral regurgitation (must explicitly connect remodeling → dysfunction → regurgitation/incompetence).  \n- 0.10 points: Correctly names at least one advanced downstream consequence of chronic volume overload/regurgitation such as left atrial and left ventricular remodeling, atrial tears, chordal rupture, or congestive heart failure.\n\nDeductions (max 0.25 points):  \n- Deduct 0.05–0.25 points (severity-based) for excessive irrelevant material beyond what is needed to answer the three requested elements (e.g., unrelated treatments, unrelated valve diseases, or extensive comparative discussion of humans vs breeds not asked). Final score cannot be below 0."}
{"query": "Explain how noroviruses are taxonomically classified from family level down to genogroups and genotypes, specify the molecular basis used to define these genotypes, and identify the four known canine norovirus (CNV) genotypes along with the key limitation that has prevented precise investigation of CNV pathogenicity.", "response": "Rubric (Total = 1.0 point; Minimum = 0 points):\n\n- (0.25) Correctly identifies noroviruses as members of the family **Caliciviridae**.  \n- (0.25) Correctly states that noroviruses are classified into **seven genogroups (GI–GVII)** and into **>40 genotypes**.  \n- (0.25) Correctly states that genotypes are defined based on **major capsid protein VP1 sequence**.  \n- (0.25) Correctly lists all four CNV genotypes: **GIV.2, GVI.1, GVI.2, and GVII**, and states the main limitation as **lack of a suitable cell culture system for CNV**, preventing precise pathogenicity investigation.\n\nDeductions (max 0.25 points):  \n- Deduct **0.05–0.25** if the response adds substantial irrelevant content (e.g., extended country-by-country detection lists or unrelated clinical descriptions) that obscures the required classification/limitation points. The deduction magnitude should match severity. Final score cannot be below 0."}
{"query": "Explain how variation in the length of the polyglutamine (polyQ) repeat in the N-terminal transactivation domain of the androgen receptor (AR) relates to (i) AR transcriptional activity and (ii) prostate cancer risk, and state the direction of the association reported in both humans and dogs.", "response": "Rubric (Total = 1.0 point; Min = 0 points):  \n- 0.5 points: Correctly states the activity relationship: polyQ length is inversely related to AR transcriptional activity (shorter polyQ → higher transcriptional activity; longer polyQ → lower activity).  \n- 0.25 points: Correctly states the human risk association: shorter polyQ repeats are associated with higher prostate cancer risk in humans.  \n- 0.25 points: Correctly states the canine epidemiological conclusion: shorter polyQ repeats may be disadvantageous in dogs with respect to prostate cancer incidence (i.e., associated with higher incidence/risk or a less favorable outcome).\n\nDeductions (max 0.25 points):  \n- Deduct 0.05–0.25 points if the response adds substantial irrelevant material (e.g., unrelated AR domains, treatments, or molecular pathways not asked for) that obscures the required directional relationships.  \n- Final score cannot be below 0."}
{"query": "Explain where *Wolbachia pipientis* is primarily located within *Dirofilaria immitis*, summarize the experimental evidence that the symbiosis is obligate, and state one therapeutic implication of this relationship for heartworm treatment.", "response": "Rubric (Total = 1.0 point; Min = 0.0):  \n- **Location in the nematode (0.35 points):** Correctly identifies that large Wolbachia colonies reside in the **subdermal lateral cords of both males and females** and in the **female reproductive structures**.  \n- **Evidence for obligate symbiosis (0.35 points):** Correctly states that **antibiotic treatment** of the nematodes **rapidly disrupts embryogenesis and/or larval progression and/or adult growth**, demonstrating dependence on Wolbachia.  \n- **Therapeutic implication (0.30 points):** Correctly states that treatment is being developed/used that includes **antibiotics in combination with macrocyclic lactones (e.g., ivermectin)** (or equivalent wording indicating dual therapy targeting Wolbachia plus standard heartworm drugs).\n\nDeductions (max 0.25 points):  \n- Deduct **0.05–0.25** for substantial irrelevant or excessive extra content beyond what is asked (severity-based), such as extended discussion of unrelated Wolbachia-host systems or general immunology not tied to the required points.  \n- Final score cannot go below **0.0**."}
{"query": "In clinical management of canine atopic dermatitis, why is multimodal (combination) therapy commonly favored over monotherapy, and how do three specific interventions (choose from glucocorticoids, ciclosporin, antihistamines, essential fatty acids, allergen-specific immunotherapy, and intermittent antimicrobials) each address different practical needs or limitations in treatment?", "response": "Rubric (Total Score: 1.0 point; Minimum: 0 points):  \n- 0.30 points: States a valid overarching rationale for multimodal therapy (any one): monotherapy efficacy data may not reflect real-world practice; combination is often necessary/more beneficial; multimodal approach targets multiple points from antigen exposure to clinical signs; concurrent management of complications (secondary infections).  \n- 0.60 points: Correctly explains three distinct interventions (0.20 each) with a specific practical need/limitation they address:  \n  - Glucocorticoids: commonly prescribed; often used with bathing/antihistamines/fatty acids (combination use).  \n  - Antihistamines: limited benefit for atopic dermatitis overall but still frequently used to treat pruritus.  \n  - Essential fatty acids: inexpensive/common; frequently used in combination.  \n  - Allergen-specific immunotherapy (ASIT): slow onset; other therapies often used concurrently during first months.  \n  - Intermittent antimicrobials: used as needed to eliminate secondary infections.  \n  - Ciclosporin: acceptable as a listed common intervention (credit only if linked to combination/multimodal use; no extra details required).  \n- 0.10 points: Coherence and completeness—answer clearly connects multimodal rationale to the three chosen interventions without contradicting the listed facts.  \n- Deductions (max 0.25 points): Subtract 0.05–0.25 for excessive irrelevant content that obscures the required points (e.g., detailed pathophysiology, dosing regimens, or therapies not listed). Final score cannot be below 0."}
{"query": "A multifaceted stem-cell-based strategy for spinal cord injury repair aims to overcome limited mammalian spinal cord regeneration. Describe the key therapeutic actions such a strategy should combine (from activating endogenous cells through tissue-level remodeling), and explain two specific protective or reparative mechanisms attributed to mesenchymal stromal cells and/or neural crest stem cells.", "response": "Rubric (Total Score: 1.0 Point; Max Deduction: 0.25 Points):\n\n- Combined therapeutic actions (0.6 points total):\n  - 0.15: States activation of resident neural stem cells from a dormant state.\n  - 0.15: States differentiation into relevant cell types (neurons and/or glia).\n  - 0.15: States regulation of scar formation and/or prevention of cyst formation.\n  - 0.15: States secretion of neurotrophic and/or other factors to promote matrix repair/regeneration.\n\n- Two mechanisms of mesenchymal stromal cells and/or neural crest stem cells (0.4 points total):\n  - 0.2: Correctly identifies modulation of oxidative stress as one mechanism.\n  - 0.2: Correctly identifies secretion of cytokines/growth factors producing protective effects (any two effects earn credit): immunomodulatory, anti-inflammatory, pro-angiogenic, anti-apoptotic.\n\nDeductions for excess content (up to -0.25 points):\n- Deduct 0.05–0.25 if the response includes substantial irrelevant material (e.g., unrelated spinal cord anatomy, detailed descriptions of transplantation trial history, or mechanisms not asked for) that obscures the required points. The final score cannot go below 0."}
{"query": "Explain why aged pet dogs are considered a strong spontaneous translational model for human brain aging and Alzheimer’s disease-like neurodegeneration, and identify two specific protein quality-control systems implicated in proteotoxic stress responses that are highlighted as treatment-relevant targets.", "response": "Rubric (Total = 1.0 point; Min = 0.0):  \n- (0.35) Model justification—human relevance: States that elderly dogs naturally develop cognitive dysfunction and neuropathological hallmarks similar to humans, including Alzheimer’s disease-like pathology.  \n- (0.25) Model justification—translational environment: Notes that pet dogs share similar living conditions and diets with humans, supporting translational applicability.  \n- (0.20) Aging mechanism relevant to intervention: Mentions oxidative damage accumulating in the aging canine brain, motivating antioxidant prevention/treatment studies.  \n- (0.20) Protein quality-control targets: Correctly identifies both systems: (1) ubiquitin-proteasome system (UPS) and (2) Heat Shock Proteins (HSPs), and connects them to protein quality control/proteotoxic stress (at least implicitly).  \n\nDeductions (max 0.25):  \n- Deduct up to 0.25 for excessive irrelevant content that obscures the required points (e.g., lengthy discussion of unrelated diseases, unrelated molecular pathways, or detailed therapeutic regimens not asked for)."}
{"query": "In veterinary oncology, what is the clinical rationale for identifying reliable serum tumor biomarkers for canine mammary tumors (CMTs), and which two serum markers are most widely used in clinical practice (noting their long-standing use in human breast cancer) such that combining their preoperative levels may improve diagnostic and treatment-related decision-making?", "response": "Rubric (Total Score: 1.0 point; Minimum: 0 points):  \n- **0.45 points**: States the rationale for serum tumor biomarkers in CMTs as enabling **screening/early diagnosis** and aiding **monitoring of disease course** (progress/response to chemotherapy and/or recurrence) in a way that supports **treatment decisions**.  \n  - Full credit requires at least: (i) early diagnosis/screening and (ii) at least one monitoring function (progress/chemo response/recurrence) tied to clinical decision-making.  \n- **0.45 points**: Correctly identifies the two serum tumor markers as **carcinoembryonic antigen (CEA)** and **cancer antigen 15-3 (CA 15-3)**.  \n- **0.10 points**: Clearly indicates that **combining preoperative CEA and CA 15-3 levels** can provide **useful information for diagnosis and treatment** (i.e., better clinical utility than either alone).  \n\nDeductions (Max 0.25 points):  \n- Deduct **0.05–0.25** for excessive irrelevant content beyond the required points (e.g., lengthy discussion of unrelated biomarkers, detailed tumor histology not asked for, or treatment protocols not requested), proportional to severity.  \n- Final score cannot be below **0**."}
{"query": "Explain how close contact between pets and owners can contribute to the spread of antimicrobial resistance involving Staphylococcus species, and describe (1) how CRISPR systems can inhibit this process via antiplasmid immunity and (2) how CRISPR spacer sequences can be used as “molecular clocks” to reconstruct a bacterial strain’s history of genetic invasions.", "response": "Rubric (Total Score: 1.0 point; Minimum: 0 points)\n\n- 0.4 points: Pet–owner close contact and Staphylococcus as AMR reservoirs  \n  - 0.2 points for stating that close contact enables exchange of microorganisms and/or genetic material between pets and owners.  \n  - 0.2 points for stating that typically harmless Staphylococcus in animal/human microbiota can serve as reservoirs of antimicrobial resistance genes that can be transferred to more virulent species, increasing resistance to drug therapy.\n\n- 0.3 points: CRISPR antiplasmid immunity mechanism (conceptual)  \n  - 0.3 points for clearly stating that CRISPR systems can inhibit the spread/acquisition of resistance genes by providing antiplasmid immunity (i.e., blocking/defending against plasmid-mediated gene transfer).\n\n- 0.3 points: CRISPR spacers as molecular clocks  \n  - 0.3 points for stating that CRISPR spacer sequences record past genetic invasions and can be analyzed to track/reconstruct the history/timeline of genetic invasions experienced by a bacterial strain.\n\nDeductions (Max 0.25 points):  \n- Deduct 0.05–0.25 points for excessive irrelevant content that obscures the required elements (e.g., extended unrelated discussion of specific antibiotics, unrelated CRISPR biochemistry details beyond “antiplasmid immunity,” or clinical treatment guidelines).  \n- Total score cannot go below 0."}
{"query": "In studies using power-law scaling of trait size against body size, what range of scaling exponents would most strongly suggest a sexually selected ornament/weapon rather than a naturally selected trait, and what evolutionary explanation is often invoked for why such steep positive allometry can occur?", "response": "Rubric (Total Score: 1.0 point; Minimum: 0 points)\n\n- Scaling-exponent criterion (0.5 points)  \n  - 0.5: States that sexually selected ornaments/weapons typically show positive allometry with slope \\(b>1\\) (for same-dimension comparisons), with steep values commonly around 1.5–2.0 and sometimes as high as ~3.4; contrasts this with natural-selection traits often being near isometry (\\(b \\approx 1\\)).  \n  - 0.0: Does not identify \\(b>1\\) (or gives incorrect direction), or fails to distinguish from isometry/natural-selection expectation.\n\n- Evolutionary explanation (0.5 points)  \n  - 0.5: Identifies the handicap principle (costly/disadvantageous traits signal higher individual quality because only high-quality individuals can bear the cost).  \n  - 0.0: Provides a different/incorrect explanation or omits an explanation.\n\nDeductions for excessive irrelevant content (max 0.25 points)  \n- Deduct up to 0.25 if the response adds substantial extraneous material beyond scaling interpretation and the handicap-principle explanation (e.g., long digressions on unrelated allometry models, statistical fitting procedures, or unrelated examples), proportional to severity. Final score cannot go below 0."}
{"query": "Explain how the conducting airway epithelium achieves an effective first-line defense against inhaled pathogens by integrating (i) its cellular composition and regenerative capacity with (ii) its barrier and clearance mechanisms; include the roles of tight junctions, the mucociliary escalator, and basal cells.", "response": "Rubric (Total = 1.0 point; Minimum = 0 points):  \n- 0.35 points: Barrier integrity mechanism  \n  - Correctly states that tight junctions are apical intercellular complexes that maintain epithelial integrity and enable an impermeable barrier function.  \n- 0.35 points: Clearance mechanism  \n  - Correctly explains the mucociliary escalator as (a) mucus from secretory cells trapping inhaled particles/pathogens and (b) coordinated ciliary beating moving this mucus anteriorly toward the pharynx for clearance.  \n- 0.30 points: Cellular composition + regeneration  \n  - Identifies that the airway epithelium is a pseudostratified columnar epithelium composed of multiple specialized cell types (any 4 or more correct examples such as basal, ciliated, goblet, club, brush, neuroendocrine, ionocytes, Hillock cells).  \n  - Includes that a subset of basal cells can self-renew and differentiate into ciliated and secretory cells to regenerate the epithelium after injury and preserve the barrier.\n\nDeductions (maximum deduction = 0.25 points):  \n- Deduct 0.05–0.25 points for excessive irrelevant material that goes beyond the requested mechanisms (e.g., extended discussion of adaptive immunity, detailed pathogen examples, or unrelated organ systems) that obscures or replaces the required elements.  \n- Final score cannot be below 0."}
{"query": "Context 1\n\n  \nDescribe Lactobacillus reuteri in terms of (i) Gram stain and motility, (ii) metabolic/fermentation type, (iii) typical ecological niche in vertebrates, and (iv) at least three distinct probiotic functions it can provide in humans or animals.", "response": "Rubric (Total = 1.0 point; Min = 0):  \n- 0.25 pts: Correctly identifies it as Gram-positive and non-motile.  \n- 0.25 pts: Correctly states it is obligately heterofermentative.  \n- 0.25 pts: Correctly states it commonly resides/persists in the gastrointestinal tract (intestinal microbiota) of humans/other vertebrates.  \n- 0.25 pts: Lists at least three correct probiotic effects from the following (any three): colonizes the intestine; modulates host immune system; produces/secretes antimicrobial compounds; prevents diarrhea; reduces infant colic; prevents colitis.  \n\nDeductions (max 0.25 pts):  \n- Deduct 0.05–0.25 pts for excessive irrelevant content that goes well beyond the requested descriptors/functions (severity-based). Final score not below 0."}
{"query": "Describe the key virological features of Canine parvovirus type 2 (CPV-2) by stating its envelope status, genome type and length, genome organization (major ORFs), known major variants, typical disease outcome in young dogs, and two factors that contribute to its high contagiousness and persistence in the environment.", "response": "Rubric (Total Score: 1.0 point; Min: 0 points)\n\n- Envelope status (0.10): States CPV-2 is **non-enveloped**.  \n- Genome type (0.10): States CPV-2 is **single-stranded DNA**.  \n- Genome length (0.10): Gives genome length as **5323 nucleotides** (accept “~5.3 kb” if clearly equivalent).  \n- Genome organization (0.10): States it has **at least 2 major open reading frames (ORFs)**.  \n- Variants (0.15): Lists **CPV-2a, CPV-2b, and CPV-2c**.  \n- Disease in young dogs (0.15): Identifies **(often fatal) gastroenteritis in young dogs** (must include gastroenteritis and severity such as fatal/high mortality).  \n- High contagiousness—factor 1 (0.10): Mentions **low infectious dose requirement** (or equivalent phrasing indicating few virions needed to infect).  \n- High contagiousness—factor 2 (0.10): Mentions **high titers of transmissible virus in stools** (fecal shedding).  \n- Environmental persistence (0.10): States **high environmental resistance** and/or **viable outside host for at least a year** (must include the “~1 year” timescale or “at least a year”).  \n\nDeductions for extraneous content (max −0.25):  \n- Deduct **0.05–0.25** if the response adds substantial irrelevant material (e.g., detailed treatment protocols, unrelated canine diseases, vaccine schedules) that obscures the required points. The deduction magnitude depends on severity.  \n- Final score floor: **0.00**."}
{"query": "Canine theileriosis is an emerging tick-borne piroplasmid disease in dogs. Explain why the causative organism is only provisionally classified as *Theileria annae*, identify key known and unknown aspects of its epidemiology (geographic distribution and vectors), and name one combination therapy reported to show better clinical efficacy.", "response": "Rubric (Total = 1.0 point; Minimum = 0 points):  \n- **Provisional classification rationale (0.35 points):**  \n  - 0.35: States that the agent is not yet accurately classified, but PCR evidence shows it resembles the *Theileria* genus, so it is provisionally named *Theileria annae*.  \n  - 0.0: Missing/incorrect rationale.\n\n- **Geographic distribution (0.25 points):**  \n  - 0.25: Identifies it as endemic in most European countries and not reported in Asia to date.  \n  - 0.0: Missing/incorrect distribution.\n\n- **Vector status (0.25 points):**  \n  - 0.25: States that the vectors are not determined/unknown, while noting *T. annae* DNA has been detected in the hard tick *Ixodes hexagonus* in Northwestern Spain (and/or other tick species).  \n  - 0.0: Missing/incorrect vector status.\n\n- **Effective therapy (0.15 points):**  \n  - 0.15: Names at least one reported effective regimen: **atovaquone** OR **buparvaquone plus azithromycin**.  \n  - 0.0: Missing/incorrect therapy.\n\n- **Deductions for excessive irrelevant content (max 0.25 points):**  \n  - Deduct **0.05–0.25** if the response adds substantial non-asked material (e.g., lengthy clinical sign lists, detailed discussion of other *Theileria* species in canines, or extensive background on tick biology) that obscures the required points.  \n  - Total score after deductions cannot be below 0."}
{"query": "Explain why *Babesia rossi* infection is considered clinically important in domestic dogs in South Africa, describe how naturally occurring canine disease is objectively classified into two categories, and identify (i) the dominant type of host immune response implicated in severity and (ii) two key pathophysiological features that make this disease a useful comparative model for human severe malaria.", "response": "Rubric (Total = 1.0 point; Min = 0):  \n- **Clinical importance in South African dogs (0.25 points):** States that *B. rossi* causes the most severe canine babesiosis and is a leading cause of infectious morbidity and mortality among susceptible domestic dogs in South Africa.  \n- **Objective classification scheme (0.25 points):** States that clinical presentation plus laboratory measurables are used to classify cases as **uncomplicated** vs **complicated** babesiosis.  \n- **Dominant host response (0.25 points):** Identifies the host response as a **pro-inflammatory cytokine storm**.  \n- **Comparative features with severe malaria (0.25 points):** Correctly names **hemolysis** and **inflammation leading to multiple organ dysfunction** as the shared key pathophysiological features.\n\nDeductions (max 0.25 points):  \n- Deduct **0.05–0.25** for excessive irrelevant material beyond what is asked (e.g., detailed organ-specific pathology not requested, extensive discussion of predictors of poor outcome without tying to the required points).  \n- Final score cannot go below **0**."}
{"query": "Explain how tick transmission and intravascular hemolysis together drive the key clinical signs of bovine babesiosis, and identify the two principal Babesia species involved as well as the two tick vectors implicated in Algeria.", "response": "Rubric (Total = 1.0 point; Minimum = 0.0):  \n- **0.25 points:** Correctly names the two principal Babesia species: **Babesia bovis** and **Babesia bigemina**.  \n- **0.50 points:** Correctly links pathogenesis to signs by stating that **tick-borne infection leads to intravascular hemolysis** (and associated vascular/coagulation dysfunction/hypotensive shock) producing predominant signs such as **high fever, hemoglobinemia, and hemoglobinuria** (credit if at least two of these signs are explicitly connected to hemolysis/vascular effects).  \n- **0.25 points:** Correctly identifies the two tick vectors implicated in Algeria: **Boophilus annulatus** and **Rhipicephalus bursa**.  \n\nDeductions (max 0.25 points):  \n- Deduct **0.10–0.25** for substantial irrelevant additions (e.g., lengthy historical details, extensive global distribution statistics) that go well beyond answering the asked mechanisms/species/vectors. The total score after deductions cannot be below **0.0**."}
{"query": "Explain how histotripsy achieves noninvasive volumetric ablation of benign prostatic hypertrophy (BPH) tissue, including the key ultrasound pulse parameters, the cavitation-driven mechanical mechanism at the cellular level, how the ablation volume is created, and the expected ultrasound imaging appearance change during treatment.", "response": "Rubric (Total Score: 1.0 point; Min Score: 0.0 points):\n\n- Ultrasound pulse parameters (0.25 points)  \n  - 0.25: Correctly states high-amplitude, short ultrasound pulses (<50 μs) delivered at a low duty cycle (<1%).  \n  - 0.0: Missing/incorrect parameters.\n\n- Mechanism of tissue destruction (0.35 points)  \n  - 0.35: Explains that compression/rarefaction generates microbubbles that oscillate, coalesce, and collapse (cavitation), causing mechanical fractionation/homogenization of tissue at the cellular level into a fine slurry of acellular debris.  \n  - 0.0: Does not describe cavitation and mechanical fractionation/homogenization accurately.\n\n- How volumetric ablation is achieved (0.20 points)  \n  - 0.20: States that volumetric ablation is produced by passing/sweeping the transducer’s cigar-shaped focal volume through the targeted region.  \n  - 0.0: Missing/incorrect description of how a volume (not just a point) is treated.\n\n- Imaging appearance change (0.20 points)  \n  - 0.20: Correctly states that as tissue is homogenized, the ultrasound appearance becomes progressively hypoechoic.  \n  - 0.0: Missing/incorrect imaging change.\n\nDeductions for excessive irrelevant content (max 0.25 points):  \n- Deduct 0.05–0.25 if the response adds substantial unrelated material (e.g., detailed comparisons to other BPH surgeries, unrelated safety statistics, or claims beyond the described model such as human efficacy outcomes). The deduction depends on severity. Final score cannot be below 0."}
{"query": "Explain the mechanism of action of sodium-glucose cotransporter 2 (SGLT2) inhibitors in glucose control, and identify which specific SGLT2 inhibitors have demonstrated improved cardiorenal outcomes in diabetic patients as well as which agents are approved for chronic heart failure and chronic kidney disease in non-diabetic patients.", "response": "Rubric (Total = 1.0 point; Minimum = 0 points):\n\n- Mechanism of action (0.35 points)  \n  - 0.35: States that SGLT2 inhibitors lower blood glucose by inhibiting SGLT2-mediated glucose reabsorption in the proximal renal tubule, thereby increasing urinary glucose excretion.  \n  - 0: Mechanism is missing or incorrect.\n\n- Cardiorenal outcome benefit in diabetes (0.35 points)  \n  - 0.35: Correctly names all three: empagliflozin, canagliflozin, and dapagliflozin as having improved cardiorenal outcomes in diabetic patients.  \n  - 0.20: Names exactly two of the three correctly.  \n  - 0.10: Names exactly one of the three correctly.  \n  - 0: Names none correctly or includes substitutions that indicate misunderstanding.\n\n- Approvals in non-diabetic chronic heart failure and chronic kidney disease (0.30 points)  \n  - 0.30: Correctly identifies dapagliflozin and empagliflozin as approved for chronic heart failure and chronic kidney disease in patients without diabetes.  \n  - 0.15: Correctly identifies only one of the two.  \n  - 0: Identifies neither correctly.\n\nDeductions for excessive irrelevant content (max 0.25 points):  \n- Deduct 0.05–0.25 if the response adds substantial unrelated material (e.g., listing all 10 approved inhibitors or regions of approval when not asked, detailed adverse effects, unrelated trial details).  \n- Apply larger deductions (up to 0.25) when irrelevant content is extensive enough to obscure the required items.  \n- Final score cannot be below 0."}
{"query": "Explain how molecular typing evidence supports cross-species transmission of methicillin-resistant *Staphylococcus aureus* (MRSA) between humans and dogs, including the role of the mecA gene, the relevance of MLST sequence types ST22 and ST5, how PFGE macrorestriction patterns are used as evidence, and what is meant by an extended-host-spectrum genotype (EHSG).", "response": "Rubric (Total Score: 1.0 point; Minimum: 0 points):\n\n- (0.25) mecA and MRSA definition: Correctly states that MRSA strains harbor the mecA gene, which encodes methicillin resistance.  \n- (0.25) MLST evidence and STs: Correctly explains that MLST shows dogs are predominantly infected with common regional human-origin lineages and specifically identifies ST22 and ST5 as examples.  \n- (0.25) PFGE evidence for cross-species transmission: Correctly states that indistinguishable PFGE macrorestriction patterns between canine- and human-origin MRSA strains indicate cross-species transmission (shared/very closely related strains).  \n- (0.25) EHSG definition: Correctly defines EHSG as genetic lineages able to infect multiple animal species as well as humans.\n\nDeductions (Maximum deduction: 0.25 points):\n- Deduct 0.05–0.25 for excessive irrelevant content beyond the requested items (e.g., lengthy discussion of unrelated diseases, treatment guidelines, or detailed methodology not needed to answer the question), proportional to severity. The final score cannot be below 0."}
{"query": "How does mammary cancer susceptibility differ among carnivores/omnivores versus herbivores, and what specific evidence supports classifying pigs as an intermediate case with respect to mammary tumor development?", "response": "Rubric (Total = 1.0 point; Min = 0.0 points):  \n- 0.5 points: Correctly states the overall pattern that carnivores/omnivores are generally susceptible to mammary (breast) cancer, while herbivores show much lower/rare occurrence.  \n- 0.25 points: Provides at least one correct supporting example with malignancy/occurrence figures for carnivores (e.g., female dogs: mammary tumors most common neoplasm; up to ~50% malignant; cats: ~17% of neoplasms with ~80–90% malignant; wild carnivores also develop similar-pattern tumors).  \n- 0.25 points: Correctly explains why pigs can be seen as intermediate by citing both (i) naturally occurring mammary tumors are rare in pigs and (ii) porcine epithelial cells can become neoplastic after oncogenic transformation and form tumors when introduced into mouse mammary glands, highlighting the importance of host environment.\n\nDeductions (max 0.25 points):  \n- Deduct 0.05–0.25 points for substantial irrelevant or speculative content (e.g., unrelated molecular pathways, treatment discussions, or unmentioned evolutionary claims). Final score cannot go below 0.0."}
{"query": "Explain why tuberculosis is considered a re-emerging major public-health threat, and quantify (with ranges) the estimated contribution of *Mycobacterium bovis* to human tuberculosis in developing versus developed countries; also state the reported annual burden in Brazil in terms of new cases and deaths.", "response": "Rubric (Total = 1.0 point; Minimum = 0 points):\n\n- Re-emerging/major-threat rationale (0.30 points total)  \n  - 0.15: States that increased reports of human tuberculosis contribute to it being considered re-emerging/major threat.  \n  - 0.15: States both key drivers: higher burden particularly among people living with HIV/AIDS AND the rise of multidrug-resistant isolates.\n\n- *M. bovis* contribution by country type (0.30 points total)  \n  - 0.15: Gives the developing-country estimate: ~10–15% of human TB cases.  \n  - 0.15: Gives the developed-country estimate: ~1–2% of human TB cases.\n\n- Brazil annual burden (0.40 points total)  \n  - 0.20: Reports ~70,000 new cases annually.  \n  - 0.20: Reports ~4,600 deaths annually.\n\nDeductions for excess/irrelevant content (max 0.25 points):  \n- Deduct up to 0.25 if the response includes substantial unrelated information (e.g., extensive discussion of WHO rankings by year, detailed narrative about nontuberculous mycobacteria) that is not required to answer the question and obscures the requested facts.  \n- Final score cannot be below 0."}
{"query": "In bovine tuberculosis caused by *Mycobacterium bovis*, which anatomical sites are most frequently affected by granulomatous lesions, and which organs are noted as less frequently affected?", "response": "Rubric (Total Score: 1.0 point; Minimum: 0 points):  \n- **0.6 points**: Correctly identifies the most frequently affected sites as the **retropharyngeal, tracheobronchial, and mediastinal lymph nodes, and the lungs** (all must be present for full 0.6; if only lymph nodes or only lungs are given, award **0.3**).  \n- **0.4 points**: Correctly lists **at least four** of the less frequently affected organs/sites: **regional lymph nodes, spleen, liver, kidney, intestine, mesenteric lymph nodes, vertebrae, spinal cord** (0.1 each up to 0.4).  \n\nDeductions (max 0.25 points):  \n- Deduct **0.05–0.25** for excessive irrelevant material that goes beyond the asked anatomical distribution (e.g., lengthy discussion of human extrapulmonary TB trends, meningitis case counts, or ocular TB rarity) depending on severity.  \n- Final score cannot be below **0.0**."}
{"query": "Explain the prion hypothesis for transmissible spongiform encephalopathies (TSEs) by describing (i) what prions are mainly composed of, (ii) the molecular conversion event central to TSE pathogenesis, (iii) why the pathogenic prion isoform is unusually resistant to inactivation, and (iv) why detecting that isoform is considered both a reliable marker of infection and the gold-standard basis for diagnosis.", "response": "Rubric (Total = 1.0 point; Min = 0 points):  \n- 0.25 points: Correctly identifies the infectious agent as a prion composed mainly (if not entirely) of the abnormal disease-associated prion protein isoform PrP^Sc (not nucleic-acid–based).  \n- 0.25 points: Correctly states the central pathogenic event is conversion/misfolding of host-encoded cellular PrP^C into PrP^Sc, with accumulation in the central nervous system.  \n- 0.25 points: Correctly explains that the altered protein folding/conformation of PrP^Sc is what leads to its characteristic resistance to inactivation.  \n- 0.25 points: Correctly states that PrP^Sc correlates with TSE infectivity, making it a reliable infection marker, and that biochemical detection of PrP^Sc is the gold standard for diagnosis.  \n\nDeductions (max 0.25 points):  \n- Deduct 0.05–0.25 points for excessive irrelevant material that obscures the required elements (e.g., long discussion of unrelated neurodegenerative diseases, treatment speculation, or detailed laboratory protocols not asked for). The total score cannot go below 0."}
{"query": "Compare *Dirofilaria immitis* and *Dirofilaria repens* by identifying (1) their mosquito vector groups, (2) their primary anatomical locations in dogs, and (3) the typical clinical manifestations they cause in dogs and in humans.", "response": "Rubric (Total = 1.0 point; Min = 0):  \n- **Vector groups (0.25 points):** Correctly states that transmission occurs via culicid mosquitoes, specifically naming the groups **Culex spp., Aedes spp., and Anopheles spp.**  \n- **Anatomical location in dogs (0.35 points):**  \n  - **0.20**: Correctly states *D. immitis* adults are in the **pulmonary arteries and right ventricle** in dogs.  \n  - **0.15**: Correctly states *D. repens* adults are mainly in **subcutaneous tissues** (accept also mention of **subconjunctival, pulmonary, and/or peri-muscular connective fascia**).  \n- **Clinical manifestations (0.40 points):**  \n  - **0.20**: Correctly contrasts dog disease: *D. immitis* can cause **life-threatening cardiopulmonary disease**, while *D. repens* is **often asymptomatic** but may cause **subcutaneous nodules and/or allergic dermatitis**.  \n  - **0.20**: Correctly states human *D. repens* commonly presents with **tissue nodules** (accept “nodules in tissues”); mentioning that both species are agents of **human dirofilariasis** is acceptable but not required.  \n- **Deductions for irrelevance (max −0.25 points):** Subtract **0.05–0.25** if the response adds substantial unrelated material (e.g., treatment regimens, detailed lifecycle stages not asked for, epidemiologic statistics not in scope) that obscures the required comparisons. Final score cannot go below **0**."}
{"query": "Explain the full transmission pathway of human fascioliasis from exposure to clinical outcome, and contrast one major chronic complication in humans with one major economic impact in bovines.", "response": "Rubric (Total = 1.0 point; Minimum = 0 points):\n\n- Transmission pathway (0.4 points)  \n  - 0.2: Identifies the causative agents as *Fasciola hepatica* and/or *Fasciola gigantica*.  \n  - 0.2: States infection occurs via ingestion of larval stages on raw/undercooked aquatic vegetables and/or contaminated water.\n\n- Clinical course and chronic human complication (0.3 points)  \n  - 0.15: Describes the sequence: symptomless incubation period followed by acute phase and then chronic phase.  \n  - 0.15: Names liver fibrosis (hardening of the liver due to chronic inflammation) as a chronic complication in humans.\n\n- Bovine economic impact (0.3 points)  \n  - 0.3: States at least one correct economic/livestock impact in bovines: liver damage/poor growth leading to reduced meat and milk production and/or increased mortality causing economic losses.\n\nDeductions (max 0.25 points):  \n- Deduct 0.05–0.25 for excessive irrelevant material that goes well beyond what is asked (e.g., detailed treatment regimens, unrelated parasites, or extensive global policy discussion). Deduction amount depends on severity. Final score cannot go below 0."}
{"query": "Describe the key virion structure and genome organization of bovine papillomavirus (BPV), including (i) the type/size of its genome, (ii) the capsid architecture and major/minor capsid protein copy numbers, and (iii) how the genome is partitioned into early, late, and long control regions with their approximate proportions and principal genetic/regulatory contents.", "response": "Rubric (Total = 1.0 point; Minimum = 0 points):\n\n- Genome type and size (0.25 points)  \n  - 0.25: States BPV has a double-stranded circular DNA genome of ~8 kb.  \n  - 0: Incorrect genome type (e.g., RNA, linear DNA) and/or no approximate size.\n\n- Capsid architecture and protein composition (0.30 points)  \n  - 0.15: Identifies an icosahedral capsid with 72 capsomeres.  \n  - 0.15: Gives correct capsid protein copy-number organization: 360 copies of L1 and ~12 copies of L2 per capsomere (i.e., L2 arranged in ~12 copies).  \n  - 0: Missing/incorrect key structural details above.\n\n- Genome partitioning and proportions (0.30 points)  \n  - 0.15: Correctly partitions into early, late, and LCR regions (and may note two polyadenylation sites separating regions).  \n  - 0.15: Provides approximate proportions: early ~50%, late ~40%, LCR ~10% (≈850 bp).  \n  - 0: Missing/incorrect partitioning and/or proportions.\n\n- Key contents of each region (0.15 points)  \n  - 0.10: Lists early genes/proteins E1, E2, E3, E4, E5, E6, E7.  \n  - 0.05: Notes late region encodes L1 and L2, and/or LCR contains origin of replication and multiple transcription-factor binding sites.  \n  - 0: Does not correctly identify these contents.\n\nDeductions for irrelevance/overreach (max 0.25 points):  \n- Deduct 0.05–0.25 if the response adds substantial extraneous material not asked for (e.g., detailed clinical lesion descriptions, epidemiology, treatment), to the point that it obscures the required structural/genomic elements. Final score cannot go below 0."}
{"query": "Describe the major etiologic agent and host range of bovine trypanosomiasis in South America, and explain how transmission differs between African and South American settings, including named examples of vectors.", "response": "Rubric (Total = 1.0 point; minimum = 0):  \n- **0.35 points**: Correctly identifies **Trypanosoma vivax (T. vivax)** as the **main** cause of bovine trypanosomiasis in South American countries and notes it is considered the **most pathogenic/most important** agent in cattle veterinary practice.  \n- **0.25 points**: Correctly states host range beyond cattle, including **buffaloes** and at least one wildlife host: **capybaras** and/or **wild ungulates such as deer**.  \n- **0.30 points**: Correctly contrasts transmission routes by region: **cyclical transmission by tsetse flies in Africa** versus **mechanical transmission by other blood-sucking insects in South America**.  \n- **0.10 points**: Provides at least one correct example of mechanically transmitting insects: **Stomoxys calcitrans** and/or **tabanids**.\n\nDeductions (max 0.25 points):  \n- Deduct **0.05–0.25** if the response includes substantial irrelevant material (e.g., treatment regimens, detailed clinical signs, or unrelated parasite species) that obscures the required elements. The total score cannot go below **0**."}
{"query": "Describe how bovine papillomavirus (BPV) infection typically progresses in epithelial tissue, including the usual outcome of the lesions and the condition under which they may become malignant, and classify the sequenced BPV types (BPV1–BPV11) into their correct genera while identifying the unclassified type.", "response": "Rubric (Total = 1.0 point; Minimum = 0 points):\n\n- (0.25) Infection site/pathology: States that BPV infects **basal epithelial cells** and leads to **papillomas/warts (papillomas)**.  \n- (0.25) Lesion course and malignancy condition: States lesions are **usually benign and tend to regress**, but can become **malignant with environmental co-factors**.  \n- (0.40) Correct genus classification of sequenced BPV types:  \n  - (0.15) **Deltapapillomavirus**: correctly assigns **BPV1 and BPV2**.  \n  - (0.15) **Xipapillomavirus**: correctly assigns **BPV3, BPV4, BPV6, BPV9, BPV10, BPV11**.  \n  - (0.10) **Epsilonpapillomavirus**: correctly assigns **BPV5 and BPV8**.  \n- (0.10) Unclassified type: Identifies **BPV7** as **unclassified**.\n\nDeductions (max 0.25 points):  \n- Deduct **0.05–0.25** for excessive irrelevant content beyond what is asked (e.g., unrelated BPV molecular biology, treatment details, or extensive discussion of non-bovine papillomaviruses). The deduction depends on severity. Final score cannot be below 0."}
{"query": "Bovine papillomaviruses (BPVs) are grouped into genera using homology within a specific highly conserved genomic region. Identify this genomic region and correctly assign BPV types 1–13 to their respective genera as currently well characterized.", "response": "Rubric (Total Score: 1.0 Point; Minimum: 0 Points):  \n- **Genomic region used for classification (0.2 points):**  \n  - 0.2: Correctly identifies the **L1 ORF** (L1 open reading frame) as the conserved region used for genus classification.  \n  - 0.0: Any other region or missing/unclear.\n\n- **Correct genus-to-type assignments (0.8 points total):**  \n  - **Deltapapillomavirus (0.2 points):**  \n    - 0.2: Correctly lists **BPV-1, BPV-2, BPV-13**.  \n    - 0.0: Any omission or incorrect inclusion.  \n  - **Xipapillomavirus (0.2 points):**  \n    - 0.2: Correctly lists **BPV-3, BPV-4, BPV-6, BPV-9, BPV-10, BPV-11, BPV-12**.  \n    - 0.0: Any omission or incorrect inclusion.  \n  - **Epsilon papillomavirus (0.2 points):**  \n    - 0.2: Correctly lists **BPV-5, BPV-8**.  \n    - 0.0: Any omission or incorrect inclusion.  \n  - **Dyoxipapillomavirus (0.2 points):**  \n    - 0.2: Correctly lists **BPV-7**.  \n    - 0.0: Any omission or incorrect inclusion.\n\n- **Deductions for excessive irrelevant content (max 0.25 points):**  \n  - Deduct **0.05–0.25** if the response adds substantial unrelated material (e.g., lesion pathology details, treatment, epidemiology beyond classification) that obscures or overwhelms the required classification content.  \n  - Total score cannot go below **0.0**."}
{"query": "Explain how infection timing and viral biotype contribute to the generation of persistently infected (PI) calves in bovine viral diarrhea virus (BVDV), and why PI animals are central targets in herd-level eradication programs.", "response": "Rubric (Total Score: 1.0 point; Minimum: 0 points)\n\n- PI calf generation mechanism (0.5 points)  \n  - 0.25: States that infection occurs during early gestation (early pregnancy).  \n  - 0.25: States that infection involves noncytopathic BVDV leading to persistently infected calves.\n\n- Why PI animals drive spread / eradication rationale (0.5 points)  \n  - 0.25: States that PI calves continuously shed virus.  \n  - 0.25: Specifies shedding occurs broadly from all mucosal surfaces and thus they are major sources maintaining herd transmission; therefore identification and removal is critical.\n\nDeductions (max 0.25 points)  \n- Deduct 0.05–0.25 for excessive irrelevant content that obscures the required points (e.g., long descriptions of unrelated clinical signs, detailed taxonomy beyond what is asked).  \n- Final score cannot be below 0."}
{"query": "Explain how bovine respiratory syncytial virus (BRSV) and bovine parainfluenza virus-3 (BPI-3) contribute to pneumonia in young cattle and buffaloes, and state what specific evidence gap has been identified regarding these viruses in India.", "response": "Rubric (Total Score: 1.0 Point; Minimum: 0.0 Points):  \n- Contribution to pneumonia (0.7 points):  \n  - 0.35 points: Correctly states that BRSV and BPI-3 can *primarily cause* pneumonia in young animals.  \n  - 0.35 points: Correctly states that BRSV and BPI-3 can also *predispose* animals to developing pneumonia (i.e., act as contributing factors in a multifactorial disease process).  \n- Identified evidence gap in India (0.3 points):  \n  - 0.3 points: Correctly states that there have been *no reports* documenting involvement of BRSV and BPI-3 in Indian cattle and buffaloes suffering from pneumonia.  \n\nDeductions (Max 0.25 points):  \n- Deduct 0.05–0.25 points if the response adds excessive irrelevant material (e.g., detailed treatment protocols, unrelated pathogens, or general economic analysis beyond noting losses) that dilutes or obscures the required points.  \n- Final score cannot be below 0.0."}
{"query": "Explain two mechanisms by which bovines can disproportionately amplify human transmission of *Schistosoma japonicum* in agricultural regions, and quantify the estimated share of human transmission attributed to bovines in Eastern China.", "response": "Rubric (Total Score: 1.0 point; Minimum: 0.0 points)  \n\n- Mechanism 1 (0.35 points):  \n  - 0.35 points for correctly stating that close environmental/behavioral overlap between humans and bovines during agricultural production increases exposure/contamination near transmission sites.  \n  - 0 points if this mechanism is missing or incorrect.\n\n- Mechanism 2 (0.35 points):  \n  - 0.35 points for correctly stating that bovines produce very large quantities of feces (up to ~100× human daily fecal output), increasing environmental contamination with parasite eggs.  \n  - 0 points if this mechanism is missing or incorrect.\n\n- Quantification (0.30 points):  \n  - 0.30 points for correctly stating that bovines may account for as much as ~75% of human transmission in Eastern China.  \n  - 0 points if the percentage is missing or incorrect.\n\nDeductions for excessive irrelevant content (max deduction: 0.25 points):  \n- Deduct 0.05–0.25 points if the response adds substantial unrelated details (e.g., broad global prevalence statistics, lists of many animal host species, extensive history of control programs) that are not needed to answer the mechanisms and quantified contribution.  \n- Total score cannot go below 0.0 points."}
{"query": "A cattle farm in an endemic region wants to reduce transmission of bovine tropical theileriosis (Theileria annulata), a tick-borne disease impacting pure bred cattle. What three control options can be implemented, and for each option state the specific target or mechanism by which it reduces tick exposure or infection risk?", "response": "Rubric (Total = 1.0 point; Min = 0.0 points):  \n- (0.35) Correctly identifies acaricide application and specifies it is applied to cattle and to barn walls.  \n- (0.35) Correctly identifies roughcasting of barn outer and inner wall surfaces and states the mechanism/target: destroying nymph lodging sites (nymph lodgings).  \n- (0.30) Correctly identifies vaccination using a local attenuated cell line vaccine.  \n\nDeductions (max 0.25 points):  \n- Deduct 0.05–0.25 for excessive irrelevant content (e.g., detailed parasite life cycle, clinical signs, or treatment protocols) that is not needed to answer the question; severity-based.  \n- Final score cannot be below 0.0."}
{"query": "Mycobacterium bovis causes bovine tuberculosis and can infect many mammalian species. Describe (1) its intracellular lifestyle and why that matters for disease impact, (2) at least five non-bovine mammal species it can infect (including at least one wildlife species and humans), and (3) the main transmission routes in cattle and the key clinical/productivity effects seen in severe bovine infection.", "response": "Rubric (Total Score: 1.0 Point; Minimum: 0.0 Points)\n\n- Intracellular lifestyle and significance (0.25 points)  \n  - 0.15: States that M. bovis is an intracellular bacterium.  \n  - 0.10: Explains significance consistent with the context (e.g., disease effects can be variable with minimal signs in recent infection but more severe/chronic impacts over time).\n\n- Host range (0.35 points)  \n  - 0.35: Correctly lists at least five susceptible non-bovine mammals from the following, and must include humans and at least one wildlife species: goats, dogs, pigs, lions, elephants, badgers, possums, deer, bison, humans.\n\n- Transmission routes in cattle (0.20 points)  \n  - 0.20: Identifies inhalation and/or ingestion as the main routes (full credit if both are given; 0.10 if only one is given).\n\n- Severe infection effects in cattle (0.20 points)  \n  - 0.10: Notes loss of appetite and weight loss in severe infection.  \n  - 0.10: Notes decreased productive parameters (reduced productivity).\n\nDeductions for excessive irrelevant content (max 0.25 points)  \n- Deduct 0.05–0.25 if the response adds substantial unrelated material (e.g., treatment regimens, diagnostic test details, unrelated epidemiology) that obscures the required points.  \n- Total score after deductions cannot be below 0."}
{"query": "Collagens are described as fibrous proteins with a triple-helical supramolecular structure and are said to comprise about 30% of the vertebrate protein pool. Explain how this triple-helical, hierarchical organization supports collagen’s primary mechanical role in tissues, and name two distinct non-mechanical biological functions collagens also perform.", "response": "Rubric (Total Score: 1.0 Point; Minimum: 0.0):  \n- Mechanical role linked to structure (0.5 points)  \n  - 0.5: Clearly explains that the triple-helix/hierarchical assembly enables collagen to form insoluble, high-strength fibrils that provide structural support and mechanical properties to tissues.  \n  - 0.25: Mentions strength/structural support but does not connect it to triple-helix/hierarchical fibril formation.  \n  - 0.0: Does not describe the mechanical role or gives an incorrect mechanism.\n\n- Two non-mechanical functions (0.5 points)  \n  - 0.25 each (max 0.5) for correctly naming any two of the following: signaling, differentiation, motion, communication, apoptosis, binding growth factors to promote tissue repair/regeneration.  \n  - 0.0: Fewer than two correct non-mechanical functions, or functions are incorrect.\n\n- Deductions for excessive irrelevant content (max 0.25 points)  \n  - Deduct 0.1–0.25 if the response adds substantial unrelated detail (e.g., extensive discussion of unrelated collagen types, diseases, or experimental methods) that obscures the required points.  \n  - Final score cannot go below 0.0."}
{"query": "PMEL is typically linked to fibril formation in eumelanosomes, yet certain bovine PMEL variants influence both eumelanic and pheomelanic pigmentation. Identify two specific bovine PMEL mutations associated with coat color dilution (include their mutation notation and the cattle breeds), and explain why their effects on pheomelanic pigmentation are biologically notable.", "response": "Rubric (Total Score: 1.0 point; minimum 0.0):  \n- 0.4 points: Correctly identifies the non-synonymous mutation **PMEL c.64G>A** in the signal peptide region as causative for the Dilution locus, and correctly links it to **extreme coat color dilution in Charolais** cattle.  \n- 0.4 points: Correctly identifies the **three-base-pair deletion c.50_52delTTC** in the N-terminal region, and correctly links it to coat color dilution in **Highland and Galloway** breeds.  \n- 0.2 points: Correctly explains why the pheomelanic effect is notable: **in other species, pheomelanosomes are presumed to lack PMEL expression and show no fibril formation**, so PMEL variants affecting pheomelanic pigmentation is unexpected/remarkable.\n\nDeductions (maximum 0.25 points):  \n- Deduct **0.05–0.25** for excessive irrelevant content beyond what is asked (e.g., extended discussion of rat tail syndrome hair phenotypes or crossbreeding history without tying it to the requested mutations/biological significance)."}
{"query": "Explain the etiological agents and geographic epidemiology of bovine babesiosis by naming the protozoan genus responsible, identifying the three most common Babesia species infecting cattle, and describing where each of these species is most commonly found globally.", "response": "Rubric (Total Score: 1.0 point; Minimum: 0 points)\n\n- Protozoan genus identified (0.25 points)  \n  - 0.25: Correctly states the causative protozoa belong to the genus **Babesia**.  \n  - 0: Incorrect genus or not stated.\n\n- Three most common species in cattle identified (0.45 points)  \n  - 0.15: Correctly names **Babesia bovis**.  \n  - 0.15: Correctly names **Babesia bigemia**.  \n  - 0.15: Correctly names **Babesia divergens**.  \n  - 0: Species missing/incorrect (award only the relevant subpoints earned).\n\n- Geographic distribution correctly matched (0.30 points)  \n  - 0.15: Correctly links **B. bovis** and **B. bigemia** as more common in **Africa, Asia, Australia, Central America, and South America**.  \n  - 0.15: Correctly links **B. divergens** as more common in **parts of Europe and North Africa**.  \n  - 0: Distribution not stated or mismatched.\n\nDeductions for extraneous or off-target content (max 0.25 points)  \n- Deduct 0.05–0.25 if the response includes excessive irrelevant material (e.g., lengthy discussion of clinical signs, treatment, detailed tick biology, or unrelated statistics) that obscures the requested etiological and geographic details.  \n- Total score after deductions cannot go below 0."}
{"query": "Explain the life-cycle role of cattle in cystic echinococcosis caused by *Echinococcus granulosus* sensu lato, and compare the typical epidemiological pattern of the disease in Italy by contrasting endemicity and prevalence ranges in central/southern regions (including major islands) versus northern Italy; additionally, state what recent finding challenges the idea that northern Italy is free of local transmission.", "response": "Rubric (Total = 1.0 point; Minimum = 0 points):  \n\n- **Cattle’s role in the life cycle (0.25 points)**  \n  - 0.25: Clearly states that cattle act as **intermediate hosts** and **harbour the larval stage (hydatid cyst)**.  \n  - 0: Does not identify cattle as intermediate hosts and/or does not mention hydatid cyst/larval stage.\n\n- **Central/southern Italy endemicity + prevalence ranges (0.35 points)**  \n  - 0.35: Describes central/southern Italy (including major islands) as **medium to highly endemic** and gives prevalence ranges of **~5–80% in sheep** and **~3–70% in cattle**.  \n  - 0.2: Gives correct endemicity characterization but only one correct prevalence range (sheep or cattle), or gives both ranges but with minor numeric errors that preserve the clear order of magnitude.  \n  - 0: Missing endemicity characterization and/or does not provide meaningful prevalence information.\n\n- **Northern Italy pattern (0.25 points)**  \n  - 0.25: States CE is **rarely reported** in northern Italy and that cattle prevalence is **generally below 1%**.  \n  - 0.1: Indicates rarity/low prevalence but does not provide the “below 1%” detail.  \n  - 0: Incorrectly describes northern Italy as highly endemic or provides incompatible prevalence.\n\n- **Finding suggesting local transmission in the north (0.15 points)**  \n  - 0.15: Mentions **rare autochthonous cases in dogs** in northern Italy, specifically noting reports in the **Veneto region**.  \n  - 0.1: Mentions autochthonous dog cases in northern Italy but omits Veneto.  \n  - 0: Does not mention autochthonous dog cases.\n\n- **Deductions for excessive irrelevant content (max −0.25 points)**  \n  - Deduct **0.05–0.25** if the response includes substantial unrelated material (e.g., detailed treatment protocols, extensive parasite taxonomy beyond what is asked, or long discussions of unrelated countries) that obscures the requested points.  \n  - Total score cannot go below 0."}
{"query": "Explain the ICTV-proposed renaming of the original species BVDV-1, BVDV-2, CSFV, and BDV within the genus *Pestivirus* (family *Flaviviridae*), and identify which of these are classified as ruminant pestiviruses.", "response": "Rubric (Total = 1.0 point; Min = 0.0 points):  \n- **0.50 points:** Correctly maps all four original virus species to the proposed *Pestivirus* letter designations:  \n  - BVDV-1 → **Pestivirus A**  \n  - BVDV-2 → **Pestivirus B**  \n  - CSFV → **Pestivirus C**  \n  - BDV → **Pestivirus D**  \n  (Partial mapping: award **0.125 points** per correctly mapped virus; max 0.50.)  \n- **0.50 points:** Correctly identifies the ruminant pestiviruses as **BDV, BVDV-1, and BVDV-2** (i.e., Pestivirus D, A, and B).  \n  (If only two are correctly identified, award **0.33**; if only one, award **0.17**; if none, **0**.)\n\nDeductions (max 0.25 points):  \n- Deduct **0.10–0.25** if the response includes substantial extraneous material beyond what is needed (e.g., lengthy discussion of other pestiviruses in giraffes/pigs/rats/bats, isolation status, or details not asked), with the deduction scaled to severity.  \n- Final score cannot go below **0.0**."}
{"query": "In the gene expression cascade of Bovine herpesvirus 4 (BoHV-4), describe the temporal order and functional roles of immediate early (IE), early (E), and late (L) genes, including when IE products are expressed, what enables their transcription, how they regulate subsequent phases, and what prerequisite is required for late gene expression.", "response": "Rubric (Total Score: 1.0 Point; Minimum: 0.0 Points)\n\n- IE timing (0.2): States that IE gene products are expressed ~2–4 hours post-infection (hpi).  \n- IE transcription condition (0.2): States that IE genes are transcribed in the absence of de novo viral gene expression.  \n- IE → E regulation (0.2): States that IE gene products activate expression of E gene products.  \n- E role (0.2): States that E gene products are involved in viral DNA replication.  \n- L prerequisites and role (0.2): States that L gene expression occurs after DNA replication and requires DNA synthesis, and that L genes encode structural components of the virion.\n\nDeductions (Max 0.25 Points):  \n- Deduct 0.05–0.25 points for excessive irrelevant content (e.g., unrelated BoHV-4 disease manifestations, host immune responses, or therapeutic discussions) that is not needed to answer the question.  \n- Final score cannot go below 0.0."}
{"query": "Explain why infections with *Campylobacter fetus* subsp. *fetus* in heifers can present with only mild mucosal inflammation yet still lead to major reproductive losses; include (i) the organism’s tissue tropism and key reproductive outcomes, (ii) how interaction with bull spermatozoa can contribute to fertility problems, and (iii) two specific outer-surface features that help the bacterium evade or blunt host immune responses and how each feature does so.", "response": "Rubric (Total = 1.0 point; Minimum = 0 points):  \n\n- **Tropism and reproductive impact (0.35 points total)**  \n  - 0.20: Correctly states tropism for **placental and reproductive tract tissues**.  \n  - 0.15: Correctly identifies a major reproductive outcome as **sporadic and/or epidemic septic abortion** (septic abortions).\n\n- **Effect via bull spermatozoa (0.20 points total)**  \n  - 0.20: States that the bacterium **irreversibly attaches to bull spermatozoa** and **affects sperm quality**, linking this to reduced fertility/reproductive problems.\n\n- **Immune evasion/blunted inflammation mechanisms—two features (0.45 points total)**  \n  - 0.20: Identifies **lipooligosaccharides (LOS) instead of LPS** as an outer-membrane composition feature associated with a **light inflammatory reaction** (reduced/altered inflammatory stimulation).  \n  - 0.25: Identifies the **S-layer** and correctly explains it **protects against complement and opsonization-phagocytosis** and/or **prevents recognition by the host innate immune system**.\n\n- **Deductions for excess/irrelevant content (maximum deduction = 0.25 points)**  \n  - Deduct **0.10** for mild excess that is not asked for (e.g., lengthy general discussion of campylobacteriosis without addressing the three required parts).  \n  - Deduct **0.15–0.25** for substantial irrelevant detail that obscures the required items or introduces extensive unrelated claims (final score cannot go below 0)."}
{"query": "Explain why primary bovine endothelial cells are an effective in vitro model for Neospora caninum replication, linking your explanation to the parasite’s intracellular life cycle stage, host-cell requirements, and in vivo cell-type preference.", "response": "Rubric (Total Score: 1.0 point; Minimum: 0 points)\n\n- Intracellular requirement and host-cell type (0.35 points)  \n  - 0.35: States that N. caninum is an obligate intracellular parasite and that tachyzoite (asexual) replication must occur inside nucleated host cells.  \n  - 0.0: Does not state both obligate intracellular nature and nucleated-cell requirement for tachyzoite replication.\n\n- In vivo preference supports the model choice (0.35 points)  \n  - 0.35: Identifies endothelium/endothelial cells as the preferred in vivo infection target, making bovine endothelial cells biologically relevant for culture.  \n  - 0.0: Does not mention endothelial preference/relevance.\n\n- In vitro outcome/utility (0.20 points)  \n  - 0.20: Connects the model to high tachyzoite proliferation/efficient in vitro replication in primary bovine endothelial cells.  \n  - 0.0: Does not mention high proliferation/replication advantage.\n\n- Deductions for excessive irrelevant content (max 0.25 points)  \n  - Subtract 0.05–0.25 if the response includes substantial off-target material (e.g., extended discussion of abortion economics, unrelated parasites, or detailed pathogenesis not asked for) that obscures the required links.  \n  - Final score cannot be below 0."}
{"query": "In feline sperm cryopreservation used for assisted reproductive technologies, what biological parameter has become especially critical to evaluate due to the high efficiency of intracytoplasmic sperm injection (ICSI), and what is a common underlying cause of damage to this parameter?", "response": "Rubric (Total Score: 1.0 point; Min: 0.0):  \n- (0.5 points) Correctly identifies the key parameter as sperm DNA integrity (DNA damage/fragmentation acceptable).  \n- (0.5 points) Correctly identifies oxidative stress in the male reproductive tract as a common cause of damage to sperm DNA.  \n\nDeductions (max 0.25 points):  \n- Deduct 0.05–0.25 points for substantial irrelevant or excessive additional content beyond what is needed to answer (e.g., lengthy descriptions of collection methods or listing multiple ART procedures without addressing the two required points), proportional to severity.  \n- Final score cannot be below 0.0."}
{"query": "Describe the key virion morphology and genome organization of astroviruses, including particle size and envelope status, the ICTV genus-level classification and host range, the names and order of the three ORFs and what each encodes, and the specific translational feature that occurs between ORF1a and ORF1b.", "response": "Rubric (Total Score: 1.0 point; minimum 0 points):  \n- **Virion morphology (0.25 points)**  \n  - 0.10: States astroviruses are **non-enveloped**.  \n  - 0.10: Gives correct size range (**~27–30 nm** diameter).  \n  - 0.05: Identifies **icosahedral capsid** and/or **star-like (five- or six-pointed) appearance** under negative-stain EM.  \n- **ICTV classification + host range (0.20 points)**  \n  - 0.10: Names both genera: **Mamastrovirus** and **Avastrovirus**.  \n  - 0.10: Correctly links hosts: **Mamastrovirus infects mammals**; **Avastrovirus infects birds**.  \n- **Genome organization and ORFs (0.45 points)**  \n  - 0.10: States genome length **~6.8–7.9 kb** and is **RNA**.  \n  - 0.10: Lists key genome elements in correct general layout: **5′ UTR → ORF1a → ORF1b → ORF2 → 3′ UTR → poly(A) tail**.  \n  - 0.15: Correctly states **ORF1a/ORF1b encode nonstructural proteins**, including **serine protease** and **RNA-dependent RNA polymerase (RdRp)**.  \n  - 0.10: Correctly states **ORF2 encodes the capsid protein** and is expressed from **subgenomic RNA**.  \n- **Translational feature (0.10 points)**  \n  - 0.10: Identifies a **frameshift between ORF1a and ORF1b**.  \n\nDeductions (max 0.25 points):  \n- Deduct **0.05–0.25** for excessive irrelevant content that obscures the required items (severity-based). Final score cannot go below **0**."}
{"query": "Explain how kisspeptin regulates mammalian reproduction at the neuroendocrine level, and identify the specific receptor it binds (including an alternative name for that receptor).", "response": "Rubric (Total = 1.0 point; Minimum = 0 points):  \n- **0.5 points:** States that kisspeptin acts centrally in the hypothalamus by regulating/activating **GnRH neurons** (neuroendocrine mechanism).  \n- **0.5 points:** Correctly names the receptor as **Kiss1r** and provides the alternative designation **GPR54**.  \n\nDeductions (max 0.25 points):  \n- Deduct **0.1–0.25 points** if the response includes substantial irrelevant content (e.g., long species lists or unrelated reproductive physiology) that obscures the required mechanism/receptor identification.  \n- Final score cannot be below **0**."}
{"query": "Explain why papillomaviruses are generally host-specific and identify the bovine papillomavirus types that are clearly documented to infect more than one species, including the genus they belong to and the main disease outcomes they cause in bovines versus equids.", "response": "Rubric (Total Score: 1.0 point; minimum 0.0):  \n- **Host-specificity rationale (0.25 points):** States that papillomaviruses generally co-evolve with their hosts (host–virus co-evolution), which explains their high host specificity and why they usually do not cross species barriers.  \n- **Multi-species BPV types (0.25 points):** Correctly identifies **BPV1, BPV2, and BPV13** as the only papillomaviruses clearly documented to infect more than one species.  \n- **Genus identification (0.25 points):** Correctly states these types belong to the genus **Deltapapillomaviruses**.  \n- **Disease outcomes by host (0.25 points):** Correctly distinguishes outcomes: **fibropapillomas/skin tumours in bovines** and **sarcoids (skin tumours) in equids**.  \n\nDeductions (max 0.25 points):  \n- Deduct **0.05–0.25** for excessive irrelevant content that goes beyond what is needed to answer (e.g., lengthy lists of PV counts across species, unrelated phylogenetic details), proportional to severity. Final score cannot be below 0."}
{"query": "Context 1\n\n  \nIn macroevolutionary studies of mammalian body mass, what is the key distinction between a “passive” trend (Cope’s rule sensu lato) and an “active” trend (Cope’s rule sensu stricto), and what pattern of change in the distribution of body sizes would justify recognizing Cope’s rule sensu stricto?", "response": "Rubric (Total Score: 1.0 point; Minimum: 0 points)\n\n- 0.5 points: Correctly defines the passive trend (sensu lato) as an apparent increase in body mass driven by increased variance and/or expansion of the upper end without an increase in the lower bound (i.e., small body sizes do not increase).  \n- 0.5 points: Correctly defines the active trend (sensu stricto) as requiring increases in both lower and upper bounds of body size (i.e., within-lineage shift toward larger sizes across the distribution, including the minimum).  \n\nDeductions (max 0.25 points; score floor = 0):  \n- Deduct up to 0.25 points if the response adds substantial irrelevant material (e.g., long discussions of cited authors, methods papers, or the Cenozoic timeline) that obscures whether the required passive vs active distinction and the “both bounds increase” criterion were correctly stated."}
{"query": "In systemic amyloidosis classification by fibril chemistry, identify the precursor protein source for AA versus AL amyloid and state the shared ultrastructural/biophysical properties of amyloid fibrils that define amyloidosis.", "response": "Rubric (Total Score: 1.0 Point; Min: 0.0 Points):  \n- **AA vs AL precursor sources (0.6 points total):**  \n  - **0.3 points:** Correctly states **AA amyloid** is derived from **serum amyloid A (SAA)**, an **acute-phase protein** (often described as associated with chronic infection/inflammation).  \n  - **0.3 points:** Correctly states **AL amyloid** is derived from **immunoglobulin light chains** (classically tied to **plasma cell dyscrasia**).  \n\n- **Defining fibril properties (0.4 points total):**  \n  - **0.2 points:** States amyloid deposits are **extracellular** and **insoluble fibrillar proteins**.  \n  - **0.2 points:** States fibrils are approximately **~10 nm** and have a **β-pleated sheet** conformation.  \n\n- **Deductions for excessive irrelevant content (max −0.25 points):**  \n  - Deduct **0.1–0.25** if the response adds substantial non-asked material (e.g., extensive clinical manifestations, organ-by-organ complications, unrelated amyloid subtypes) that obscures the required points.  \n  - Total score cannot go below **0.0**."}
{"query": "Describe the major clinical presentations of feline infectious peritonitis (FIP), including hallmark signs and distinguishing features of the wet versus dry forms, and state the typical prognosis within one year after disease onset in affected cats.", "response": "Rubric (Total Score: 1.0 point; Minimum: 0.0):  \n- 0.3 points: Identifies non-specific systemic signs of FIP (fever plus at least one of: loss of appetite, weight loss, jaundice, diarrhoea).  \n- 0.4 points: Correctly distinguishes forms:  \n  - 0.2 points for wet form described as accumulation of protein-rich exudate/effusion in abdominal and/or chest cavities.  \n  - 0.2 points for dry form described as neurological deficits and/or ocular lesions.  \n- 0.3 points: States prognosis: no effective treatment and ~95% of affected cats die within 1 year of onset (credit only if both “no effective treatment” and the ~95%/within-one-year mortality are conveyed).  \n\nDeductions (max 0.25 points):  \n- Deduct 0.05–0.25 points for excessive irrelevant content (e.g., lengthy discussion of diagnostic histopathology or ante-mortem testing details not asked), proportional to severity.  \n- Final score cannot be below 0.0."}
{"query": "Explain why proximity to domestic cats can increase infectious-disease risk for the Tsushima leopard cat, and identify three specific viruses implicated in documented or investigated transmission/spillover between domestic cats and Tsushima leopard cats (or their close leopard-cat relatives in Japan).", "response": "Rubric (Total = 1.0 point; Min = 0.0 points):  \n- (0.5 points) Mechanism/risk explanation: States that areas with higher domestic-cat density/proximity increase opportunities for contact and pathogen transmission, and notes that GIS analysis found higher FIV infection risk for Tsushima leopard cats in densely domestic-cat–populated areas.  \n- (0.5 points) Viruses (any three; 0.1667 points each): Correctly names three of the following as relevant to documented or studied spillover/transmission in this system:  \n  1) Feline immunodeficiency virus (FIV)  \n  2) Felis catus gammaherpesvirus 1 (FcaGHV1)  \n  3) Feline leukemia virus (FeLV) (not found in Tsushima leopard cats in one study but shown able to replicate in their cells)  \n  4) Feline foamy virus (FFV) (detected in Iriomote leopard cats; discussed as potentially pathogenic)  \n\nDeductions (max 0.25 points):  \n- Deduct 0.05–0.25 points (severity-based) for excessive irrelevant content that goes beyond what is needed to answer (e.g., detailed morphology, population numbers, or unrelated pathology/coinfection discussion). Final score cannot be below 0."}
{"query": "Explain why detecting FeLV proviral DNA by PCR can change the interpretation of “recovery” in antigen-negative cats, and evaluate what the reported saliva RNA findings and test-and-removal program outcomes imply about the role of regressive (latent) infection in natural FeLV transmission.", "response": "Rubric (Total = 1.0 point; Minimum = 0 points):\n\n- **PCR provirus detection vs antigen testing (0.5 points)**  \n  - **0.5**: States that antigen tests can miss infection (relatively insensitive), and that PCR detection of proviral DNA shows some antigen-negative cats still harbor FeLV (often low-level, transcriptionally active/persistent virus), so “recovered” status may be incorrect.  \n  - **0.25**: Mentions either antigen testing is insensitive *or* PCR finds provirus in some antigen-negative cats, but does not clearly connect this to reinterpreting “recovery.”  \n  - **0**: Does not identify the key contrast between antigen testing and PCR provirus detection.\n\n- **Implications for natural transmission from regressive infection (0.5 points)**  \n  - **0.5**: Concludes that regressive infection likely contributes little to natural transmission, supported by: (i) viral RNA absent from saliva in most provirus-positive/antigen-negative cats (e.g., ~96%), and (ii) success of test-and-removal programs relying on antigen detection, implying antigen-negative/provirus-positive cats are generally not major shedders/transmitters.  \n  - **0.25**: Provides the correct overall conclusion (limited role in transmission) but cites only one supporting line of evidence (saliva RNA *or* program success) or describes the evidence vaguely.  \n  - **0**: Concludes regressive infection is a major driver of natural transmission, or provides no coherent implication.\n\n- **Deductions for excessive irrelevant content (max −0.25 points)**  \n  - Deduct **0.05–0.25** if the response adds substantial off-topic material (e.g., detailed FeLV treatment protocols, unrelated clinical staging, or broad virology background) that obscures the required points.  \n  - Final score cannot be below **0**."}
{"query": "Describe the host range and age group most affected by feline calicivirus (FCV), state the reported mortality rate for that age group, and explain the key mechanism that enables FCV to continue spreading after clinical signs improve.", "response": "Rubric (Total Score: 1.0 Point; Min: 0 Points)\n\n- Host range and most affected age group (0.35 points)  \n  - 0.20: Correctly identifies susceptible hosts as domestic cats and other wild felines (e.g., tigers, cheetahs).  \n  - 0.15: Correctly identifies the mainly infected age group as kittens 6–84 days old.\n\n- Mortality rate (0.25 points)  \n  - 0.25: States the mortality rate for that age group as 67%.\n\n- Post-recovery spread mechanism (0.40 points)  \n  - 0.20: States that clinical symptoms may improve/relieve around 14–18 days after infection but shedding continues.  \n  - 0.20: Specifies that FCV is still excreted via saliva and nasal secretions, enabling substantial ongoing transmission/contagious spread.\n\nDeductions (Max 0.25 points)  \n- Deduct 0.05–0.25 for excessive irrelevant material that obscures the required elements (e.g., long discussion of unrelated diseases, treatment protocols, or virology details not asked).  \n- Total score cannot go below 0."}
{"query": "In domestic cats, what is feline chronic gingivostomatitis (FCGS), what oral site is especially affected by its inflammatory lesions, what key clinical/behavioral signs commonly accompany it, what is its reported prevalence range, and what is currently known about its etiology?", "response": "Rubric (Total Score: 1.0 point; Minimum: 0 points)\n\n- Disease definition (0.2): States that FCGS is a chronic inflammatory mucosal disease of the oral cavity in cats.  \n- Typical lesion distribution/site (0.2): Identifies that lesions are extensive throughout the oral cavity, especially lateral to the palatoglossal folds.  \n- Common clinical/behavioral signs (0.2): Mentions severe pain plus at least two of the following: hyporexia, poor grooming, irritability (altered behavior).  \n- Prevalence (0.2): Gives the prevalence range as approximately 0.7% to 12% of domestic cats.  \n- Etiology status (0.2): States that the etiology/cause remains elusive/unknown.\n\nDeductions (max 0.25):  \n- Deduct 0.05–0.25 for excessive irrelevant content (e.g., extended discussion of unrelated oral diseases, detailed treatment protocols not asked for) that obscures the required elements. Final score not below 0."}
{"query": "Mesenchymal stem cells exert anti-inflammatory, tissue-protective, and anti-fibrotic effects through secreted mediators, yet feline mesenchymal stem cells have shown limited benefit in chronic kidney disease in cats. Identify four specific bioactive substances secreted by mesenchymal stem cells that mediate these effects, and state two proposed biological reasons feline MSCs may fail to substantially improve chronic kidney disease outcomes.", "response": "Rubric (Total = 1.0 point; Minimum = 0 points):\n\n- Secreted mediators (0.6 points total):  \n  - 0.15 points each for correctly naming any four of the following MSC-secreted substances:  \n    - indoleamine 2,3-dioxygenase (IDO)  \n    - prostaglandin E2 (PGE2)  \n    - hepatocyte growth factor (HGF)  \n    - tumor necrosis factor-stimulated gene/protein-6 (TSG-6)  \n  (Max 0.6 points)\n\n- Reasons for limited efficacy of feline MSCs in feline CKD (0.4 points total):  \n  - 0.2 points for stating that feline MSCs may have lower biological activity.  \n  - 0.2 points for stating one of the following: earlier loss of proliferative activity and stemness, OR poorer ability to produce bioactive mediators without stimulation.  \n  (Max 0.4 points)\n\nDeductions for irrelevance / excess (max deduction 0.25 points):  \n- Deduct 0.1–0.25 points (severity-based) if the response includes substantial additional material beyond what is asked (e.g., lengthy discussion of unrelated feline inflammatory diseases, detailed CKD pathophysiology, or unrelated clinical trial design details) that obscures the required items.  \n- Final score cannot go below 0."}
{"query": "Explain how geographic region and indoor/outdoor status can influence the prevalence of Feline Immunodeficiency Virus (FIV) and Feline Leukemia Virus (FeLV) in domestic cats, and identify at least four specific risk factors that increase the likelihood of infection.", "response": "Rubric (Total Score: 1.0 point; Minimum: 0.0 points)\n\n- Prevalence variation by region and lifestyle (0.4 points)  \n  - 0.2: States that prevalence differs by geographic region.  \n  - 0.2: States that prevalence differs by indoor vs. outdoor status (e.g., outdoor cats at different/higher risk than indoor cats).\n\n- Risk factors (0.6 points)  \n  Award 0.15 points each (up to 0.6) for correctly naming any four of the following risk factors:  \n  - geriatric/older cats  \n  - male sex  \n  - mixed breed  \n  - aggressive behavior  \n  - co-infection with other retroviruses  \n  - outdoor contact with non-hierarchical cat communities (e.g., roaming/stray group exposure)\n\nDeductions for excess/irrelevant content (max 0.25 points)  \n- Deduct 0.05–0.25 if the response adds substantial unrelated material (e.g., detailed virology, transmission routes, clinical signs, vaccine protocols, or shelter management specifics not asked for) that obscures the required points.  \n- Final score cannot go below 0.0."}
{"query": "Describe the major infection outcomes of feline leukemia virus (FeLV) in cats—abortive, regressive, and progressive—in terms of viral control/viremia dynamics and bone marrow (hematopoietic stem cell) involvement, and state the typical mortality timeframe after diagnosis for FeLV-positive cats.", "response": "Rubric (Total = 1.0 point; Min = 0.0 points):  \n- **0.25 points**: Correctly defines **abortive infection** as early control preventing spread to target tissues (no established systemic spread).  \n- **0.30 points**: Correctly explains **regressive infection** as partial immune containment with **viremia lasting only weeks**, and notes that in some cases virus reaches **bone marrow hematopoietic stem cells** and can persist **latently as integrated proviral DNA**.  \n- **0.30 points**: Correctly explains **progressive infection** as failure of early immunity with **massive replication/spread**, including infection of **bone marrow hematopoietic stem cells**, leading to **persistent viremia**.  \n- **0.15 points**: States that FeLV-positive cats **typically die within ~1–3 years after initial diagnosis** (often due to complications/secondary infections from immunodeficiency is acceptable but not required).  \n\nDeductions (max 0.25 points):  \n- Deduct **0.05–0.25** for substantial irrelevant add-ons that go beyond what is asked (e.g., lengthy unrelated virology, treatment protocols, vaccine schedules, or extensive clinical sign lists not tied to the requested outcomes). The total score cannot go below **0.0**."}
{"query": "Explain how human-driven habitat encroachment and fragmentation can increase extinction risk for endangered wildlife through shared pathogens, and use the Serengeti canine distemper case to illustrate why vaccinating domestic reservoir hosts may reduce—but not necessarily eliminate—spillover into wild carnivores.", "response": "Rubric (Total Score: 1.0 Point; Min Score: 0.0 Points):  \n- **0.35 pts**: Correctly explains the mechanism that increased contact between domestic animals and wildlife (via encroachment/fragmentation) raises opportunities for cross-species pathogen transmission.  \n- **0.35 pts**: Correctly explains why domestic animals can sustain pathogen circulation (they often outnumber wildlife and can act as reservoir/maintenance hosts), thereby threatening small/endangered wildlife populations with severe declines or extinction.  \n- **0.30 pts**: Correctly uses the Serengeti example: canine distemper spilled over from domestic dogs to lions, nearly causing local lion extinction, and transmission to lions still occurred even after widespread dog vaccination reduced infection in dogs—showing that control remains complex once pathogens are established in/near protected areas.\n\nDeductions (Max 0.25 Points):  \n- Deduct **0.05–0.25 pts** for excessive irrelevant detail that obscures the required points (e.g., long tangents about unrelated diseases, vaccination logistics, or general conservation history).  \n- Final score cannot be below **0.0 pts**."}
{"query": "Compare Feline immunodeficiency virus (FIV) and Feline leukemia virus (FeLV) by stating (1) each virus’s retroviral genus, (2) the major disease process each is primarily associated with, and (3) the most typical immunochromatography-kit target used to diagnose each infection; also name an alternative nucleic-acid test and a conserved genomic region it commonly targets for either virus.", "response": "Rubric (Total = 1.0 point; Min = 0):  \n- Viral genus identification (0.30):  \n  - 0.15: Correctly identifies FIV as a lentivirus.  \n  - 0.15: Correctly identifies FeLV as a gammaretrovirus.  \n- Primary disease association (0.30):  \n  - 0.15: States FIV causes progressive immune system deterioration leading to prominent secondary infections (HIV-1–like immunodeficiency).  \n  - 0.15: States FeLV is associated with proliferative/degenerative/oncogenic diseases affecting erythroid, myeloid, and lymphoid lineages.  \n- Typical immunochromatography-kit diagnostic target (0.25):  \n  - 0.125: States FIV diagnosis commonly uses detection of antibodies against structural proteins.  \n  - 0.125: States FeLV diagnosis commonly uses detection of viral antigens.  \n- Alternative test and conserved region (0.15):  \n  - 0.10: Names PCR as an alternative diagnostic method.  \n  - 0.05: Specifies that PCR often targets conserved sequences in the pol region.  \n\nDeductions (max 0.25):  \n- Deduct 0.05–0.25 for substantial irrelevant additions that obscure the required comparisons (e.g., extended retrovirus replication details or unrelated feline diseases). The total score cannot go below 0."}
{"query": "In cats, what is the reported prevalence range for thrombocytopenia, how common are clinical bleeding diatheses and primary immune-mediated thrombocytopenia, and what are three major pathophysiologic categories of causes of thrombocytopenia?", "response": "Rubric (Total = 1.0 point; minimum = 0.0):  \n- **Prevalence range stated correctly (0.25 points):** Gives **1.2%–3.1%**.  \n- **Bleeding diatheses frequency characterized correctly (0.20 points):** States that clinical bleeding diatheses associated with feline thrombocytopenia are **uncommonly reported**.  \n- **Primary immune-mediated thrombocytopenia frequency characterized correctly (0.20 points):** States it **appears rare**, supported by mention of **isolated case reports and small case series** (e.g., 4–5 cases).  \n- **Three major cause categories correctly identified (0.35 points total; 0.116 points each):** Provides three of the following categories (or equivalent wording):  \n  1) **Decreased production** due to **bone marrow disease/reduced megakaryocytosis**;  \n  2) **Immune-mediated destruction secondary to underlying triggers** (e.g., **neoplasia or infection**);  \n  3) **Consumption** due to **haemorrhage, thrombosis, or DIC**.  \n\nDeductions (max 0.25 points):  \n- Deduct **0.05–0.25** if the response includes substantial irrelevant material (e.g., extensive treatment protocols or unrelated hematologic disorders) that obscures the required items. Final score cannot go below **0.0**."}
{"query": "In feline immunodeficiency virus (FIV), which specific Vif amino-acid motifs/regions determine selective counteraction of feline APOBEC3Z2 versus APOBEC3Z3, and what Vif residue range constitutes the general APOBEC3 binding domain that is separate from these selective determinants?", "response": "Rubric (Total Score: 1.0 point; Min: 0 points):  \n- 0.4 points: Correctly identifies the FIV Vif motifs that selectively interact with/counteract FcaA3Z2 as **12LF13** and **18GG19** (both must be present for full credit; if only one is given, award 0.2).  \n- 0.3 points: Correctly identifies the region regulating exclusive degradation of FcaA3Z3 as residues **M24, L25, and I27** (all three required; if only 1–2 residues are correctly given, award 0.15).  \n- 0.3 points: Correctly states the general feline APOBEC3 binding domain maps to FIV Vif residues **50–80**, distinct from the selective interaction sites.\n\nDeductions (max 0.25 points):  \n- Deduct up to **0.25** for excessive irrelevant content that goes beyond the asked molecular determinants (e.g., lengthy discussion of FIV epidemiology, disease symptoms, or broad APOBEC biology not tied to the specific motifs/ranges).  \n- Final score cannot be below **0**."}
{"query": "In feline infectious peritonitis (FIP) with central nervous system involvement, identify the typical distribution and types of CNS lesions, explain how these lesions can lead to altered cerebrospinal fluid (CSF) dynamics (naming the resulting complications), and state why CSF analysis findings can support suspicion but are not diagnostic.", "response": "Rubric (Total Score: 1.0 point; Minimum: 0.0 points)\n\n- Lesion distribution and types (0.40 points)  \n  - 0.20: States lesions typically involve both brain and spinal cord and are surface-related and multifocal.  \n  - 0.20: Correctly names at least three lesion types: meningitis, choroid plexitis, ependymitis, periventriculitis.\n\n- CSF dynamics and complications (0.30 points)  \n  - 0.15: Explains lesions can increase CSF viscosity and/or cause obstruction to CSF flow.  \n  - 0.15: Correctly names at least one resulting complication: obstructive hydrocephalus or hydromyelia. (Full 0.15 if at least one is correct; both acceptable.)\n\n- Why CSF findings are supportive but not diagnostic (0.30 points)  \n  - 0.15: Identifies typical CSF findings (at least one): neutrophilic or pyogranulomatous pleocytosis and/or elevated protein concentration; acknowledges CSF may also be unremarkable.  \n  - 0.15: States non-specificity: similar CSF changes can occur in other inflammatory CNS diseases and/or hypertensive encephalopathy with disruptive vascular disease, so CSF cannot confirm FIP.\n\nDeductions (max 0.25 points)  \n- Deduct 0.05–0.25 for excessive irrelevant content that obscures the required points (e.g., detailed treatment protocols, unrelated virology, extensive differential diagnosis lists beyond what is asked). Total score cannot go below 0.0."}
{"query": "Explain the two most important physiological functions of the kidney, identify which nitrogenous waste products are specifically highlighted as examples of metabolic wastes eliminated by the kidney, and state which animal model is more commonly used for urologic experimental studies versus which animal is considered most appropriate for bilateral renal ischemia research.", "response": "Rubric (Total Score: 1.0 Point; Minimum: 0.0 Points):\n\n- Kidney functions (0.40 points total)  \n  - 0.20: States that the kidney maintains water and electrolyte balance/homeostasis.  \n  - 0.20: States that the kidney eliminates harmful metabolic waste products.\n\n- Specific nitrogenous waste examples (0.20 points total)  \n  - 0.10: Correctly names urea.  \n  - 0.10: Correctly names creatinine.\n\n- Animal models (0.40 points total)  \n  - 0.20: Identifies pig kidneys as more commonly used for urologic experimental studies due to structural similarity to human kidneys.  \n  - 0.20: Identifies cats as the most appropriate model for bilateral renal ischemia.\n\nDeductions for extraneous content (max 0.25 points):  \n- Deduct 0.05–0.25 if the response includes substantial irrelevant material (e.g., detailed clinical test lists, unrelated renal diseases, or broad anatomy/physiology not needed to answer), with the deduction scaled to severity.  \n- Total score cannot go below 0.0."}
{"query": "Explain how inducible cyclo-oxygenase-2 (COX-2) overexpression can promote breast tumor progression by naming at least three distinct downstream effects on tumor biology and identifying the biochemical pathway step COX-2 controls.", "response": "Rubric (Total Score: 1.0 Point; Minimum: 0 Points)\n\n- Rate-limiting pathway step (0.4 points)  \n  - 0.4: States that COX-2 catalyzes the **rate-limiting step in prostanoid (prostaglandin) biosynthesis** (prostaglandin H-synthase activity).  \n  - 0.0: Does not identify this rate-limiting role/pathway.\n\n- Tumor-promoting downstream effects (0.6 points total; 0.2 each, max 0.6)  \n  Award 0.2 points for each correct, distinct effect (any three):  \n  - Increased **tumor cell survival**  \n  - Enhanced **tumor cell invasiveness/invasion**  \n  - Increased **angiogenesis/neovascularization**  \n  - **Immune evasion** (evasion from host immune system)  \n  - **Downregulation of apoptosis** (reduced tumor apoptosis)  \n  - Increased **growth/proliferation**  \n  - 0.0 for effects not relevant to COX-2 as described or vague restatements without a clear effect.\n\n- Deductions for excessive irrelevant content (max 0.25 points)  \n  - Deduct 0.05–0.25 if the response adds substantial unrelated material (e.g., detailed drug regimens, unrelated signaling pathways, or epidemiology) that obscures the requested mechanisms.  \n  - Total score cannot go below 0."}
{"query": "Explain why vaccination may fail to fully prevent reinfection by feline calicivirus (FCV) despite FCV being considered to have only one serotype, and include (i) the viral property most directly responsible for this limitation, (ii) the quantitative evolutionary rate range given for that property, and (iii) one therapeutic strategy implication that follows.", "response": "Rubric (Total Score: 1.0 point; Minimum: 0 points):  \n- 0.45 points: States that the key reason is the high evolutionary (mutation/substitution) rate of the FCV capsid protein leading to antigenic/strain variation that can evade vaccine protection (mutant and/or wild-type reinfections).  \n- 0.25 points: Correctly gives the substitution rate range as approximately \\(1.3 \\times 10^{-2}\\) to \\(2.6 \\times 10^{-2}\\) substitutions per nucleotide per year (values must be essentially correct; minor formatting differences acceptable).  \n- 0.30 points: Provides a correct therapeutic implication: the need to develop safe and effective antiviral drug(s), either as monotherapy or in combination therapy, because vaccination alone is insufficient.\n\nDeductions (max 0.25 points; final score not below 0):  \n- Deduct 0.05–0.25 points if the response includes substantial extraneous material that is not asked for (e.g., detailed symptom lists, mortality statistics, host range discussion) and obscures the required points; deduction severity depends on how much irrelevant content dominates."}
{"query": "Describe the taxonomy and basic virological properties of feline coronavirus (FCoV), and differentiate the two FCoV pathotypes by typical clinical outcome and the disease entity associated with the lethal systemic form.", "response": "Rubric (Total Score: 1.0 Point; Min Score: 0.0 Points)\n\n- Taxonomy and viral properties (0.5 points total)\n  - 0.1: Identifies FCoV as an enveloped single-stranded RNA virus.\n  - 0.4: Correctly states its classification: order Nidovirales; family Coronaviridae; subfamily Coronavirinae; genus Alphacoronavirus; species alphacoronavirus 1.\n\n- Pathotype differentiation and clinical outcomes (0.5 points total)\n  - 0.25: Correctly identifies feline enteric coronavirus (FECoV) as the pathotype typically causing asymptomatic infection or mild, self-limiting gastrointestinal disease.\n  - 0.25: Correctly identifies feline infectious peritonitis virus (FIPV) as the pathotype that causes feline infectious peritonitis (FIP), described as a lethal, systemic, immune-mediated disease (a possible complication in a small proportion of infected cats).\n\nDeductions (Max 0.25 points)  \n- Deduct 0.05–0.25 points for excessive irrelevant content that obscures the required elements (e.g., lengthy discussion of unrelated feline diseases, treatment regimens, or epidemiology beyond “widespread worldwide”), proportional to severity.  \n- Final score cannot be below 0.0."}
{"query": "Explain how a feline enteric coronavirus (FECV) infection can give rise to the FIP-causing biotype, describing the key change in cell tropism and the contrasting roles of cell-mediated versus humoral immunity in the development of effusive (wet) and non-effusive (dry) feline infectious peritonitis.", "response": "Rubric (Total = 1.0 point; Minimum = 0 points):  \n- **Biotype emergence via mutation (0.25 points):** States that FIP virus (FIPV) can arise as a mutated variant generated during replication of FECV in intestinal enterocytes.  \n- **Tropism shift / macrophage replication (0.30 points):** States that FIPV loses enterocyte tropism and gains the ability to replicate in macrophages/monocytes (intracellular replication in these cells is the key pathogenic shift).  \n- **Cell-mediated immunity protective (0.20 points):** Clearly indicates that effective cell-mediated (cellular) immunity tends to be protective against disease development.  \n- **Humoral immunity and effusive (wet) FIP mechanism + dry form positioning (0.25 points):** States that antibodies from humoral immunity can enhance virus uptake by macrophages (antibody-dependent enhancement) contributing to effusive/wet FIP signs, and that non-effusive/dry FIP corresponds to a partially effective cellular response (intermediate status).  \n\nDeductions (max 0.25 points):  \n- Deduct **0.05–0.25** for excessive irrelevant material that is not asked for and obscures the required elements (e.g., lengthy discussion of unrelated clinical management, unrelated virology, or non-contextual epidemiology). Final score cannot go below **0**."}
{"query": "In Crandell-Rees Feline Kidney (CRFK) cells exposed to X-rays, what cellular outcome is linked to inhibited proliferation, what evidence-based assay can be used to detect that outcome, and which DNA damage response signaling event (including the modified residue and the upstream kinase) indicates activation of the major double-strand break pathway?", "response": "Rubric (Total Score: 1.0 point; minimum 0 points)\n\n- 0.4 points: Identifies the proliferation-inhibiting outcome as double-strand-break (DSB)-triggered cellular senescence (not apoptosis or generic “cell death”).  \n- 0.3 points: Names an appropriate detection method for senescence: senescence-associated β-galactosidase (SA-β-gal) staining assay (morphological change alone is insufficient).  \n- 0.3 points: Correctly states the DDR signaling event as phosphorylation of H2AX at Ser139 (γH2AX) mediated/activated by ATM kinase.  \n\nDeductions (max 0.25 points):  \n- Deduct 0.05–0.25 points for excessive irrelevant content (e.g., extended discussion of radiation types, clinical feline oncology, or mechanisms not asked for) that obscures the required elements. Total score cannot go below 0."}
{"query": "A cat presents with upper respiratory signs (nasal/ocular discharge, sneezing, coughing) plus oral ulcerations; another cat presents with dendritic corneal ulcers; a third cat has acute or chronic conjunctivitis with blepharospasm and serous or mucopurulent ocular discharge. For each presentation, identify the most likely causative agent and specify the distinguishing lesion(s) that support the identification.", "response": "Rubric (Total = 1.0 point; Minimum = 0 points):  \n- 0.35 points: Correctly identifies feline calicivirus (FCV) as most likely cause for the case with oral ulcerations (lesion: oral ulcerations).  \n- 0.35 points: Correctly identifies feline herpesvirus-1 (FHV-1) as most likely cause for the case with dendritic corneal ulcers (lesion: dendritic corneal ulcers).  \n- 0.30 points: Correctly identifies Chlamydia felis as most likely cause for the case with conjunctivitis + blepharospasm + serous/mucopurulent ocular discharge (lesions: conjunctivitis and blepharospasm with serous or mucopurulent discharge).  \n\nDeductions (max 0.25 points):  \n- Deduct 0.05–0.25 points for excessive irrelevant content beyond what is needed to match each agent to its distinguishing lesion(s) (severity-based).  \n- Final score cannot be below 0."}
{"query": "Explain why feline alpha-1-acid glycoprotein (AGP) is considered a strong biomarker for feline infectious peritonitis (FIP), including (i) how its serum concentration and sialylation pattern change in FIP, (ii) what is known about the relationship between AGP sialylation and antiviral protection, and (iii) what transient AGP changes may be observed in clinically healthy cats living in feline coronavirus (FCoV)-endemic environments.", "response": "Rubric (Total Score: 1.0 point; minimum 0):  \n- **0.35 points:** States that AGP shows **marked/huge increases in serum concentration in FIP**, making it a powerful biomarker (especially when pre-test probability is high).  \n- **0.35 points:** Correctly describes **AGP sialylation in FIP as decreased (hyposialylated)**.  \n- **0.20 points:** Describes the antiviral link: **higher AGP sialylation (in humans) is associated with protection from viral infections** (i.e., sialylation rate seems protective).  \n- **0.10 points:** Notes that **clinically healthy cats in FCoV-endemic environments can show transient increases in AGP concentration and transient increases in AGP sialylation**.\n\nDeductions (max 0.25 points):  \n- Deduct **0.05–0.25** for excessive irrelevant content that obscures the required points (e.g., long descriptions of FIP clinical signs, detailed coronavirus biology beyond identifying FCoV as the cause, or unrelated acute-phase proteins).  \n- Final score cannot be below **0**."}
{"query": "Explain why domestic cats are predisposed to urolithiasis, and specify the urinary pH conditions that favor (i) struvite urolith formation and (ii) oxalate urolith formation.", "response": "Rubric (Total = 1.0 point; minimum = 0):  \n- 0.40 points: Correctly explains the physiological predisposition: cats’ desert origin leads to naturally more concentrated, more saturated urine, which (together with urinary pH changes) promotes crystal precipitation and urolith formation.  \n- 0.30 points: Correctly states that increased urinary pH > 6.4 favors struvite uroliths.  \n- 0.30 points: Correctly states that reduced urinary pH < 6.2 favors oxalate uroliths.  \n\nDeductions (max 0.25 points):  \n- Deduct 0.05–0.25 points if the response includes substantial irrelevant or speculative content (e.g., unrelated treatments, non-pH risk factors not asked for) that obscures the required elements. The total score cannot go below 0."}
{"query": "Explain how feline enteric coronavirus (FECV) can give rise to feline infectious peritonitis virus (FIPV) under the internal mutation hypothesis, including the key change in cell tropism, the consequence for viral dissemination, and at least three major pathological/clinical features that characterize feline infectious peritonitis (FIP).", "response": "Rubric (Total Score: 1.0 Point; Minimum: 0):  \n- 0.25 points: States that FIPV arises from genetic mutations in FECV (internal mutation hypothesis).  \n- 0.25 points: Identifies the tropism switch from intestinal enterocytes to peritoneal-type macrophages.  \n- 0.20 points: Explains that macrophage tropism enables systemic spread/dissemination and drives an immunoinflammatory syndrome.  \n- 0.30 points: Lists at least three correct FIP features (any three): fever; pyogranulomatous perivasculitis; effusion accumulation; fibrinous exudate; high mortality; multisystemic inflammatory involvement (e.g., abdominal/thoracic cavities, CNS, eyes).  \n\nDeductions (Max 0.25 points):  \n- Deduct 0.05–0.25 points for excessive irrelevant content beyond what is asked (severity-based), such as detailed transmission mechanics beyond a brief mention, extensive treatment speculation, or unrelated coronavirus taxonomy.  \n- Final score cannot be less than 0."}
{"query": "Explain how gammaherpesviruses can persist long-term in humans and under what immune or clinical conditions reactivation is suspected to occur; then name the two human gammaherpesviruses associated with tumorigenesis and state two key risk factors that increase Epstein–Barr virus oncogenic potential.", "response": "Rubric (Total = 1.0 point; Minimum = 0 points):\n\n- Persistence mechanism (0.25 points)  \n  - 0.25: States that infection often persists via latency (lifelong/persistent infection with latent phase and possible reactivation).  \n  - 0: Does not mention latency/persistence mechanism.\n\n- Reactivation conditions (0.25 points)  \n  - 0.25: Identifies reactivation as suspected during co-infections and/or when cell-mediated immunity is compromised (e.g., loss of T-cell immunity/immunosuppression).  \n  - 0: Reactivation conditions missing or incorrect.\n\n- Tumorigenic human gammaherpesviruses (0.25 points)  \n  - 0.25: Correctly names both Epstein–Barr virus (EBV) and Kaposi’s sarcoma-associated herpesvirus (KSHV).  \n  - 0: One or both viruses incorrect/missing.\n\n- EBV oncogenic risk factors (0.25 points)  \n  - 0.25: Provides both: loss of T-cell immunity and genetic predisposition.  \n  - 0.125: Provides only one of the two correctly.  \n  - 0: Neither factor correct.\n\nDeductions for excessive irrelevant content (max −0.25 points):  \nDeduct 0.05–0.25 if the response includes substantial unrelated material (e.g., detailed virology outside GHVs, unrelated diseases, treatment protocols) that obscures the required points. Final score cannot be below 0."}
{"query": "Explain how myiasis is classified using (1) the host–parasite relationship and (2) the anatomical localization of larvae, including how facultative myiasis is further subdivided and what is meant by “neurological” and “respiratory” myiasis.", "response": "Rubric (Total = 1.0 point; Minimum = 0 points):\n\n- **Host–parasite relationship classification (0.30 points)**\n  - 0.15: Correctly distinguishes **obligatory myiasis** as requiring a **living host for development**.\n  - 0.15: Correctly distinguishes **facultative myiasis** as **only occasionally using living hosts** and **usually developing on decaying matter**.\n\n- **Facultative subtype classification (0.25 points)**\n  - 0.15: States that facultative myiasis can be **primary, secondary, or tertiary**.\n  - 0.10: Correctly explains **primary** = can **initiate** myiasis; **secondary/tertiary** = **superimpose on pre-existing** myiasis.\n\n- **Anatomical localization classification (0.35 points)**\n  - 0.10: Notes the **external vs internal** localization framing.\n  - 0.25: Correctly lists relevant localization types (any **five or more** earn full 0.25): **auricular, cutaneous, gastrointestinal, ophthalmic, oral, urogenital**.\n\n- **Definitions of “neurological” and “respiratory” myiasis (0.10 points)**\n  - 0.05: “Neurological” myiasis involves **structures of the nervous system**.\n  - 0.05: “Respiratory” myiasis involves **structures of the respiratory system**.\n\n- **Deductions for excessive irrelevant content (max deduction = 0.25 points)**\n  - Deduct 0.05–0.25 if the response adds substantial off-topic material (e.g., detailed treatment regimens, unrelated life-cycle details, epidemiology) that obscures the required classification points.  \n  - Final score cannot go below 0."}
{"query": "Explain the cellular pathology underlying retinitis pigmentosa, identify the primary retinal cell types affected, describe the typical sequence of visual symptoms over time, and state the approximate global prevalence.", "response": "Rubric (Total Score: 1.0 point; Minimum: 0.0 points)\n\n- Cellular pathology and affected cells (0.45 points)  \n  - 0.25: States that RP is a retinal degenerative disease characterized by photoreceptor destruction/degeneration.  \n  - 0.20: Correctly identifies that rods and cones degenerate (both cell types must be mentioned).\n\n- Symptom progression (0.35 points)  \n  - 0.20: Mentions night blindness as an early/typical symptom.  \n  - 0.15: Mentions peripheral vision loss progressing and eventual loss of central vision (must include progression to central vision loss).\n\n- Prevalence (0.20 points)  \n  - 0.20: Gives an approximate worldwide prevalence of about 1 in 4,000 (minor rephrasing like “~1/4000” acceptable).\n\nDeductions (max 0.25 points)  \n- Deduct 0.05–0.25 for excessive irrelevant content beyond what is asked (e.g., extended discussion of unrelated retinal diseases, detailed genetics not requested, lengthy treatment speculation). Deduction magnitude depends on severity. Final score cannot go below 0.0."}
{"query": "Describe the etiologic agent responsible for severe fever with thrombocytopenia syndrome (SFTS) by naming the virus and its taxonomic family, and identify the primary tick vector/reservoir implicated in human infection; additionally, list at least four mammalian host species in which viral RNA or antibodies have been detected.", "response": "Rubric (Total Score: 1.0 point; Minimum: 0.0):  \n- (0.25) Correctly names the causative virus as SFTS virus (SFTSV) (a novel Dabie bandavirus).  \n- (0.25) Correctly states the viral family as Phenuiviridae.  \n- (0.25) Correctly identifies Haemaphysalis longicornis as the main tick vector/reservoir implicated in human infection.  \n- (0.25) Correctly lists ≥4 mammalian host species with detected SFTSV RNA or antibodies (any four of: goats, sheep, cattle, pigs, dogs, cats, boars, deer).  \n\nDeductions (max 0.25 points):  \n- Deduct 0.05–0.25 for excessive irrelevant content beyond what is asked (e.g., lengthy symptom lists, unrelated epidemiology), proportional to severity. Final score cannot be below 0.0."}
{"query": "Explain how feline coronavirus and feline calicivirus infections can shift from typically mild, localized disease to severe systemic illness in cats, and distinguish the key clinical-pathologic features and epidemiologic significance of feline infectious peritonitis (FIP) versus virulent systemic feline calicivirus (vs-FCV). Include FCoV biotypes/serotypes and the origin of serotype II.", "response": "Rubric (Total Score: 1.0 point; Min Score: 0.0 points)\n\n- FCoV typical vs severe disease transition (0.15):  \n  - 0.15 if states FCoV usually causes mild/asymptomatic enteric infection but can cause fatal systemic disease as FIP.  \n  - 0.0 otherwise.\n\n- FIP defining pathology and outcome (0.20):  \n  - 0.10 for “systemic pyogranulomatous inflammation in various organs.”  \n  - 0.10 for progression to “fluid accumulation in the abdominal cavity (effusion/ascites) and death.”  \n  - 0.0–0.20 partial credit if only one element is correct.\n\n- Epidemiologic significance of FIP (0.15):  \n  - 0.15 if notes FIP is relatively uncommon overall but is a leading cause of death in young cats.  \n  - 0.0 otherwise.\n\n- FCoV biotypes and serotypes, including serotype II origin (0.30):  \n  - 0.10 for identifying two biotypes: feline enteric coronavirus and FIP coronavirus.  \n  - 0.10 for identifying two serotypes: I and II, with serotype I more prevalent.  \n  - 0.10 for stating serotype II appears derived from recombination with canine coronavirus in the spike (S) protein.  \n  - 0.0–0.30 partial credit based on correct components.\n\n- vs-FCV distinguishing features (0.20):  \n  - 0.10 for expanded tissue tropism/systemic infection with high mortality (up to ~67%).  \n  - 0.10 for characteristic signs such as facial/limb edema, vasculitis, and multi-organ dysfunction (contrast with typical FCV upper respiratory/oral ulceration).  \n  - 0.0–0.20 partial credit if only one element is correct.\n\nDeductions for excess/irrelevant content (max 0.25):  \n- Deduct 0.05–0.25 if the response adds substantial unrelated information (e.g., detailed vaccine histories, unrelated feline diseases, molecular mechanisms not asked for) that obscures the required points.  \n- Total score after deductions cannot be below 0.0."}
{"query": "In a comparative anatomical study of felids, how do differences in (1) the number and spinal-cord-level origins of the subscapular nerves supplying musculus subscapularis, and (2) the pattern of ventral-ramus contributions to nervus medianus, distinguish snow leopards (Panthera uncia) from domestic cats (Felis catus), and what functional prey-capture implications are associated with each difference?", "response": "Rubric (Total = 1.0 point; Min = 0 points):  \n\n- Subscapular nerve pattern in *P. uncia* vs *F. catus* (0.5 points)  \n  - 0.5: Correctly states that *P. uncia* has a larger number of nn. subscapulares supplying an extensively pennate m. subscapularis, with the nerves deriving from more spinal cord levels than in *F. catus* (which has fewer subscapular nerves from fewer levels).  \n  - 0.0: Does not clearly identify this directionality (e.g., claims the opposite or gives no comparative description).\n\n- Median nerve contributions and functional implication (0.5 points)  \n  - 0.25: Correctly states that in *F. catus* the n. medianus receives direct contributions from more ventral rami than in *P. uncia*.  \n  - 0.25: Correctly links this to function by stating it is associated with greater reliance on manual dexterity in prey capture in *F. catus* (contrasted with *P. uncia* being less reliant on dexterity and more on powerful/stabilizing forelimb use for large prey).  \n  - 0.0: Missing or incorrect comparative pattern and/or missing or incorrect functional implication.\n\nDeductions (max 0.25 points):  \n- Deduct 0.05–0.25 for excessive irrelevant detail that is not asked (e.g., extended discussion of other nerves like the suprascapular nerve or latissimus dorsi innervation without tying it to the two specified comparisons), with deduction magnitude based on severity. Final score cannot go below 0."}
{"query": "Explain why parrots and other birds were historically viewed by scientists as incapable of complex cognition, and describe the specific mistaken neuroanatomical assumption about the avian telencephalon that supported this view.", "response": "Rubric (Total Score: 1.0 point):  \n- 0.5 points: States that the historical view was driven (at least in part) by the belief that birds lacked mammal-like brain structures associated with higher cognition (i.e., no equivalents to neocortical structures used in mammalian cognitive processing).  \n- 0.5 points: Correctly describes the mistaken assumption/terminology that the entire avian telencephalon was considered to be only (or essentially) an enlarged basal ganglia, implying an absence of neocortical equivalents.\n\nDeductions (max 0.25 points):  \n- Deduct 0.05–0.25 points if the response includes substantial irrelevant material (e.g., discussion of parrot pet history or imitation/attachment behaviors beyond what is needed to answer), with the amount depending on severity. The final score cannot go below 0.0."}
{"query": "White-tailed deer are a major blood-meal host for adult blacklegged ticks but are not reservoirs for *Borrelia burgdorferi*. Explain how increasing deer abundance can still be associated with higher Lyme disease risk in some regions, and give one reason this association may fail to predict Lyme disease presence in other areas with similarly high deer densities.", "response": "Rubric (Total Score: 1.0 point; minimum 0.0):  \n- **0.5 points:** Explains the mechanism for a positive association despite deer not being reservoirs: higher deer abundance can increase adult tick feeding success and reproduction, raising blacklegged tick abundance (and thus potential exposure risk).  \n- **0.5 points:** Provides one valid reason the association may not hold across regions, such as: deer overabundance can occur where Lyme disease remains rare; other necessary enzootic-cycle factors vary (e.g., availability of competent reservoir hosts, ecological/community composition, or other contributing environmental factors).  \n\nDeductions (max 0.25 points):  \n- Deduct **0.1–0.25 points** for substantial irrelevant additions (e.g., detailed clinical features of Lyme disease or unrelated tick species biology) that obscure the required explanation."}
{"query": "Explain how feline calicivirus (FCV) can produce markedly different clinical outcomes across infected animals, and describe the host range evidence that raises concern about cross-species transmission and wider ecological impact.", "response": "Rubric (Total Score: 1.0 point; Minimum: 0 points)\n\n- 0.5 points: Clinical outcome variability explained  \n  - Award 0.5 if the answer states that FCV strains vary in tropism and virulence, leading to a spectrum from nonpathogenic infection to a typical mild syndrome (fever/pyrexia, oral ulceration, mild respiratory and conjunctival signs) and, in some strains, severe systemic disease with high mortality (virulent systemic disease/FCV-VSD).  \n  - Award 0.25 if the answer mentions strain-dependent differences and contrasts mild disease vs severe systemic/high-mortality disease but omits key example signs or FCV-VSD.\n\n- 0.5 points: Host range/cross-species/ecological concern described  \n  - Award 0.5 if the answer correctly identifies infection in domestic cats and other felids, reports documented infection in dogs as evidence of cross-species potential, and notes concern for infection of wildcats (ecological impact beyond domestic cats).  \n  - Award 0.25 if the answer includes cats + either dogs or wild felids, but not both.\n\nDeductions for excessive irrelevant content (max 0.25 points):  \n- Deduct up to 0.25 if the response adds substantial unrelated material (e.g., detailed virology methods, unrelated feline pathogens, vaccine schedules, or treatment protocols) that is not needed to answer the question. The total score cannot fall below 0."}
{"query": "Identify four human polyomaviruses strongly linked to clinical disease and, for each, name one major associated disease outcome, including any distinctive pathogenic feature noted for one of them.", "response": "Rubric (Total Score: 1.0 point; Minimum: 0.0):  \n- 0.25 points: Correctly names HPyV-1 (BK polyomavirus, BKPyV) and links it to nephropathy (especially kidney transplant-associated nephropathy / transplant failure).  \n- 0.25 points: Correctly names HPyV-2 (JC polyomavirus, JCPyV) and links it to progressive multifocal leukoencephalopathy (PML; demyelinating disease).  \n- 0.25 points: Correctly names HPyV-5 (Merkel cell polyomavirus, MCPyV) and links it to Merkel cell carcinoma, including the distinctive feature that it can integrate into the cellular genome.  \n- 0.25 points: Correctly names HPyV-8 (Trichodysplasia spinulosa-associated polyomavirus, TSPyV) and links it to Trichodysplasia spinulosa (TS).  \n\nDeductions (Max 0.25 points):  \n- Deduct 0.05–0.25 points (severity-based) for excessive irrelevant information beyond the requested virus–disease mappings (e.g., lengthy unrelated virology details or speculation about mechanisms).  \n- Final score cannot be below 0.0."}
{"query": "For a preclinical program aiming to test candidate therapeutics and vaccines for New World hantaviruses that cause hantavirus pulmonary syndrome, identify (1) the two most commonly associated viruses and their primary geographic regions, (2) the key clinical features and approximate case-fatality rate of the syndrome, and (3) the single animal model that best reproduces the human disease and the specific aspects of human illness it faithfully mimics.", "response": "Rubric (Total = 1.0 point; Minimum = 0 points):  \n- **0.2**: Names the two viruses: **Sin Nombre virus** and **Andes virus**.  \n- **0.2**: Correctly links geography: **Sin Nombre—North America; Andes—South America**.  \n- **0.2**: States key clinical features: **fever** plus **sudden/rapid onset of severe respiratory distress** and **cardiogenic shock** (must include respiratory distress and cardiogenic shock; fever may be included as part of this point).  \n- **0.2**: Gives approximate fatality: **up to ~50%**.  \n- **0.2**: Identifies the animal model as the **Syrian hamster model (Andes virus infection)** and specifies at least two faithfully mimicked aspects: **incubation period**, **pathophysiology**, and/or **sudden rapid respiratory distress**.\n\nDeductions (max **0.25**):  \n- Deduct **0.05–0.25** for substantial extraneous content that goes beyond what is asked (e.g., detailed hantavirus taxonomy, unrelated animal models, or extended epidemiology) depending on severity. Final score cannot be below 0."}
{"query": "Snake venom proteins and peptides make up most of venom’s dry weight and can act enzymatically and/or toxically. Identify (i) the approximate percentage range of venom dry weight constituted by proteins and peptides, (ii) whether all venoms share the same full set of enzymes and toxins, and (iii) name four common enzyme classes found in snake venom.", "response": "Rubric (Total Score: 1.0 Point)  \n- Proteins/peptides abundance (0.35 points): States that proteins and peptides constitute about **90–95%** of venom dry weight.  \n- Variability across venoms (0.25 points): Correctly states **no single venom contains all** enzymes and toxins (i.e., combinations/concentrations vary; not all venoms share the full set).  \n- Enzyme classes (0.40 points): Names **any four** of the following enzyme classes: **acetylcholinesterases, L-amino acid oxidases, phospholipases A2, proteases (metalloproteases and/or serine proteases), hyaluronidases, fibrogenases, collagenases, elastases, catalases**. (0.10 points each up to 0.40)\n\nDeductions (Max 0.25 points)  \n- Deduct **0.05–0.25** for excessive irrelevant material (e.g., detailed clinical syndromes, treatment protocols, or unrelated taxonomy) that obscures the requested items, proportional to severity. Final score cannot be below 0."}
{"query": "Snake venom contains both enzymatic and non-enzymatic toxins that drive morbidity and mortality. Name at least three enzymatic toxin classes and at least three non-enzymatic toxin/component classes found in snake venom, and state two distinct severe physical outcomes of envenomation that can occur even when the victim survives.", "response": "Rubric (Total Score: 1.0 Point; Minimum: 0.0 Points)\n\n- Enzymatic toxin classes (0.4 points)  \n  - 0.4 points: Correctly names at least three enzymatic toxin classes from: snake venom metalloproteases (SVMPs), phospholipase A₂ (PLA₂), L-amino acid oxidases (LAAO), serine proteases.  \n  - 0.2 points: Correctly names exactly two of the listed enzymatic toxin classes.  \n  - 0.0 points: Names fewer than two correct enzymatic toxin classes, or lists only items not in the accepted set.\n\n- Non-enzymatic toxin/component classes (0.4 points)  \n  - 0.4 points: Correctly names at least three non-enzymatic classes/components from: disintegrins, three-finger toxins, protease inhibitors.  \n  - 0.2 points: Correctly names exactly two of the listed non-enzymatic classes/components.  \n  - 0.0 points: Names fewer than two correct non-enzymatic classes/components, or lists only items not in the accepted set.\n\n- Severe physical outcomes in survivors (0.2 points)  \n  - 0.2 points: Correctly states two outcomes from: amputation, necrosis, severe local damage.  \n  - 0.1 points: Correctly states one outcome from the list.  \n  - 0.0 points: No correct outcomes stated.\n\nDeductions for excessive irrelevant content (max 0.25 points)  \n- Deduct 0.10–0.25 points if substantial extraneous material is included beyond what is asked (e.g., extended discussion of global death statistics or regional epidemiology), with the deduction proportional to severity.  \n- Final score cannot be below 0.0 points."}
{"query": "Characterize Rabbit Hemorrhagic Disease Virus 2 (RHDV2) by describing its taxonomy (genus and family), key virion and genome properties, typical incubation period, expected time-to-death after infection, approximate maximum mortality rate, initial detection location/year, and one plausible mechanism contributing to its rapid global spread.", "response": "Rubric (Total Score: 1.0 point; Minimum: 0 points)\n\n- Taxonomy (0.2 points)  \n  - 0.1: Correctly states genus **Lagovirus**.  \n  - 0.1: Correctly states family **Caliciviridae**.\n\n- Virion/genome properties (0.2 points)  \n  - 0.1: Identifies the virus as **non-enveloped** and **icosahedral**.  \n  - 0.1: Identifies the genome as **single-stranded RNA**.\n\n- Disease timing and severity (0.4 points)  \n  - 0.15: States incubation period is **~3–9 days**.  \n  - 0.15: States fatal outcome can occur **~2–4 days after infection**.  \n  - 0.10: States mortality can be **up to ~80%**.\n\n- Emergence and spread mechanism (0.2 points)  \n  - 0.10: States first detection was **France, 2010**.  \n  - 0.10: Provides a plausible mechanism: **human-mediated movement/transport of rabbits** contributing to global dissemination.\n\nDeductions for excessive irrelevant content (max 0.25 points)  \n- Deduct up to **0.25** if the response includes substantial extraneous material not needed to answer (e.g., long descriptions of clinical pathology, unrelated virology, detailed citation lists), with the size of the deduction proportional to the amount of irrelevant content. The final score cannot go below 0."}
{"query": "Classify rabbit haemorrhagic disease viruses within Caliciviridae by naming their genus, genogroup, and the four GI genotypes, and then distinguish which genotypes are pathogenic versus non-pathogenic and identify the historically named antigenic/variant designations associated with GI.1 and GI.2.", "response": "Rubric (Total Score: 1.0 point; Minimum: 0 points)\n\n- Taxonomic placement (0.25 points)  \n  - 0.15: States the genus as *Lagovirus europaeus*.  \n  - 0.10: States the genogroup as GI.\n\n- GI genotype list (0.25 points)  \n  - 0.25: Correctly lists all four genotypes: GI.1, GI.2, GI.3, GI.4 (all required; otherwise 0 for this sub-point).\n\n- Pathogenic vs non-pathogenic distinction (0.30 points)  \n  - 0.15: Identifies GI.1 and GI.2 as pathogenic RHD viruses.  \n  - 0.15: Identifies GI.3 and GI.4 as non-pathogenic RCV viruses.\n\n- Variant/antigenic designation mapping (0.20 points)  \n  - 0.10: Correctly links RHDVa to GI.1a (GI.1a-RHDVa).  \n  - 0.10: Correctly links RHDVb/RHDV2 to GI.2 (GI.2-RHDV2/b).\n\nDeductions for excess/irrelevant content (max 0.25 points)  \n- Deduct 0.05–0.25 if the response adds substantial information not asked for (e.g., long descriptions of host range, mortality rates, outbreak history, phylogenogroups/pathotypes) that obscures the requested classification and mappings.  \n- Final score cannot be below 0."}
{"query": "Compare FeLV-A, FeLV-B, and FeLV-C by describing (i) how each subgroup arises genetically, (ii) whether it can spread naturally from cat to cat, and (iii) one key disease association characteristic of each.", "response": "Rubric (Total = 1.0 point; Minimum = 0.0):  \n- Genetic origin (0.45 points total)  \n  - 0.15: FeLV-A identified as the “parent/main” subgroup that other variants derive from (i.e., not defined here by recombination/mutation relative to another FeLV subgroup).  \n  - 0.15: FeLV-B correctly described as arising via recombination between FeLV-A and endogenous FeLV sequences (endogenous retroviral LTR involvement).  \n  - 0.15: FeLV-C correctly described as arising de novo by mutations in the env gene of FeLV-A.  \n\n- Natural cat-to-cat transmission (0.30 points total)  \n  - 0.15: FeLV-A correctly identified as the only subgroup listed that is naturally contagious cat-to-cat.  \n  - 0.15: FeLV-B correctly identified as not horizontally transmissible unless co-transmitted with FeLV-A.  \n  - (FeLV-C transmission status is not awarded if asserted; it is not specified here—see deductions for overreach.)  \n\n- Disease association (0.25 points total)  \n  - 0.10: FeLV-A correctly linked to at least one of: macrocytic anaemia, immunosuppression, lymphoma.  \n  - 0.10: FeLV-B correctly linked to being tumorigenic.  \n  - 0.05: FeLV-C correctly linked to aplastic anaemia.  \n\nDeductions (max 0.25 points):  \n- Deduct 0.10–0.25 for substantial irrelevant add-ons or unsupported claims (e.g., asserting specific transmission properties for FeLV-C, adding unrelated subgroup details like FeLV-T receptor usage, or extended discussion beyond the requested comparisons).  \n- Final score cannot go below 0.0."}
{"query": "Explain the key cellular and structural events that drive atherosclerosis from initiation to life‑threatening complications, and distinguish the defining features of stable versus vulnerable plaques, including the mechanism by which acute arterial occlusion occurs.", "response": "Rubric (Total Score: 1.0 Point; Minimum: 0.0 Points)\n\n- Initiation and early lesion formation (0.25 points)  \n  - 0.10: Mentions LDL deposition as an initiating event.  \n  - 0.10: Includes endothelial dysfunction and inflammatory activation (chronic inflammatory process with multiple cell types/cytokines or pro-inflammatory agents).  \n  - 0.05: Describes subendothelial foam cell accumulation and fatty streak formation.\n\n- Plaque progression to fibroatheroma (0.25 points)  \n  - 0.10: States VSMC migration into the intima.  \n  - 0.10: States extracellular matrix elaboration by VSMCs.  \n  - 0.05: Identifies fibroatheroma as having a fibrous cap over a lipid core.\n\n- Stable vs vulnerable plaque features (0.25 points)  \n  - 0.125: Correctly describes stable lesions as having a thick fibrous cap and small lipid core.  \n  - 0.125: Correctly describes vulnerable lesions as having a thin fibrous cap and large lipid core.\n\n- Mechanism of acute complication (0.25 points)  \n  - 0.15: States that fibrous cap rupture triggers superimposed thrombosis.  \n  - 0.10: States thrombosis can occlude the arterial lumen and disrupt blood flow (acute arterial occlusion).\n\nDeductions for excess/irrelevant content (max 0.25 points)  \n- Deduct 0.05–0.25 if the response adds substantial unrelated material (e.g., detailed treatment regimens, unrelated risk-factor catalogs, unrelated molecular pathways) that obscures the required sequence/features.  \n- Final score cannot be below 0.0."}
{"query": "Explain where estrogens are synthesized in the body (include both gonadal and non-gonadal sites), then describe how estrogens exert their effects at the molecular level by naming the two main poultry estrogen receptors and outlining how these receptors regulate gene expression.", "response": "Rubric (Total = 1.0 point; Minimum = 0 points):  \n\n- **Synthesis sites (0.4 points total)**\n  - **0.2**: Correctly identifies major gonadal synthesis from cholesterol mainly in the **ovaries**, specifically including **granulosa cells** and **corpora lutea**.  \n  - **0.2**: Correctly lists at least **two** non-gonadal production sites from: **heart, liver, skin, brain, adipose tissue, adrenal glands**.\n\n- **Receptors identified (0.3 points total)**\n  - **0.15**: Names **estrogen receptor 1** (ESR1 / ERα / ER1).  \n  - **0.15**: Names **estrogen receptor 2** (ESR2 / ERβ / ER2).\n\n- **Molecular mechanism (0.3 points total)**\n  - **0.15**: States that ERs are **nuclear receptor superfamily** members that act as **transcription factors**.  \n  - **0.15**: Explains that ERs regulate gene expression by binding **estrogen response elements (EREs)** to initiate **gene transcription** (mentioning interaction with other transcription factors is acceptable but not required).\n\n- **Deductions for excess/irrelevant content (max −0.25 points)**\n  - Deduct **0.05–0.25** if the response contains substantial unrelated material (e.g., extended disease discussions, unrelated endocrine pathways) that obscures the required points.  \n  - Total score cannot go below **0**."}
{"query": "Explain why Duck Hepatitis A Virus 3 (DHAV-3) is considered a major threat to intensive duck production in China by describing (i) the most vulnerable age group and approximate mortality level, (ii) key disease features observed in fatal cases, and (iii) the epidemiological/serotype-related factors that have made DHAV-3 the predominant problem since 2013.", "response": "Rubric (Total = 1.0 point; Minimum = 0.0 points):\n\n- Vulnerable age group + mortality (0.35 points)  \n  - 0.20: Identifies ducklings younger than 14 days as the high-risk group.  \n  - 0.15: States mortality is approximately ~90% in that group.\n\n- Fatal-case clinical/pathological features (0.25 points)  \n  - 0.15: Mentions opisthotonos (opisthotonos posturing).  \n  - 0.10: Mentions severe liver multiple ecchymoses (hemorrhagic/ecchymotic liver lesions).\n\n- Epidemiological/serotype predominance factors (0.40 points)  \n  - 0.15: States DHAV has three serotypes and correctly distinguishes DHAV-3 from DHAV-1 and DHAV-2.  \n  - 0.15: States DHAV-3 has been the predominant viral type in China since 2013.  \n  - 0.10: Notes at least one impact/driver: rapid transmission and/or high morbidity/mortality causing major economic loss in intensive farms.\n\nDeductions for excessive/irrelevant content (max 0.25 points):  \n- Deduct 0.05–0.25 if the response adds substantial unrelated material (e.g., vaccine protocols, molecular biology not asked for, unrelated diseases), to the point that it obscures or crowds out the required elements.  \n- Final score cannot go below 0.0."}
{"query": "Explain why a relatively small fraction of synapses from the thalamus (about 1–5% of synapses into primary visual cortex) can still drive activity across the entire visual cortex, and describe two mechanistic features of thalamus-to-cortex signaling that shape how sensory information is transformed as it reaches cortical circuits.", "response": "Rubric (Total Score: 1.0 point; Minimum: 0 points)\n\n- 0.5 points: Explains the “small fraction, large effect” problem correctly by stating that thalamocortical synapses must act cooperatively (i.e., coordinated/summating action across inputs) to drive widespread cortical activity despite being few in number.  \n  - Full credit (0.5): Explicitly links widespread cortical driving to cooperative action/summation of thalamocortical synapses.  \n  - No credit (0.0): Attributes the effect to unrelated mechanisms (e.g., “more thalamic synapses than stated,” “direct input to all layers equally,” or purely cortical spontaneous activity) without mentioning cooperative thalamocortical action.\n\n- 0.5 points: Correctly gives two distinct mechanistic features that shape sensory transformation at the thalamus-to-cortex interface:  \n  - 0.25 points for stating that (except smell) sensory signals are routed through the thalamus before reaching cortex (thalamic relay role).  \n  - 0.25 points for stating either (a) thalamic relay to cortex is orderly/topographical, or (b) thalamic input to cortical input layer can target excitatory or inhibitory cortical neurons, altering the nature of the signal.  \n  - Full credit (0.5): Provides two features from the list above, clearly and correctly.  \n  - Partial credit (0.25): Provides only one correct feature, or provides two but one is vague/incorrect.  \n  - No credit (0.0): Provides none of these features or substitutes unrelated details.\n\nDeductions (Max 0.25 points):  \n- Deduct 0.05–0.25 points for excessive irrelevant content that obscures the required elements (e.g., extended discussion of unrelated brain regions, detailed molecular pathways not implied here, or long digressions on olfaction beyond noting its exception).  \n- Maximum total deduction is 0.25 points; final score cannot go below 0."}
{"query": "Explain how Duck Virus Enteritis (duck plague) can spread within and between continents, identify the causative agent with its taxonomic placement (genus, family, subfamily), and state the principal transmission routes (including whether they can be horizontal and/or vertical).", "response": "Rubric (Total = 1.0 point; minimum = 0.0 points):  \n- **0.4 points (Causative agent + taxonomy):** Correctly names the agent as duck enteritis virus (DEV) / Anatid herpesvirus 1 **and** places it in **genus Mardivirus, family Herpesviridae, subfamily Alpha-herpesvirinae**. (All elements required for full 0.4.)  \n- **0.3 points (Intercontinental spread mechanism):** Correctly states that **migratory waterfowl** play a crucial role in transmission **within and between continents**.  \n- **0.3 points (Transmission routes):** Correctly states that spread occurs via **oral–fecal discharges** and that transmission can be **horizontal and/or vertical**. (Must include oral–fecal plus both horizontal/vertical possibility.)  \n\nDeductions (max 0.25 points):  \n- Deduct **0.05–0.25** for excessive irrelevant content (e.g., detailed lesion lists, vaccine schedules, mortality percentages) that is not asked and substantially obscures the required points. Final score cannot go below 0."}
{"query": "Mitogen-activated protein kinases (MAPKs) are described as serine/threonine-specific kinases present in all eukaryotic cells and involved in major cellular functions. Explain what MAPKs do in signal transduction and list at least four distinct cellular processes that MAPK pathways help regulate; also state how many mammalian MAPKs have been characterized and into how many groups.", "response": "Rubric (Total = 1.0 point; Minimum = 0 points):  \n- (0.25) Correctly states MAPKs function as serine/threonine kinases that transduce/convert extracellular stimuli (signals) into cellular responses.  \n- (0.40) Lists at least four regulated processes, drawn from: mitosis, differentiation, metabolism, motility, apoptosis, cell survival. (Award 0.10 each up to four; max 0.40.)  \n- (0.20) Correctly states that 14 mammalian MAPKs have been characterized.  \n- (0.15) Correctly states they are classified into 7 groups.  \n\nDeductions (max 0.25):  \n- Deduct 0.05–0.25 for substantial extraneous content that goes beyond answering the prompt (e.g., detailed MAPK cascade components or unrelated pathway families) in proportion to severity and how much it obscures the required elements. Final score not below 0."}
{"query": "In fowl cholera (avian pasteurellosis) affecting ducks and other birds, identify the causative bacterium, describe the major clinical disease forms and potential outcome severity, and explain why the Pasteurella multocida outer membrane protein H (OmpH) is a notable vaccine antigen and what protection it is intended to provide.", "response": "Rubric (Total = 1.0 point; Min = 0 points):  \n\n- **Causative agent (0.25 points)**  \n  - 0.25: States that fowl cholera is caused by **Pasteurella multocida**.  \n  - 0: Does not correctly identify **Pasteurella multocida**.\n\n- **Disease forms and severity (0.35 points)**  \n  - 0.20: Identifies the disease forms as **acute septicaemia** and **chronic** (both required for full 0.20).  \n  - 0.15: Notes that it can also present as **localized infections** and/or emphasizes **high morbidity/mortality**, including that mortality can reach **up to 100%** (must include either localized infections plus high morbidity/mortality, or explicitly “up to 100% mortality” for full 0.15).  \n  - 0: Missing both the key forms (acute septicaemia and chronic) and the high-severity characterization.\n\n- **OmpH significance and intended protection (0.40 points)**  \n  - 0.20: Explains that **OmpH is a major outer membrane protein** (in the envelope/capsule) and is **strongly immunogenic/protective antigen**.  \n  - 0.20: States that OmpH has been **incorporated into a fowl cholera vaccine** and is intended to provide **protective immunity against P. multocida** (in **chickens and ducks**).  \n  - 0: Does not connect OmpH to immunogenicity/protective antigen and vaccine protection against **P. multocida**.\n\n- **Deductions for excessive irrelevant content (max −0.25 points)**  \n  - Deduct **0.05–0.25** if the response includes substantial extraneous material that is not asked (e.g., unrelated pathogens, treatment protocols, extensive outbreak history), with deduction proportional to severity.  \n  - Final score cannot go below **0**."}
{"query": "Describe the taxonomic classification of novel goose parvovirus (N-GPV) and explain two distinct transmission routes by which classical waterfowl parvoviruses/N-GPV can spread among waterfowl, including the specific biological materials implicated in each route.", "response": "Rubric (Total = 1.0 point; Min = 0 points):  \n- **Taxonomy (0.35 points)**  \n  - 0.20: Identifies N-GPV as a **waterfowl parvovirus** in the **family Parvoviridae**.  \n  - 0.15: Correctly specifies the **genus Dependoparvovirus**.  \n- **Transmission route 1: vertical (0.30 points)**  \n  - 0.30: States **vertical transmission via eggs** from infected breeders to susceptible young goslings/offspring.  \n- **Transmission route 2: horizontal (0.30 points)**  \n  - 0.30: States **horizontal transmission via direct contact and/or via excretions/secretions**, and explicitly links this to **sputum (oral shedding/oral swabs)** and **stool (cloacal shedding/cloacal swabs)**.  \n- **Deductions for excessive irrelevant content (max deduction = 0.25 points)**  \n  - Deduct up to **0.25** if the response adds substantial non-asked material (e.g., extended vaccine history, unrelated clinical signs, or details about human parvovirus B19 beyond naming it) that obscures the required items.  \n  - Final score cannot go below **0**."}
{"query": "Phosphoenolpyruvate carboxykinase 1 (PCK1) is widely viewed as a gluconeogenic control point, yet it is also expressed in tissues that do not export glucose. Explain how PCK1 can still be physiologically important in such tissues by describing its role in glyceroneogenesis and predicting the metabolic consequence of deleting PCK1 in adipose tissue on triglyceride storage.", "response": "Rubric (Total Score: 1.0 point; Min: 0 points):\n\n- Role in non-glucose-producing tissues via glyceroneogenesis (0.5 points)  \n  - 0.5: Clearly states that PCK1 supports glyceroneogenesis, i.e., de novo production of glycerol-3-phosphate from non-glucose/non-glycerol precursors, enabling re-esterification of free fatty acids (especially during fasting).  \n  - 0.0: Does not connect PCK1 to glyceroneogenesis and glycerol-3-phosphate production/re-esterification.\n\n- Predicted consequence of adipose PCK1 deletion (0.5 points)  \n  - 0.5: Predicts that deleting PCK1 in adipose tissue inhibits glyceroneogenesis and reduces triglyceride deposition/storage (i.e., less triglyceride stored in adipose).  \n  - 0.0: Predicts the wrong direction (e.g., increased triglyceride storage) or gives no clear prediction.\n\nDeductions for excessive irrelevant content (max 0.25 points):  \n- Deduct 0.05–0.25 if the response includes substantial unrelated material (e.g., detailed step-by-step gluconeogenesis reactions, unrelated hormonal pathways, or citations/history) that obscures the required points. Final score cannot be below 0."}
{"query": "Explain how N6-methyladenosine (m6A) RNA modification influences stem cell fate decisions and embryonic development, and describe the functional consequence of knocking out the m6A “writer” factor METTL3 on the balance between stem cell self-renewal and differentiation.", "response": "Rubric (Total Score: 1.0 point; Min: 0 points):  \n- (0.5 points) Stem cells & fate decisions: Correctly states that m6A regulates expression of key genes to control the balance between stem cell self-renewal and differentiation, including its role in directed differentiation/fate determination toward specific lineages.  \n- (0.5 points) METTL3 knockout consequence: Correctly states that loss of METTL3 (an m6A modification factor) disrupts the proliferation/differentiation balance (imbalance), leading to impaired stem cell function.  \n\nDeductions (max 0.25 points):  \n- Deduct 0.05–0.25 points for excessive irrelevant content beyond what is needed to answer (e.g., unrelated mechanisms, diseases, or detailed molecular pathways not asked for), proportional to severity. Final score cannot go below 0."}
{"query": "Evaluate the traditional view of ducks and geese in Newcastle disease virus (NDV) ecology versus the evidence of their disease susceptibility, citing (i) relative susceptibility among major poultry species and (ii) two lines of evidence that challenge the “reservoir-only” assumption.", "response": "Rubric (Total Score: 1.0 point; minimum 0):  \n- **0.4 points:** Correctly states relative susceptibility in poultry: **chickens and turkeys are most susceptible; ducks and geese are least susceptible**.  \n- **0.6 points:** Provides **two** distinct evidence-based points that contradict a “reservoir-only” role (0.3 each):  \n  - **0.3:** Notes **frequent goose outbreaks in China since 1997** with major economic losses.  \n  - **0.3:** Notes **NDV isolates from ducks (including clinically healthy ducks) with some pathogenic for ducks and/or increasing natural ND cases in ducks**, supporting that ducks can be susceptible, not only carriers.  \n\nDeductions (max 0.25 points):  \n- Deduct **0.05–0.25** for excessive irrelevant content (e.g., unrelated NDV molecular biology, vaccine protocols, or non-avian hosts) that obscures the required points. Final score cannot go below 0."}
{"query": "Explain how skeletal muscle growth mechanisms differ between prenatal/very early postnatal development and later postnatal development in vertebrates, and describe the specific cellular role of satellite cells in postnatal skeletal muscle growth.", "response": "Rubric (Total Score: 1.0 point; Minimum: 0 points)  \n- **0.5 points:** Correctly states that **prenatal and very early postnatal** skeletal muscle growth occurs mainly by **increasing the number of muscle fibers (hyperplasia)**.  \n- **0.5 points:** Correctly states that **later postnatal** skeletal muscle growth occurs mainly by **muscle fiber enlargement (hypertrophy)** and includes the role of **satellite cells proliferating and contributing new myonuclei that are incorporated into existing myofibers**.\n\nDeductions (max 0.25 points):  \n- Deduct **0.05–0.25** for substantial irrelevant or extraneous content that is not asked for (e.g., extended discussion of duck breeds, economic benefits, or general tissue functions) that obscures the core mechanisms.  \n- Final score cannot be below **0**."}
{"query": "Explain how TBK1 activates both the NF-κB pathway and the type I interferon response, and identify the key upstream adaptor proteins and TBK1 domains required for these downstream phosphorylation events.", "response": "Rubric (Total = 1.0 point; Minimum = 0 points):\n\n- NF-κB activation mechanism (0.30 points)  \n  - 0.15: States that TBK1 directly phosphorylates IKKβ.  \n  - 0.15: States that this leads to IκB degradation, enabling NF-κB activation.\n\n- Type I IFN/IRF3 activation mechanism (0.30 points)  \n  - 0.15: States that TBK1 phosphorylates IRF3, leading to IRF3 nuclear translocation.  \n  - 0.15: States that this induces type I interferon (IFN) expression/production.\n\n- Upstream adaptor proteins (0.20 points)  \n  - 0.20: Correctly identifies TRAF3 and TANK as adaptor proteins assembling with TBK1 (TRAF3 and TANK both required for full credit).\n\n- Required TBK1 domains (0.20 points)  \n  - 0.10: Identifies the kinase domain (KD) as essential for phosphorylation of downstream targets.  \n  - 0.10: Identifies the ubiquitin-like domain (ULD) as also essential (both KD and ULD required for full credit).\n\nDeductions for excessive extraneous content (maximum deduction: 0.25 points):  \n- Deduct 0.05–0.25 if the response adds substantial unrelated material (e.g., detailed TBK1 roles beyond NF-κB/IRF3/type I IFN, unrelated pathway components, or extensive speculation).  \n- Final score cannot be below 0."}
{"query": "A Pekin duck has tetrachromatic vision with cone cell peak absorptions at 415 nm, 455 nm, 508 nm, and 571 nm, and its cones contain oil droplets that filter incoming light. Explain how having four cone types (rather than three) and oil droplet filtering together improve the duck’s ability to discriminate colors compared with a typical human visual system, and identify the four peak absorption wavelengths.", "response": "Rubric (Total Score: 1.0 Point; Minimum: 0.0 Points)\n\n- 0.5 points: Correctly identifies all four cone peak absorption wavelengths as 415 nm, 455 nm, 508 nm, and 571 nm.  \n  - If any wavelength is missing or incorrect: 0 points for this scoring point.\n\n- 0.5 points: Correctly explains both required mechanisms of improved color discrimination:  \n  - (i) Tetrachromacy: four distinct cone types provide an additional spectral channel compared with trichromacy, expanding color discrimination beyond typical humans.  \n  - (ii) Oil droplets: filter incident light before it reaches pigments, reducing spectral overlap among cones and thereby enhancing color discrimination in the brain.  \n  - If only one mechanism is explained, or if explanations are incorrect/vague: 0 points for this scoring point.\n\nDeductions (Max 0.25 points):  \n- Deduct 0.05–0.25 points for excessive irrelevant content that distracts from the two required explanations and the four wavelengths (e.g., long discussion of non-visual bird anatomy, lighting technology, or unrelated behavioral claims).  \n- Total score after deductions cannot be below 0.0."}
{"query": "Explain why ducks are considered the principal natural reservoir for influenza A viruses (IAVs), identify the two HA/NA subtype combinations not found in ducks, and describe how the typical disease impact of high-pathogenic H5 IAVs differs between ducks and other hosts such as chickens and humans. Additionally, name at least two non-MHC immune elements that have been studied to help explain ducks’ relative resistance to IAV infection.", "response": "Rubric (Total Score: 1.0 point; minimum 0 points):  \n- Reservoir status and subtype breadth (0.30): States that ducks harbor all HA and NA subtypes of IAVs (i.e., broad subtype diversity) and are the principal natural reservoir.  \n- Exceptions (0.20): Correctly identifies both missing subtype combinations: H17N10 and H18N11.  \n- Differential disease impact (0.30): Correctly contrasts that many IAVs including high-pathogenic H5 cause little harm in ducks but can cause respiratory and systemic disease in other hosts (e.g., chickens and humans).  \n- Non-MHC immune elements (0.20): Names at least two correct examples from: β-defensins, type I interferon, RIG-I, pro-inflammatory cytokines.\n\nDeductions (max 0.25):  \n- Deduct 0.05–0.25 for excessive irrelevant content that goes well beyond what is asked (severity-based), such as extended discussion of unrelated influenza evolution, detailed molecular pathways not requested, or host species not referenced in the question. Final score cannot be below 0."}
{"query": "Describe the chemokine RANTES in terms of (i) its chemokine subgroup classification, (ii) approximate molecular mass, (iii) at least four distinct mammalian cell types that produce it, (iv) the major leukocyte populations it recruits via chemotaxis, and (v) two mechanistically different ways it can inhibit viral infection, including an example virus for each mechanism.", "response": "Rubric (Total = 1.0 point; Min = 0 points):  \n- **Chemokine classification (0.15 pts):** States that RANTES belongs to the **CC** chemokine group/subfamily.  \n- **Molecular mass (0.10 pts):** Gives an approximate size of **~8 kDa**.  \n- **Producing cell types (0.25 pts):** Correctly lists **at least four** of the following producers: **lymphocytes, macrophages, fibroblasts, platelets, smooth muscle cells, endothelial cells, epithelial cells**. (0.25 if ≥4 correct; 0.15 if 3 correct; 0.05 if 1–2 correct; 0 if none correct.)  \n- **Chemotactic target cells (0.25 pts):** Identifies the main recruited cells as **T-cells, eosinophils, mononuclear phagocytes, basophils, mast cells**. (0.25 if ≥4 of these are correct; 0.15 if 3; 0.05 if 1–2; 0 if none.)  \n- **Antiviral mechanisms with examples (0.25 pts):** Provides **both** mechanisms and matches each to an example:  \n  - **Receptor agonism** mechanism with example **HIV** (0.125 pts)  \n  - **Direct binding to viral envelope glycoproteins** with example **human herpesvirus** (0.125 pts)  \n  (If only one mechanism+correct example is given: 0.125 pts; if mechanisms/examples are mismatched: 0 pts for that portion.)\n\nDeductions (max 0.25 pts):  \n- Deduct **0.05–0.25** for substantial irrelevant or extraneous material that obscures the required items (severity-based). Final score cannot go below **0**."}
{"query": "STING (also called TMEM173/MPYS/MITA/ERIS) acts as a scaffold in the type I interferon signaling pathway during RNA virus infection. Describe (i) STING’s subcellular localization and membrane topology, (ii) the experimental effects of STING overexpression versus STING knockdown on IRF3 activation and viral replication, and (iii) STING’s functional position relative to RIG-I/MAVS and TBK1/IRF3, including which RNA sensor it can bind and which related sensor it cannot.", "response": "Rubric (Total Score: 1.0 point; minimum 0):  \n\n- **Localization & topology (0.25 points)**  \n  - 0.15: States STING is an ER-associated membrane protein (endoplasmic reticulum as primary location).  \n  - 0.10: States STING has **4 or 5 transmembrane regions** and is **partly in mitochondria and/or mitochondria-associated membranes (MAMs)**.\n\n- **Overexpression vs knockdown effects (0.30 points)**  \n  - 0.15: Overexpression **activates IRF3** and **suppresses viral replication**.  \n  - 0.15: Reduced expression/knockdown (e.g., RNAi) **inhibits IRF3 activation** and **increases viral replication**.\n\n- **Pathway position and binding specificity (0.45 points)**  \n  - 0.20: Correctly places STING **downstream of RIG-I and MAVS** and **upstream of TBK1** (scaffold for MAVS/TBK1/IRF3 complex during RNA virus infection).  \n  - 0.15: States STING can bind **RIG-I** (and may also mention binding MAVS, TBK1, IKKε).  \n  - 0.10: Explicitly states STING binds **RIG-I rather than MDA5** (i.e., does **not** bind MDA5).\n\n- **Deductions for excess content (max −0.25 points)**  \n  - Deduct **0.05–0.25** if the response includes substantial irrelevant material (e.g., extended discussion of unrelated interferon pathways, unrelated diseases, or detailed mechanisms not asked) that obscures the required points.  \n  - Total score cannot drop below **0**."}
{"query": "Describe the sequence of molecular events in interferon-triggered JAK–STAT signaling from interferon binding at the cell surface to activation of interferon-stimulated gene transcription, including the roles of receptor conformational change/complex formation, JAK transphosphorylation, STAT SH2-domain docking, STAT dimerization, nuclear translocation, and DNA element recognition.", "response": "Rubric (Total = 1.0 point; Minimum = 0 points):  \n- 1.0 point: The answer correctly and coherently includes all of the following required elements:  \n  1) IFN binds its cell-surface receptor and induces receptor conformational change and dimerization/oligomerization.  \n  2) Receptor complex formation brings JAKs together, enabling JAK apposition and transphosphorylation on tyrosines (activation).  \n  3) Activated JAKs phosphorylate tyrosines on the receptor cytoplasmic domains, creating docking sites.  \n  4) STATs bind these phosphotyrosines via their SH2 domains and are then phosphorylated by JAKs.  \n  5) Phosphorylated STATs dissociate, form homo- or heterodimers, translocate to the nucleus, and (with other nuclear proteins) bind ISRE and/or GAS elements to drive ISG transcription.  \n  6) Excessive irrelevant content that substantially obscures the pathway (e.g., long digressions into unrelated cytokine systems or disease examples) triggers a deduction of 0.05–0.25 points depending on severity (final score not below 0).  \n\n- 0.0 points: The answer is missing one or more required elements above, or contains major mechanistic errors (e.g., STATs phosphorylate JAKs; STATs bind DNA in the cytoplasm; ISRE/GAS not involved), or is largely irrelevant."}
{"query": "Explain how influenza A virus (IAV) hemagglutinin (HA) binding preferences for sialic acid linkages help determine (i) the primary replication site in humans, (ii) the primary receptor distribution and tissue tropism in birds, and (iii) why chickens may facilitate the emergence of avian IAV strains with increased capacity to infect humans; also name one non–sialic-acid receptor class IAV can use for cell entry.", "response": "Rubric (Total = 1.0 point; Minimum = 0.0 points):\n\n- Humans—receptor and replication site (0.25 points)  \n  - 0.25: States that human-adapted IAV preferentially binds SA α-2,6-Gal, which is abundant on upper-airway epithelial cells, leading to replication primarily in the upper airways.  \n  - 0.0: Incorrect/missing linkage and/or replication site.\n\n- Birds—receptor distribution and tissue tropism (0.25 points)  \n  - 0.25: States that birds predominantly express SA α-2,3-Gal (notably in digestive tracts and lungs) and avian-adapted IAV preferentially binds SA α-2,3-Gal, shaping avian tissue tropism.  \n  - 0.0: Incorrect/missing linkage and/or tissues, or incorrect implication about avian preference.\n\n- Chickens as a “bridge” host—mechanistic justification (0.30 points)  \n  - 0.30: Explains that chickens express substantial SA α-2,6-Gal in relevant sites (e.g., intestinal tract/lungs and trachea), unlike ducks (α-2,3 dominance in trachea; α-2,6 mainly in lungs), so chickens can support/propagate avian viruses in environments that may select for or maintain α-2,6 binding, increasing potential to infect humans.  \n  - 0.15: Mentions chickens have more α-2,6 receptors than ducks and links this to increased human infection potential, but provides limited tissue specificity or incomplete comparison.  \n  - 0.0: No correct bridge-host rationale.\n\n- Non–sialic-acid receptor class (0.20 points)  \n  - 0.20: Correctly names phosphoglycans as an additional receptor class IAV can use.  \n  - 0.0: Missing or incorrect receptor class.\n\nDeductions for excess/irrelevant content (max 0.25 points):  \n- Deduct 0.05–0.25 if the response adds substantial unrelated material (e.g., detailed influenza life cycle steps, vaccine discussion, unrelated immune pathways) that obscures the required points.  \n- Total score after deductions cannot be below 0.0."}
{"query": "A disease in Pekin ducks can reach up to 90% mortality if uncontrolled and may be caused by five distinct viral agents spanning two virus families. Identify all five causative agents by name/genotype, and for each agent specify its genus and family; additionally, state which agent has been most prevalent in the Asian duck industry in recent years.", "response": "Rubric (Total = 1.0 point; Minimum = 0 points):  \n- **0.50 points (Correctly naming all five agents):**  \n  - 0.10 each for correctly listing: **DHAV-1**, **DHAV-2**, **DHAV-3**, **DHV-2**, **DHV-3**.  \n- **0.30 points (Correct genus + family assignments):**  \n  - 0.05 each for correctly assigning **DHAV-1/2/3 → genus Avihepatovirus, family Picornaviridae** (credit requires both genus and family).  \n  - 0.075 each for correctly assigning **DHV-2 → genus Avastrovirus, family Astroviridae** and **DHV-3 → genus Avastrovirus, family Astroviridae** (credit requires both genus and family).  \n- **0.20 points (Prevalence in Asia):**  \n  - 0.20 for stating **DVH-3 (i.e., DHAV-3)** has been most prevalent in the Asian duck industry in recent years.  \n\nDeductions (max 0.25 points):  \n- Deduct **0.05–0.25** for substantial irrelevant additions (e.g., lengthy discussion of symptoms, control measures, or unrelated virology) that obscure or replace the required identifications/classifications.  \n- Final score floor: **0 points**."}
{"query": "How is the Parvoviridae family taxonomically organized in terms of subfamilies and the eight genera within Parvovirinae, and which Parvovirinae genus is distinguished by the broadest host range (including examples of the host types it infects) compared with the host restriction pattern of the other genera?", "response": "Rubric (Total = 1.0 point; Min = 0.0 points):  \n- **0.45 points**: Correctly states the two Parvoviridae subfamilies and their host domains: **Parvovirinae infect vertebrates** and **Densovirinae infect invertebrates**.  \n- **0.35 points**: Correctly lists all **eight Parvovirinae genera**: **Protoparvovirus, Amdoparvovirus, Anevapovirus, Bocaparvovirus, Copiparvovirus, Erythroparvovirus, Dependoparvovirus, Tetraparvovirus**. (All must be present for full credit for this component.)  \n- **0.20 points**: Correctly identifies **Dependoparvovirus** as having the **widest host spectrum**, and gives accurate examples of host types it infects (e.g., **birds, reptiles such as snakes, and mammals including humans/primates**).  \n\nDeductions (max 0.25 points):  \n- Deduct **0.05–0.25 points** for excessive irrelevant material beyond what is needed to answer (e.g., detailed discussion of numbers of genera/species not asked for, unrelated virology/clinical details). Deduction severity depends on how much the extra content obscures the required facts. Final score cannot go below **0.0**."}
{"query": "DTMUV is a positive-sense single-stranded RNA virus that can cause encephalitis in birds. Describe its taxonomic classification, identify key epidemiological features of its emergence and spread (including year and countries), and explain the principal neuropathological findings in the CNS and the specific neuronal cell type shown to contain viral antigen.", "response": "Rubric (Total Score: 1.0 point; Minimum: 0.0 points):\n\n- **Taxonomy (0.25 points):**  \n  - 0.25: Correctly states DTMUV is a **positive-sense ssRNA virus** in **genus Flavivirus**, **family Flaviviridae**.  \n  - 0.0: Missing/incorrect taxonomy and/or genome sense/type.\n\n- **Emergence and spread (0.25 points):**  \n  - 0.25: States **first isolated in China in 2010** and notes spread to other intensive duck-farming countries including **Malaysia** and **Thailand**.  \n  - 0.0: Missing year/origin or missing/incorrect spread countries.\n\n- **CNS pathology (0.25 points):**  \n  - 0.25: Identifies **non-suppurative inflammation** with **perivascular mononuclear cell infiltration** and **focal gliosis** as key CNS lesions.  \n  - 0.0: CNS pathology missing or incorrect.\n\n- **Cellular/neuronal targeting evidence (0.25 points):**  \n  - 0.25: Specifies antigen detected in the **cytoplasm of cerebellar Purkinje cells** (and/or that neurons are primary targets with high viral RNA in brain).  \n  - 0.0: Incorrect or missing specific neuronal cell type/evidence.\n\n**Deductions for excessive irrelevant content (max −0.25 points):**  \nDeduct **0.05–0.25** if the response adds substantial off-topic material (e.g., lengthy discussion of unrelated flaviviruses, detailed clinical signs/egg production impacts not asked for, or speculation about mechanisms), proportional to severity. Final score cannot be below 0.0."}
{"query": "Explain what long non-coding RNAs (lncRNAs) are (including their defining length and coding capacity), describe at least three distinct molecular mechanisms by which they regulate gene expression, and distinguish between cis-acting and trans-acting lncRNA functions with respect to genomic location and regulatory reach.", "response": "Rubric (Total Score: 1.0 point; Min: 0 points):\n\n- Definition of lncRNAs (0.25 points)  \n  - 0.125: States that lncRNAs are >200 nucleotides in length.  \n  - 0.125: States that they lack protein-coding capacity (non-coding / previously considered “pseudo-transcriptions”).\n\n- Regulatory mechanisms (0.50 points)  \n  Award 0.166 points each (max 0.50) for correctly describing any three of the following mechanisms:  \n  - Titration/sequestration of transcription factors to affect transcription.  \n  - Alteration of splicing.  \n  - Sponging/sequestering microRNAs.  \n  - Recruiting chromatin-modifying enzymes (chromatin modification-based regulation).\n\n- Cis vs trans distinction (0.25 points)  \n  - 0.125: Correctly describes cis action as regulating expression of neighboring genes (local genomic vicinity).  \n  - 0.125: Correctly describes trans action as impacting gene expression at distant loci, including across chromosomes.\n\nDeductions for excess/irrelevant content (max −0.25 points):  \n- Deduct 0.05–0.25 if the response includes substantial material not asked for (e.g., detailed viral case studies, pathway speculation, or unrelated RNA classes) that obscures the required elements. Final score cannot go below 0."}
{"query": "Describe how TLR3 detects viral double-stranded RNA and initiates innate antiviral signaling in mammals, including (i) the cellular route by which viral RNA becomes available to TLR3 during infection, (ii) the key adaptor/signaling outputs and transcription factors activated, and (iii) two specific immune deficits observed in TLR3-deficient mice after poly(A:U) stimulation.", "response": "Rubric (Total Score: 1.0 point; Minimum: 0 points)\n\n- Viral RNA availability to TLR3 (0.3 points)  \n  - 0.3: Correctly explains that phagocytes (e.g., macrophages/dendritic cells) take up virus-infected apoptotic cells and that viral RNA is released/exposed in intracellular acidic compartments such as phagosomes via lysosomal enzymes, enabling recognition by TLR3 (ectodomain).  \n  - 0.0: Does not describe this uptake + acidic compartment release route, or gives an incorrect route.\n\n- Signaling and transcriptional activation (0.4 points)  \n  - 0.4: States that TLR3 signals via adaptor proteins to activate IRF-3, IRF-7, and NF-κB, leading to production of type I interferons and proinflammatory cytokines.  \n  - 0.2: Mentions only some of the transcription factors (at least two of IRF-3/IRF-7/NF-κB) and at least one correct output (type I IFNs or proinflammatory cytokines).  \n  - 0.0: Omits the key transcription factors and/or gives incorrect outputs.\n\n- Deficits in TLR3-deficient mice (0.3 points)  \n  - 0.3: Correctly provides two deficits: impaired/absent optimization of poly(A:U)-induced clonal T-cell expansion, and prevented/reduced production of IFN-γ and/or IL-12p40 (credit requires two distinct deficits total).  \n  - 0.15: Provides only one correct deficit.  \n  - 0.0: No correct deficits.\n\nDeductions for excessive irrelevant content (max 0.25 points)  \n- Subtract 0.05–0.25 if the response includes substantial unrelated material (e.g., extensive discussion of other TLRs not asked for, detailed viral life cycles, or broad immunology unrelated to TLR3), with the deduction scaled to severity. The final score cannot go below 0."}
{"query": "Explain how follistatin (FST) can influence skeletal muscle mass by interacting with the TGF‑β signaling pathway, and predict the muscle phenotype expected from (i) FST overexpression and (ii) FST loss/absence.", "response": "Rubric (Total = 1.0 point; Minimum = 0 points):\n\n- Mechanistic link to signaling (0.4 points)  \n  - 0.4: States that FST inhibits the TGF‑β signaling pathway and connects this inhibition to regulation of muscle development/mass.  \n  - 0.2: Mentions FST inhibits TGF‑β but does not clearly link it to muscle development/mass regulation.  \n  - 0.0: Does not mention TGF‑β inhibition or gives an incorrect pathway effect.\n\n- Predicted phenotype: overexpression (0.3 points)  \n  - 0.3: Correctly predicts muscle hypertrophy with FST overexpression.  \n  - 0.0: Incorrect or missing phenotype.\n\n- Predicted phenotype: loss/absence (0.3 points)  \n  - 0.3: Correctly predicts muscle atrophy with FST loss/absence.  \n  - 0.0: Incorrect or missing phenotype.\n\nDeductions for excess/irrelevant content (max −0.25 points):  \nDeduct 0.05–0.25 if the response adds substantial off-target material (e.g., detailed reproduction roles, unrelated pathways, or long tangents not needed to answer the mechanism/phenotypes), to the extent that it obscures the requested points. Final score cannot go below 0."}
{"query": "Describe the taxonomic classification and genome type of Duck Tembusu virus (DTMUV), and explain two host innate immune sensing pathways it can activate during infection.", "response": "Rubric (Total Score: 1.0 point; Minimum: 0 points)\n\n- Taxonomy (0.4 points)  \n  - 0.2: Identifies DTMUV as belonging to the genus *Flavivirus*.  \n  - 0.2: Identifies DTMUV as belonging to the family *Flaviviridae*.  \n\n- Genome type (0.2 points)  \n  - 0.2: States that DTMUV has a single-stranded, positive-sense RNA genome.  \n\n- Innate immune sensing pathways (0.4 points)  \n  - 0.2: Names Melanoma differentiation-associated protein 5 (MDA5) signaling as a pathway involved.  \n  - 0.2: Names Toll-like receptor 3 (TLR3) signaling as a pathway involved.  \n\nDeductions (maximum 0.25 points)  \n- Deduct 0.1–0.25 points for excessive irrelevant content that goes beyond what is needed to answer (e.g., extended discussion of unrelated detection methods, detailed lab techniques like iTRAQ steps, or broad epidemiology not asked for).  \n- Final score floor: 0 points."}
{"query": "Describe the sequential molecular events in type I interferon–induced JAK/STAT signaling that lead from interferon receptor engagement to interferon-stimulated gene (ISG) transcription, naming the key phosphorylated proteins, the complex formed, and the DNA element targeted in the nucleus.", "response": "Rubric (Total = 1.0 point; Min = 0 points):  \n- 0.25 pts: States that type I IFN binding causes IFN receptor oligomerization and activates/phosphorylates JAK kinases.  \n- 0.25 pts: States that activated JAKs phosphorylate tyrosine residues on the IFN receptor intracellular domains, creating docking sites for STATs, and that STAT1 and STAT2 are phosphorylated.  \n- 0.25 pts: States that phosphorylated STAT1/STAT2 dimerize and associate with IRF9 to form the ISGF3 complex.  \n- 0.25 pts: States that ISGF3 translocates to the nucleus and binds ISREs (interferon-stimulated response/regulatory elements) in ISG promoters to drive transcription of ISGs.  \n\nDeductions (max 0.25 pts):  \n- Deduct 0.05–0.25 pts for excessive irrelevant content (e.g., lengthy discussion of PRRs/PAMPs or antiviral effects unrelated to the asked receptor→nucleus signaling sequence), proportional to severity.  \n- Final score cannot be below 0."}
{"query": "Explain two mechanistically distinct routes by which DNA-virus-derived nucleic acids can lead to type I interferon (IFN-β) induction: one that results in activation of the RIG-I/MAVS pathway and one that proceeds via the cGAS–STING axis. For each route, name the key sensor(s), the critical nucleic-acid intermediate (if any), and the downstream signaling components that culminate in transcription factor activation.", "response": "Rubric (Total = 1.0 point; minimum = 0):  \n- **RIG-I/MAVS route (0.5 points total)**  \n  - **0.2**: Correctly identifies **RNA polymerase III** sensing **AT-rich dsDNA** as the initiating event.  \n  - **0.2**: Correctly states the intermediate is **dsRNA bearing a 5′-triphosphate (5′-ppp)** that activates **RIG-I → MAVS**.  \n  - **0.1**: Correctly links this pathway to **IFN-β induction** (e.g., “induces IFN-β production” is sufficient).  \n\n- **cGAS–STING route (0.5 points total)**  \n  - **0.2**: Correctly identifies **cGAS** as the DNA sensor and **STING** as the adaptor.  \n  - **0.2**: Correctly states **STING translocates from ER to Golgi** and activates **TBK1**, leading to **IRF3** activation (TBK1→IRF3 must be clear).  \n  - **0.1**: Correctly includes activation of **NF-κB** and/or notes resulting **type I IFN and inflammatory cytokine** induction.  \n\n- **Deductions for excess/irrelevant content (max −0.25 points)**  \n  - Deduct **0.05–0.25** if the response adds substantial off-target material (e.g., long descriptions of unrelated PRR families or detailed JAK/STAT signaling steps not asked for) that obscures the required mechanisms.  \n  - Total score cannot go below **0**."}
{"query": "Explain the two main biomechanical conflicts faced by birds that dive and swim underwater, and describe the primary anatomical/physical features that create each conflict as well as the typical locomotor strategy most waterfowl use to avoid the second conflict.", "response": "Rubric (Total = 1.0 point; Min = 0.0 points):\n\n- (0.5 points) Conflict 1 (buoyancy):  \n  - 0.5 if the answer identifies that low body density causes high buoyancy that resists/substantially hinders diving (pushes the bird upward), and correctly ties this to key features such as hollow bones and/or large air sacs and/or trapped air under waterproof plumage.  \n  - 0.25 if buoyancy is identified but the causal features are missing or incorrect.  \n  - 0.0 if buoyancy resistance is not identified.\n\n- (0.3 points) Conflict 2 (wing use in two fluids):  \n  - 0.3 if the answer explains that wings used for propulsion in both air and water face a mismatch because water is much denser/more viscous than air, making large wings inefficient underwater and small wings inefficient for flight (i.e., a trade-off/compromise reducing efficiency).  \n  - 0.15 if it mentions a general trade-off without clearly stating why (air vs water physical differences) or the large-vs-small wing consequence.  \n  - 0.0 if this conflict is not identified.\n\n- (0.2 points) Typical strategy to avoid conflict 2:  \n  - 0.2 if the answer states that most waterfowl keep wings primarily adapted for flight and swim underwater using webbed feet while keeping wings folded close to the body.  \n  - 0.1 if it mentions foot propulsion but omits wings being folded/kept for flight.  \n  - 0.0 if the avoidance strategy is incorrect or missing.\n\nDeductions for excess/irrelevant content (max 0.25 points):  \n- Deduct 0.05–0.25 if the response includes substantial unrelated material (e.g., species lists, unrelated ecology, or detailed mechanics not asked for) that obscures the required points. Final score cannot go below 0.0."}
{"query": "Explain how USP18 is functionally positioned within the ubiquitin-specific protease (UBP) family by describing (i) the shared catalytic features of UBP enzymes, (ii) how USP18 is induced by type I interferon signaling, and (iii) two distinct roles USP18 plays in interferon/ISG15-related regulation, including whether each role depends on its ISG15 isopeptidase activity.", "response": "Rubric (Total = 1.0 point; Minimum = 0.0 points):\n\n- Catalytic features shared by UBP enzymes (0.25 points)  \n  - 0.25: States that UBP family members are deubiquitinating enzymes and that catalytic activity requires conserved consensus sequences involving cysteine (Cys domain) and histidine (His domain) residues.  \n  - 0: Missing/incorrect description of the conserved catalytic Cys/His features and/or deubiquitinating function.\n\n- Interferon induction mechanism for USP18 (0.25 points)  \n  - 0.25: Identifies USP18 as a type I interferon-responsive gene rapidly upregulated by IFN-β via the JAK/STAT pathway.  \n  - 0: Does not mention IFN-β and JAK/STAT (or gives an incorrect induction pathway).\n\n- Two distinct roles of USP18 and activity dependence (0.50 points)  \n  - 0.25: Role 1—Correctly states USP18 cleaves/removes ISG15 conjugates (deISGylation) to maintain homeostasis of ISG15-conjugated proteins (this role depends on its ISG15 isopeptidase activity).  \n  - 0.25: Role 2—Correctly states USP18 negatively regulates type I IFN signaling in a manner independent of its ISG15 isopeptidase activity.  \n  - 0: One or both roles missing/incorrect, or dependence/independence reversed.\n\nDeductions (max 0.25 points):  \n- Deduct 0.05–0.25 for excessive irrelevant material that goes beyond the requested points (e.g., unrelated disease mechanisms, detailed descriptions of other deubiquitinases, extensive pathway components not required). Final score cannot go below 0.0."}